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ABSTRACT 
 
 
SHITAL KAMBLE. Effect of providers‟ procedural volume complexity on in-hospital 
complications and length of stay for gastric bypass surgery. (Under the direction of 
DR. JAMES STUDNICKI) 
 
 
Obesity and morbid obesity represent one of the major public health problems in 
the United States (U.S.) that affects nearly one-third of the adult American population. 
Gastric bypass (GB) is a complex operation, performed in a high-risk morbidly obese 
population, requiring well-trained surgeons and well-equipped hospital facilities to ensure 
optimal surgical outcomes. The volume-outcomes relationship is well-established for 
providers (both surgeons and hospitals) performing GB procedures. However, the 
findings of improved outcomes after GB for high volume providers have been attributed 
only to the high volume of GB and not the volume of other non-gastric bypass (non-GB) 
procedures. The studies in this dissertation were undertaken to examine the effect of 
provider‟s (general surgeon and hospital) non-GB complex (non-GBC) and non-complex 
(non-GBNC) volume on in-hospital complications and length of stay (LOS) for patients 
undergoing GB.  
The population-based studies used a combination of various existing retrospective 
data to address the research objectives. The datasets used include: a two-year (2003-
2004) Florida hospital inpatient discharge data as the main analytic dataset, the 2003-
2005 work Relative Value Units (RVU) data (available from the Physician Fee Schedule 
from the Centers of Medicare and Medicaid, to segment the provider‟s non-GB case load 
into non-GBC and non-GBNC procedures performed by a provider per year), 2005 Florida 
hospital characteristics file, 2005 Florida surgeon characteristics file, and 2004 Area 
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Resource File data. Separate generalized estimating equation (GEE) regression models, 
adjusting standard errors for the non-nested surgeon and hospital cluster effect, were 
constructed for each outcome: composite complications (one or more complications), 
technical complications (including unexpected reoperations, splenic injury, hemorrhage, 
anastomotic leaks, small bowel obstructions, and wound), systemic complications 
(including pulmonary, cardiac, thromboembolic, genitourinary tract, and postoperative 
shock), and LOS. Covariates included were patient characteristics, year, surgeon GB 
volume, and hospital characteristics. 
In adjusted analyses, the gastric bypass patients operated by general surgeons with 
high non-GBNC volume (>142 procedures/year) had 70% and 88% higher likelihood of 
composite and systemic complications, respectively. In contrast, those operated at 
hospitals with high non-GBNC volume (>6,478 procedures/year) had 49% and 40% lower 
likelihood of composite and technical complications, respectively. There was no clear 
association between providers‟ high non-GBC volume and adverse outcomes. 
Furthermore, patients operated by general surgeons with high GB volume (>50 GBs/year) 
had 27% and 41% lower likelihood of composite and systemic complications, 
respectively. However, those operated at hospital‟s with high GB volume (>125 
GBs/year) had 30% lower likelihood of technical complications. The study findings 
suggest that while provider GB volume matters for in-hospital complications, the 
complexity of overall surgical load also matters for general surgeons but the overall scale 
matters for hospitals to deliver better in-hospital outcomes for GB. In particular, the 
outcomes may improve if GB patients avoided general surgeons with a high volume of 
non-complex procedures and if GB patients avoided hospitals with low total volume. 
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CHAPTER 1: BACKGROUND AND LITERATURE REVIEW 
 
 
Introduction 
There is more than three decade of literature focusing on the volume-outcome 
relationship, i.e., providers performing more surgical procedures of a particular type have 
better outcomes for that procedure. Most of the research work is focused on the volume 
of a high-risk complex procedure, including gastric bypass, and the improved outcomes 
are attributed only to the volume of that “specific” procedure. There are a few studies 
examining the association of hospital volume of different complex procedures (non-
specific volume) and outcomes for a certain high-risk complex procedure. For example, 
the studies only focused on the effect of hospital volume for pancreatic resection on 
outcomes for colorectal resection. Procedures for studying hospital non-specific volume-
outcome relationship included colorectal resection, pancreatic resection, lung resection, 
esophagectomy, coronary artery bypass graft, percutaneous coronary intervention, and 
abdominal aortic aneurysm repair. However, none of these studies included provider non-
complex procedure volume and none have studied gastric bypass.  
  Gastric bypass is one of the target procedures for volume-based regionalization and 
is typically done by general surgeons at hospitals performing several other non-gastric 
bypass procedures. The population-based studies in this dissertation demonstrate the 
effect of providers‟ (surgeons and hospitals) non-specific (i.e., non-gastric bypass) 
volume on in-hospital complications and total length of stay for gastric bypass patients. 
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The studies in this dissertation use work Relative Value Units component as a proxy for 
procedural complexity, from the Centers for Medicare and Medicaid Physician Fee 
Schedule, to segment providers‟ total surgical practice into complex and non-complex 
procedures. This allows studying the effect of providers‟ non-gastric bypass (both 
complex and non-complex procedural volume) on adverse in-hospital outcomes for 
gastric bypass patients. 
Obesity and Morbid Obesity in the United States 
  Obesity  and morbid obesity represent one of the major public health problems in 
the United States (U.S.) that affects nearly one-third of the adult American population 
(approximately 60 million obese and 9 million morbidly obese).
1
 One of the most 
common and biologically relevant measurement tool to determine obesity is body mass 
index (BMI), defined as weight in kilograms (kg)/height
2
 in meters (m
2
). Obesity is 
defined as BMI ≥30 kg/m
2
 and morbid obesity (also known as extreme obesity or 
clinically severe obesity) is defined as BMI ≥40 kg/m
2
. Morbid obesity is a disease of 
excess energy stores in the form of fat.
2
 According to the National Health and 
Examination Survey (NHANES), about 32.2% of adults in the U.S. were obese and 
approximately 4.8% adults were morbidly obese during 2003-2004.
3 
The prevalence of 
morbid obesity has increased between the years 1986 and 2005.
4-6
 According to the 
Behavioral Risk Factor Surveillance System (BRFSS), the prevalence of individuals with 
a BMI ≥40 kg/m
2 
quadrupled from 1:200 in 1986 to 1:50 in 2000 and the prevalence of 
individuals with a BMI ≥50 kg/m
2 
quintupled from 1:2000 to 1:400.
4, 5
 In addition, from 
2000 to 2005, the prevalence of individuals with a BMI  ≥40 kg/m
2 
increased by 50% and 
 
 
 
 
3 
the prevalence of individuals with a BMI ≥50 kg/m
2 
increased by 75%, two and three 
times faster, respectively.
6
  
Accompanied with the increasing burden of obesity and morbid obesity, are major 
health consequences and rising economic costs. Obesity and morbid obesity are known 
risk factors for mortality,
7-14
 with approximately 112,000 excess deaths associated with 
obesity each year in the U.S.,
11
 and a number of chronic diseases including type-2 
diabetes,
14-21
 coronary heart disease (CHD)
13, 22-25
 and mortality from CHD
22
, 
hypertension,
14, 26-28
 hypertrophic cardiomyopathy,
14, 29
 hyperlipidemia,
14, 30
 stroke,
31, 32
 
sleep apnea,
33-36
 gall bladder disease,
14, 37-40
 liver disease,
41-44
 osteoarthritis,
14, 45-47
 breast 
cancer,
48, 49
 endometrial cancer,
50, 51
 colon cancer,
52-54
 hypoventilation,
14, 55
 and 
psychosocial impairments
14, 56
 including depression
14, 57, 58
 The total annual medical 
spending for overweight (defined as BMI between 25 and 29.9) or obesity is estimated to 
be $92.6 billion in 2002 dollars.
59
 Obesity solely accounted for 5.3% of medical spending 
for the adult population in the U.S.
59
 The total medical expenditures for obese adults 
ranged from $26.8 billion (estimates from 1998 Medical Expenditure Panel Survey data) 
to $47.5 billion (estimates from National Health Accounts data).
59
 The majority of 
spending for obese patients can be attributed to treatment of heart disease, 
hyperlipidemia, and diabetes.
60
  
Bariatric Surgery (Gastric Bypass) Procedures in the United States 
Bariatric Surgery as a treatment for Morbid Obesity 
Bariatric surgery has been identified as the only effective treatment associated 
with documented, substantial, and maintained weight loss as well as the amelioration of 
obesity comorbid conditions in persons with morbid obesity or for those with a BMI ≥35 
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kg/m
2
 who have a significant comorbidity, such as hypertension, diabetes, and/or sleep 
apnea.
61-68
  
In the 1950s, bariatric surgery was evolved from the jejunoileal (JI) bypass, a 
prototype of the malabsorptive (described below) obesity operations. Although the JI 
bypass was a highly effective weight-reduction operation, it was associated with several 
complications including gas-bloat syndrome, steatorrhea, electrolyte imbalance, 
nephrolithiasis, hepatic fibrosis, cutaneous eruptions, and impaired mentation.
69-71
 More 
extensive malabsorptive variations were developed that consisted of gastric bypasses with 
a long Roux limb. The first gastric bypass (GBP) was developed by Mason and Ito
71, 72
 in 
1966, where the stomach was divided horizontally and a loop gastrojejunostomy was 
created between the proximal gastric pouch and the proximal jejunum. Due to bile reflux 
problems associated with loop, Mason and Printen
71, 73
 later reduced the pouch size to 
≤50 ml to increase weight loss, and reduced ulcer formation by including the acid-
secreting mucosa in the distal stomach. There were several variations and advances in the 
gastric bypass procedures over time
71, 74-81
 and the varied types of bariatric procedures are 
described below. 
Depending on the mechanism by which weight loss is promoted, bariatric 
procedures are divided into the following groups: (1) restrictive, (2) a combination of 
restrictive and malabsorptive, or (3) malabsorbtive.
82
 Restrictive surgical procedures 
decrease the capacity of the stomach, thereby limiting the volume of food consumed 
before the feeling of satiety occurs. Gastroplasty, including vertical banded gastroplasty 
(VBG) and silastic ring vertical gastroplasty (SRVG) and gastric banding procedures 
such as adjustable silicone gastric banding (ASGB) are examples of restrictive 
 
 
 
 
5 
procedures. Combination surgical procedures are those that bypass part of the digestive 
tract, usually with a decrease in stomach capacity. Such procedures combine 
malabsorption and diminished stomach capacity as mechanisms for weight reduction. 
Roux-en-Y gastric bypass (RYGBP) and distal (extended) Roux-en-Y gastric bypass 
(RYGBP-E) are examples of combination procedures. Malabsorptive procedures are 
those that reduce nutrient absorption, typically by bypassing a part of the small intestine. 
Some of the examples of malabsorptive procedures are duodenal switch, biliopancreatic 
diversion, and isolated intestinal bypass procedures.
4, 82
  
Current research shows that there are potential long-term health benefits to 
bariatric surgery including gastric bypass. A recent systematic review and meta-analysis 
of the literature found that the percentage of excess weight loss was 47.5% under gastric 
banding, 61.6% under gastric bypass, 68.2% under gastroplasty, and 70.1% under 
biliopancreatic diversion or duodenal switch bypass. Additionally, diabetes was 
completely resolved in 76.8% of the patients while hyperlipidemia and hypertension were 
improved in 70% and 61.7% of the bariatric surgery patients, respectively.
83
 
Trends in Bariatric Surgeries (including Gastric Bypass) in the United States 
The American Society for Bariatric Surgery estimated approximately 140,000 
gastric bypass procedures were performed in the U.S. in 2005.
84
 Although there is 
increasing prevalence of morbid obesity and growth of bariatric surgeries in the past few 
years in the U.S.
4 
the surgeries are performed in less than 1% of the eligible individuals.
85
 
Santry et al. used the Nationwide Inpatient Sample (NIS) of the Healthcare Cost and 
Utilization Project (HCUP) to identify U.S. bariatric surgery admissions from 1998 to 
2002.
4
 The researchers found that the estimated number of bariatric surgical procedures 
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increased from 13,365 in 1998 to 72,177 in 2002. The authors projected approximately 
102,794 bariatric surgical procedures in 2003. Gastric bypass procedures accounted for 
more than 80% of all bariatric surgical procedures.
4
 Another study using NIS
 
data from 
1998
 
to 2002 reported that although the estimated
 
number of bariatric surgeries grew 
400% between
 
1998 and 2002 and the overall bariatric surgery rate per 100,000 covered 
lives increased from 26.8 to 43.7 between 2001 and 2005,
83
 such surgeries were 
performed on 0.6%
 
of the 11.5 million adults clinically eligible (i.e., BMI ≥40 or BMI≥35 
with obesity related most common comorbidity such as diabetes mellitus) in 2002.
85  
Despite the apparent long-term benefits, gastric bypass procedures are high-risk 
surgeries with low mortality but considerable postoperative morbidity. Santry et al. used 
1998-2002 data from NIS and indicated that the adjusted in-hospital death rate for 
bariatric surgery, particularly gastric bypass, ranged from 0.1% to 0.2%. Some of the 
postoperative early complications associated with gastric bypass include anastomotic 
leak, pulmonary embolism, wound infection, gastrointestinal hemorrhage, cardiac 
complications, unexpected reoperations, and pulmonary complications.
4, 84
 For example, 
the rates of unexpected reoperations for surgical complications ranged from 6% to 9% 
and pulmonary complications ranged from 4% to 7% in 1998 to 2002.
4
 Encinosa et al. 
found an  initial surgical complication rate for gastric bypass surgery in 2001-2002 of 
23.8%.
86
 In addition, gastric bypass is a high cost procedure. Results from 1998-2002 
NIS data indicated that the national hospital costs for bariatric surgeries escalated more 
than six-fold, from an estimated $157 million in 1998 to $948 million in 2002 in the 
U.S.
85
 Finally, gastric bypass procedures (1) require proficiency with the use of complex 
equipment, (2) are associated with an increased risk of clinically significant 
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complications, including death, and (3) are potential targets for volume-based 
regionalization, whereby patients who need a high risk procedure travel to hospitals that 
do a high volume (i.e., the number of surgeries that a particular hospital performs) of that 
procedure.
87, 88  
Provider Volume-Outcomes Relationship 
Policymakers, patients, insurers, and corporate purchasers consider provider 
volume (hospital and/or surgeon) as a proxy for quality. Over the past three decades, 
many studies have demonstrated an inverse relationship between provider (hospital 
and/or surgeon) volume and postoperative mortality and morbidity rates for a variety of 
complex
 
surgical procedures and medical conditions.
89-106 
Two systematic
 
reviews have 
evaluated the methodology and results
 
of many of these studies across a broad range of 
conditions.
107, 108  
In 2000, Dudley et al.
107
 found that, among 128 studies examining
 
40 
different procedures or conditions, approximately 79% reported a statistically
 
significant 
relationship between higher hospital case volume
 
and lower mortality outcomes; none of 
the published studies
 
reported an association between higher volume and worse 
outcomes.
 
In 2002, Halm et al
108
 examined 135 studies for 27 procedures
 
or conditions, 
many of which were also included in the previous review. This study subsequently served 
as a focus of the Institute of Medicine‟s (IOM) sponsored workshop examining the 
volume-outcome
 
relationship in the context of healthcare quality.
108, 109 
The authors
 
concluded that 77% of the studies examining either hospital
 
or physician case volume 
noted a statistically significant relationship
 
between higher volume and better health 
outcomes; however, none
 
of the reports found the opposite to be true.  
 
 
 
 
8 
In addition, previous studies have demonstrated that there is an effect of surgeon 
years of surgical experience and board certification on procedural outcomes.
110
 The 
improved outcomes could be related to the experience and skill of the operating surgeon, 
which is gained by performing more procedures (“learning-by-doing” or “practice-
makes-perfect” hypothesis) or to selectively referring patients to hospitals and surgeons 
performing more procedures.
111-113
 The idea of “practice-makes-perfect” or “learning-by-
doing” makes particular sense for complex surgical procedures, which often require 
judicious decision making and a high level of technical skill that comes with 
experience.
113, 114
 The “volume-outcomes” studies based on the “practice-makes-perfect” 
hypothesis has led the Leapfrog group, a consortium of healthcare purchasers focused on 
patient‟s quality and safety, to establish minimum volume standards for surgeons for 
specific high-risk procedures. These procedures are: pancreatic resection, elective AAA
 
repair, coronary artery by-pass graft (CABG), esophagectomy,
 
percutaneous coronary 
intervention (PCI), aortic valve replacement, and bariatric surgery (including gastric 
bypass).
114
 The standards act as a supplement to the performance criteria established at 
the hospital level. The Leapfrog group‟s recommendations rely on the use of
 
the number 
of procedures performed by a surgeon, a structural
 
characteristic, as a marker of quality. 
Although the volume-outcome relationship is more pronounced in complex 
procedures, except CABG and PCI surgeries, many high-risk procedures are done 
infrequently ( i.e., in overall low volumes).
115
 In addition, such high-risk procedures are 
performed by hospitals and surgeons with different specialties including board certified 
cardiothoracic surgeons, thoracic surgeons, vascular surgeons, general surgeons or non-
board certified surgeons. Also, total surgical practice is often composed of both high and 
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low proportions of complexity procedures. This proportion may vary depending upon the 
type of surgeon performing operations. In short, while some of these surgeon specialties 
might have a relatively homogeneous profile of operations performed, others - especially, 
general surgeons- might have a relatively heterogeneous profile of operations 
performed.
116
 
The Relationship between Provider Volume and Adverse Outcomes for Bariatric 
(including Gastric Bypass) Procedures 
 
Similar to many high-risk surgeries, provider volume has been demonstrated in 
most studies to be an important correlate of the outcomes of bariatric surgery including 
gastric bypass.
117-122
 For example, in a study by Liu et al. the risk of serious 
complications including life threatening cardiac, respiratory, or medical events was 2.5 
times greater in hospitals performing fewer than 50 gastric bypass procedures per year 
compared to hospitals that performed more than 200 gastric bypass procedures per 
year.
119
 Table 1 represents the risk of serious complications with gastric bypass 
procedures by hospital procedure volume in California from 1996 to 2000.
119
 
 
TABLE 1: Adjusted odds ratios for serious complications, by hospital volume, among 
patients undergoing a gastric bypass procedure in California, 1996-2000 
 
Hospital volume 
(cases/year) 
Hospitals, n                   
(total n=101) 
Patients, n                       
(total n=16,232) 
Adjusted Odds Ratio*              
(95% CI) 
Very low (<50) 81 2,314 2.72 (1.57 – 4.73) 
Low (50-99) 9 3,067 2.70 (1.41 – 5.20) 
Medium (100-199) 7 4,240 1.30 (0.74 – 2.29) 
High (200+), ref# 4 6,611 1.0 
*Based on hospital-level cluster corrected logistic regression models adjusted for age, gender, race, 
and comorbidities (Deyo adaptation of the Charlson Comorbidity Score). The following patient risk 
factors were pronounced in each of the models: male gender, Charlson score. #ref, reference category. 
Adapted from Liu J, et al. Characterizing the performance and outcomes of obesity surgery in 
California. The American Surgeon, 2003; 69(10):823-828. 
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Likewise, more recently, Weller and colleagues used 2003 New York inpatient 
discharge data and reported that there was a considerably higher likelihood of 
postoperative complications among surgeons performing ≤100 (vs. >100) bariatric 
procedures and for those performing ≤ 150 (vs. >150)  after risk adjustment.
105
 Table 2 
represents the main findings of this study. 
 
TABLE 2: Adjusted odds ratios for one or more postoperative complications versus no 
complications, by surgeon volume, among patients undergoing a bariatric 
procedure in New York State, 2003 
 
Surgeon volume 
surgeons, n                   
(total n=147) 
n                       
(total n=7,868) 
Adjusted Odds Ratio*              
(95% CI) 
>25 65 7,232 1.0 
≤25 82 636 1.35 (0.90 - 2.0) 
>50 49 6,631 1.0 
≤50 98 1,237 1.15 (0.79 - 1.66) 
>100 29 5,298 1.0 
≤100 118 2,570 2.39 (1.59 - 3.59) 
>150 16 3,751 1.0 
≤150 131 4,117 2.05 (1.29 - 3.25) 
*Based on generalized estimating equations models that were adjusted for age, gender, race/ethnicity, 
and comorbidities (congestive heart failure, cardiac arrhythmia, uncomplicated hypertension, other 
neurologic disorders, COPD, uncomplicated diabetes, liver disease, and peptic ulcer disease). The 
following patient risk factors were pronounced in each of the models: male gender, black race/ethnicity, 
and congestive heart failure, cardiac arrhythmia, and other neurologic disorders. ref, reference category. 
 
Adapted from Weller WE and Hannan EL. Relationship between provider volume and postoperative 
complications for bariatric procedures in New York State. J Am Coll Surg 2006; 202:753–761.  
 
 
The Relationship between Provider Volume of Non-Specific Procedures and Adverse 
Outcomes for High-Risk Surgical Procedure(s) 
 
Prior studies have demonstrated that improved outcomes of a high-risk surgical 
procedure have been attributed to hospitals and surgeons performing high volume of that 
“specific” procedure
96, 98-103, 109, 123 
but very few studies have focused their work on the 
association of provider volume for “non-specific” procedures and risk of mortality/other 
adverse outcomes related to a particular high-risk procedure. This section reviews the 
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volume-outcome studies focused on the hospital/surgeon volume of non-specific complex 
procedures. 
In 2004, Urbach et al. investigated the association between procedure-
specific/unrelated procedure volume and 30-day mortality following esophagectomy 
(ESO), excision of a segment of the colon or rectum for colorectal cancer, major lung 
resection (lobectomy or pneumonectomy) for lung cancer, repair of unruptured 
abdominal aortic aneurysm (AAA), and pancreaticoduodenectomy.
124
  The researchers 
abstracted electronic records to identify hospital discharges in Ontario, Canada between 1 
April 1994 and 31 March 1999 and linked these records to a database of vital statistics to 
obtain the vital status of the individual patients. Average hospital volume of each surgical 
procedure was calculated on the basis of the number of identical procedures done at the 
hospital over the five year study period. Hospital volume was further dichotomized into 
two volume categories (high volume hospitals and low volume hospitals) at the median 
cutoff of the average annual hospital volume. The estimates were adjusted for age, sex, 
Charlson comorbidity score (based on 19 conditions with weights on each and is widely 
used in administrative claims datasets as a means of adjusting for the higher mortality 
risks associated with comorbidities),
125
 and accounted for hospital-level clustering. 30 
day mortality appeared to be inversely related not only to the hospital volume of the same 
procedure, but also to the hospital volume of most of the other procedures with the 
exception of colorectal resection. In addition, the association of hospital volume of lung 
resection and mortality from pancreaticoduodenectomy (OR=0.36, 95% CI: 0.23, 0.57 for 
death in hospitals with a high volume of lung resection compared with low volume) was 
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much stronger than the association of hospital volume of pancreaticoduodenectomy and 
mortality from pancreaticoduodenectomy (OR=0.76, 95% CI: 0.44, 1.32).
124
 
This study had several limitations. First, the authors were not able to control for 
potential confounding factors such as a patient‟s race/ethnicity, insurance status, admit-
type, and whether the hospital was urban/rural hospital. Second, the authors did not 
account for the surgeon volume in their model. As surgeon volume is inversely associated 
with the adverse outcomes after the surgery, it could be an effect modifier. At the same 
time, it is possible that surgeon and hospital volumes are positively correlated, thus the 
surgeon volume could be a confounder which might under/over-estimate the true 
association. Third, the authors have only considered the effect of hospital volume of an 
individual non-specific complex procedure on 30-day mortality for one of the above five 
surgical procedures as opposed to considering the hospital volume of non-specific 
complex procedures in totality. By doing this, one may not be able to gauge the overall 
impact of all non-specific complex procedures done at the hospital.  
A similar study performed by Allareddy et al. (2007) focused on examining the 
association between procedure volume and in-hospital mortality after CABG, PCI, 
elective AAA repair, PAN, and ESO (5 Leapfrog group- specified procedures).
126
 The 
researchers examined the procedure-specific volume–outcome association as well as 
unrelated procedure volume–outcome association using data from the Nationwide 
Inpatient Sample (NIS) of the Healthcare Cost and Utilization Project for the years 2000 
through 2003. The analysis sample contained all patients aged ≥18 years who underwent 
CABG, PCI, AAA, PAN, or ESO as the primary procedure during the hospitalization. In-
hospital mortality was the outcome variable of interest. Hospital volume was computed 
 
 
 
 
13 
based on the average number of cases performed by a hospital per year- cases who were 
≥18 years of age and who underwent the procedure of interest during their hospitalization 
(either as primary procedure or any of the secondary procedures).  Hospitals were 
designated as either meeting or not meeting Leapfrog Group-recommended volume 
thresholds.  
The Generalized Estimating Equation method was used to adjust for possible 
clustering of similar outcomes within hospitals. The models were adjusted for covariates 
including age, sex, admission type (elective vs. nonelective), Charlson comorbid severity 
index, primary diagnosis, extent/type of primary procedure, year of procedure, hospital 
teaching status, and hospital bed size. For all 5 procedures, hospitals that did not meet 
Leapfrog Group volume thresholds were associated with significantly higher odds for in-
hospital mortality when compared with hospitals that met Leapfrog Group volume 
thresholds (p < 0.05). Hospital volume levels for PAN or ESO did not influence 
outcomes following CABG, PCI, and AAA. Similarly, hospital volumes for CABG, PCI, 
and AAA did not influence the outcomes for PAN or ESO.
126
 Although a wide range of 
confounders were used in the analysis, the researchers did not adjust for race/ethnicity as 
a potential confounder in the multivariable models. In addition, the study was focused 
only on one clinical outcome, i.e., in-hospital mortality. Also, surgeon volume was not 
accounted for in the analysis. 
Summary and Closing Remarks 
The volume-outcome relationship is attributed to economies of scale.
127, 128
 The 
quality enhancing economies of scale are based on the underlying mechanism of 
“learning-by-doing”.
127-130
 The mechanism of “learning-by-doing” a specific procedure 
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more frequently could be extended to the transferability of learning effects or spillover  
effects across the practice spectrum, i.e., performing unrelated/non-specific procedures 
(both complex and non-complex), depending upon the type of procedure performed by a 
surgeon specialty in a hospital.
129
 
There is a paucity of studies examining the association between non-specific 
procedure volume of the provider and adverse outcomes. The recent studies focusing on 
the effect of hospital volume of non-specific complex procedures on in-hospital mortality 
of a particular high-risk surgery
124, 126 
showed inconsistent results. In addition, none are 
focused on the effect of surgeon volume of non-specific complex procedures on adverse 
outcomes of a specific procedure. Moreover, previous studies are limited in considering 
only a few non-specific complex procedures from the entire spectrum of complex high-
risk surgeries performed in the U.S.  
Gastric bypass is one of the target procedures for volume-based regionalization 
and is typically done by general surgeons performing several other non-gastric bypass 
procedures. Considering the relatively heterogeneous practice profile of general surgeons 
and given the limited time and resource constraints the surgeons might trade-off between 
performing non-gastric bypass complex procedures and non-gastric bypass non-complex 
procedures, it would be important to understand the effect of non-specific procedural 
volume (both complex and non-complex procedures) on the outcomes of gastric bypass. 
There is no previous research related to the impact of provider‟s (hospital and surgeon) 
non-specific volume of both complex and non-complex procedures on adverse outcomes 
after gastric bypass.  
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The current study will investigate the effect of the surgeon and the hospital 
volume of selected non-gastric bypass surgeries (both complex and non-complex) on in-
hospital clinical and resource use outcomes after gastric bypass surgery, controlling for 
patient-level covariates and hospital-level covariates. The current study will use 2-year 
data (2003-2004) and will assume a relatively steady historical volume of non-gastric 
bypass surgeries. In the analysis, all surgeries (excluding gastric bypass) done by 
surgeons or at hospitals in a year will be examined. Work Relative Value Units (Work 
RVUs), a proxy measure of surgical complexity,
131
 obtained from Centers for Medicare 
and Medicaid
132
 will be used to allow for the selection of non-gastric bypass  procedures 
with complexities at least equivalent to gastric bypass. This study will use Elixhauser 
comorbidities in the analysis as opposed to the Charlson comorbidity index used in 
previous studies focused on non-specific volume. Elixhauser comorbidity measures have 
been shown to have better performance with administrative data compared to Charlson 
comorbidity index.
133
 Finally, the current study will use hospital-surgeon non-nested 
clustering to account for surgeon non-nested structure (i.e., one surgeon may have 
privileges to more than one hospital), as opposed to only hospital-level clustering used in 
previous literature on non-specific procedural volume.  
As the rates of bariatric surgery continue to rise in the U.S. and providers 
performing gastric bypass also perform many other non-gastric bypass procedures, it is 
important to determine whether the providers‟ non-gastric bypass procedural volume is 
associated with clinical and length of stay outcomes after gastric bypass. Findings from 
this study may (1) enhance current understanding of the volume-outcome relationship 
providing insights into the specificity aspect, and (2) aid policymakers, health insurers 
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and healthcare providers in decision-making of selectively referring patients to hospitals 
and surgeons with low adverse outcomes for a “specific” high-risk procedure, based upon 
the above mentioned provider‟s non-specific volume considerations. Thus, the 
development of population-based information on the relationship between “non-specific” 
volume and outcomes would be helpful to identify potential areas for quality 
improvement.
 
 
 
CHAPTER 2: OBJECTIVES AND HYPOTHESES 
 
 
The main objective of this study is to examine the association of provider 
(hospital and surgeon) volume of non-gastric bypass (both complex and noncomplex) 
procedures and the likelihood of adverse clinical and resource use events for patients 
undergoing gastric bypass surgery. The specific objectives and hypotheses are listed 
below. 
OBJECTIVE # 1:  To examine whether there is an association between surgeon‟s volume 
of non-gastric bypass procedures (both complex and noncomplex) and the likelihood of 
adverse clinical and resource use events for patients undergoing gastric bypass surgery. 
H1.1: Surgeon‟s high volume of non-gastric bypass complex procedures (Surgeon non-
GBC volume) is associated with decreased likelihood of in-hospital mortality, existence 
of in-hospital complications, and composite outcomes (one or more complications and 
death or any in-hospital complications) for patients undergoing gastric bypass, after 
controlling for patient-level, surgeon-level and hospital-level factors. 
H1.2: Surgeon‟s high non-GBC volume is associated with decreased total length of stay 
(LOS) for patients undergoing gastric bypass, after controlling for patient-level, surgeon-
level and hospital-level factors. 
H1.3: Surgeon‟s high volume of non-gastric bypass noncomplex procedures (Surgeon 
non-GBNC volume) is associated with decreased likelihood of in-hospital mortality, 
existence of in-hospital complications, and composite outcomes (one or more 
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complications and death or any in-hospital complications) for patients undergoing gastric 
bypass, after controlling for patient-level, surgeon-level and hospital-level factors. 
H1.4: Surgeon‟s high volume non-GBNC volume is associated with decreased total LOS 
for patients undergoing gastric bypass, after controlling for patient-level, surgeon-level 
and hospital-level factors. 
OBJECTIVE # 2:  To examine whether there is an association between hospital‟s volume 
of non-gastric bypass procedures (both complex and noncomplex) and the likelihood of 
adverse clinical and resource use events for patients undergoing gastric bypass surgery. 
H2.1: Hospital‟s high volume of non-gastric bypass complex procedures (Hospital non-
GBC volume) is associated with decreased likelihood of in-hospital mortality, existence 
of in-hospital complications, and composite outcomes (any complication  and death or in-
hospital complications) for patients undergoing gastric bypass, after controlling for 
patient-level, surgeon-level and hospital-level factors. 
H2.2: Hospital‟s high non-GBC volume is associated with decreased total LOS for patients 
undergoing gastric bypass, after controlling for patient-level, surgeon-level and hospital-
level factors. 
H2.3: Hospital‟s high volume of non-gastric bypass noncomplex procedures (Hospital 
non-GBNC volume) is associated with decreased likelihood of in-hospital mortality, 
existence of in-hospital complications, and composite outcomes (any complication and 
death or in-hospital complications) for patients undergoing gastric bypass, after 
controlling for patient-level, surgeon-level and hospital-level factors. 
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H2.4: Hospital‟s high non-GBNC volume is associated with decreased total LOS for 
patients undergoing gastric bypass, after controlling for patient-level, surgeon-level and 
hospital-level factors. 
Note- 1) A negative direction of the association between the non-GB non-complex 
procedural volume and adverse outcomes was speculated in hypotheses H1.3, H1.4, H2.3, 
and H2.4 because (a) there is no empirical evidence focused on non-specific non-complex 
volume for GB or other procedures in the literature, and (b) based on the broaden concept 
of “learning-by-doing” mechanism and the type of procedure under study, higher non-
specific non-complex procedural volume for providers may be attributed to fewer 
complications, lower total LOS per patient, and thus, better patient outcomes, indicating 
that non-specific volume matters. On the other hand, providers with higher non-specific 
non-complex procedural volume may be associated with worse outcomes as a 
consequence of distracting the provider from the core task of performing more GB 
procedures, indicating that volume specificity matters. Thus, increase in non-specific 
non-complex procedural volume effect could possibly be bi-directional. 
2) Bariatric procedures, other than gastric bypass, will be allocated to the appropriate 
non-gastric bypass category. Based on the previous work
4, 117, 134-146
 and Agency for 
Healthcare Research and Quality (AHRQ) patient safety indicators,
147
 the in-hospital 
complications that occurred during the admission stay for gastric bypass surgery are 
classified based on ICD-9-CM codes, into two categories: technical and systemic 
complications. Technical complications include small bowel obstruction,
4
 unexpected 
reoperations for surgical complications,
4, 147
 postoperative hemorrhage or hematoma,
4, 147
 
splenic complications,
4
 anastomotic complications,
4, 137, 147
 and wound: postoperative 
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infection, seroma, or dehiscence.
4, 137, 147
 Systemic complications include pulmonary 
complications: respiratory failure or postoperative pneumonia (aspiration),
4, 147
 cardiac 
complications: cardiac arrest or insufficiency, cardiorespiratory failure or heart failure 
during or resulting from a procedure,
4, 147
 thromboembolism: deep vein thrombosis 
(DVT) and/or pulmonary embolism,
117, 137, 146
  postoperative shock,
4, 147
 and genitourinary 
complications.
4, 147
  
The innovative feature of this research is the examination of the quality of care in 
a cohort of gastric bypass patients, with a focus on the relationship of providers‟ volume 
of non-specific complex procedures and clinical and resource-use outcomes using 
inpatient discharges. In addition, use of work relative value units, as a proxy measure of 
complexity, to derive provider volume for non-gastric bypass complex procedures will 
provide a unique perspective to understand provider‟s overall surgical experience. 
Theoretical Framework 
Objectives #1 and # 2 investigate the quality of care in patients with gastric bypass 
surgery by examining the association between the structure of surgical care and 
outcomes. These objectives are characterized by measures and methods applied in the 
field of health services research with a focus on the concept of Structure, Process, and 
Outcome. Figure 1 represents the theoretical framework that will guide the research 
objectives in this study. 
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The theoretical framework is based on the paradigm of Structure, Process, 
Outcome originated by Donabedian to evaluate quality of care.
148
 Elements of the IOM 
volume-quality model have been added that allow incorporation of patient selection and 
patient-level characteristics that might impact surgical outcomes.
109
  
Structure- could be defined as attributes of the institution where care is delivered. 
Structural parameters refer to inherent characteristics of the provider that could be 
associated with variation in quality. Provider volume is a widely studied structural 
measure of quality in medical/surgical care. The volume-outcome relationship varies 
depending upon the complexity of procedures. For high-risk complex procedures, such as 
pancreatic resections and esophagectomy that are performed relatively infrequently, even 
at high volume hospitals or by high volume surgeons, the “specific” volume-outcome 
association is strong.
92
 In contrast, for some frequently performed and relatively 
standardized high-risk complex procedures such as CABG, where hospital volumes may 
range from 100 to more than 1000 cases per year, the “specific” volume-outcome 
relationship is weak.
92, 149-153
  The weak relationship, where the difference in high (vs. 
low) provider volume effect is attenuated, could be explained by certificate of need 
(CON) laws and other influences which concentrate CABG cases in fewer high volume 
hospitals and surgeons.  
Process- could be defined as whether or not good medical practices are followed, 
i.e., the process parameters reflect the extent to which a provider complies with the 
guidelines for evidence-based care.  
Outcome- could be defined as the impact of the care on patient‟s health status. 
Outcomes are historically used measures of quality. For example, medical/surgical 
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outcomes can be in-hospital mortality, LOS, short- and long-term morbidities, and long-
term survival. 
In the current study, provider‟s (hospital and surgeon) gastric bypass volume, and 
non-gastric bypass volume (for both complex and non-complex procedures) will 
comprise the structure of care leading to the clinical outcomes of in-hospital mortality 
and in-hospital complications, and resource use outcomes such as LOS. From the 
theoretical model, it is clear that factors other than structure of care can affect clinical 
outcomes. Patient factors that may affect outcomes include demographic factors such as 
age, race/ethnicity or gender, insurance status, and comorbidities. These will be 
controlled for in analyses to the extent that these variables are available in the secondary 
databases. Patient (level-1) factors that are not available in the data and thus, will not be 
controlled for include lifestyle or behavioral factors such as smoking, medications, 
dietary interventions or exercise, or other patient self-management techniques that occur 
in the community outside the influence of the health care system, or possibly as a result 
of interactions between the patient and the health care system.  
Surgeon/hospital (level 2) unmeasured factors might also be possible confounders 
in the study. Surgeon‟s years from board certification might be positively correlated to 
surgeon‟s high volume, as more number of years from board certification is indicative of 
more experience and potentially high volume. Similarly, surgeon‟s years from board 
certification might be negatively correlated to in-hospital mortality for their patients, i.e., 
surgeons with more experience will have lesser adverse outcomes for their patients.  
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In summary, the Donabedian quality of care framework and IOM volume quality 
model provides the backbone in constructing the study objectives and thereby provides 
guidance for analysis of the specificity aspect of volume-outcome relationship.
 
 
 
CHAPTER 3: METHODS 
 
 
Study Design and Data Sources 
The population-based cross-sectional study used a combination of retrospective 
data and other administrative data to address the research objectives.  
Data Sources 
The following existing data sources were used:  
 Florida Hospital Inpatient Discharge Files (IPF) – to obtain main inpatient 
discharge data 
 Florida Surgeon Characteristics File (SCF) – to identify board certified general 
surgeons 
 Florida Hospital Characteristics File (HCF) – to obtain hospital variables 
 Area Resource File (ARF) - to obtain hospital major metropolitan area status 
variable 
 CMS Physician Fee Schedule Relative Value Files (RVF)  – to obtain work 
relative value units (work RVU)- a measure for procedure complexity 
 ICD-9-CM procedure/CPT procedure crosswalk – to apply work RVUs to the 
Florida hospital discharge data. 
 CMS Florida Carrier Files (FCF) –to obtain weighted work RVUs for each ICD-
9-CM procedure code in the hospital inpatient discharge file. 
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The gastric bypass discharges were identified using calendar year 2003 and 2004 
inpatient discharge records. The inpatient records from the Florida Hospital Inpatient 
Discharge Files (IPF) include diagnosis and procedure information in the form of ICD-9-
CM codes, demographics (age, sex, race/ethnicity, insurance), admit type, admit source, 
county, LOS and discharge status, as well as hospital identifier and surgeon identifier. 
Florida Surgeon Characteristics File (SCF) includes surgeon identifier, surgeon 
certification board, specialty certification area, and specialty certificate (if any). The 
Florida Hospital Characteristics File (HCF) includes hospital identifier, bed size, 
ownership status, and teaching status. The Area Resource File (ARF) includes county and 
major metropolitan area status variables. 
All of the files listed above contain a common physician identifier and /or hospital 
identifier so that they can be linked. In addition, ICD9-CM procedure/ CPT crosswalk 
was used to link the work RVU from the CMS Physician Relative Value Files (RVF) to 
the Florida Hospital Inpatient Discharge Files (IPF). General descriptions of the 
databases are given below. 
Florida Hospital Inpatient Discharge Files (IPF) 
The Florida hospital inpatient discharge data is obtained from Florida‟s Agency 
for Health Care Administration (AHCA) database. The Hospital Inpatient Data Program 
collects discharge data from 269 inpatient healthcare facilities including Acute Care 
Hospitals and Short-term Psychiatric Inpatient facilities, Comprehensive Rehabilitation 
Inpatient facilities and Long-term Psychiatric Hospitals. Reportable events include all 
acute, intensive care, and psychiatric live discharges including newborn live discharges 
and deaths.
154
 The hospital inpatient data file layout consists of the following variables 
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for the de-indentified patient-discharges: reporting year, reporting quarter, hospital 
identifier, admission type, admission source, discharge status, patient race, patient sex, 
zip code, principal diagnosis code, up to nine secondary diagnosis codes, principal 
procedure code, up to nine secondary procedure codes, principal payer, charges by 
revenue, total gross charges, attending physician identifier, operating physician identifier, 
diagnosis related group (DRG) code, refined DRG, i.e., r-DRG (if available), adjacent 
DRG, i.e., ADRG (if available), severity of illness (if available), risk of mortality (if 
available), patient age at admission, length of stay, day of the week admitted, days to 
procedure, patient county (Florida only), and patient State of residence. The diagnosis 
and procedure codes in the dataset are based on ICD-9-CM coding.
154
 
Florida Surgeon Characteristics File (SCF) 
The Florida practice profile data is obtained from the “Licensee Profile Master 
Table (All Professions)” and “Certification Supplemental File”
155
 from the State of 
Florida Department of Health (DOH). In addition, the practice profile information
156  
is 
available on the following websites- 
http://www.doh.state.fl.us/MQA/profiling/profile_about.html and 
http://www.doh.state.fl.us/MQA/profiling/guide.pdf. The data and /or website contain 
self-reported information from licensed Medical Physicians, Osteopathic Physicians, 
Podiatric Physicians, Chiropractic Physicians, and Advanced Registered Nurse 
Practitioners.
156
 The practitioner‟s information is comprised of the following: education 
and training (including other health related degrees), professional and post graduate 
training specialty, current practice and mailing addresses, staff privileges and faculty 
appointments, reported financial responsibility, reported legal actions, and any board 
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final disciplinary action taken against the practitioner.
156
 The Florida DOH website 
indicates that the practitioner profile data submitted by the practitioner has not been 
verified by the Department unless otherwise indicated.
156
 
Florida Hospital Characteristics File (HCF) 
Several data sources were used to build the hospital characteristics file.  Data 
from Florida Hospital Association provides information on hospital identifier, institution 
name, type, address, ownership, parent system, county, beds, and 
congressional/house/senate districts for all 291 hospitals in Florida 
(http://www.fha.org/hospdir.html).
157
  Data from Florida Compare Care provides 
information on hospital identifier, institution name, address, type of facility, teaching 
status, county, license type, and license expiry 
(http://www.floridahealthfinder.gov/CompareCare/ListFacilities.aspx).
158
  Florida 
Agency for Health Care administration maintains facility information on the above two 
websites. 
Area Resource File (ARF) 
The basic county-specific Area Resource File (ARF) is a database containing 
more than 6,000 variables for each of the nation's counties. ARF contains information on 
health facilities, health professions, measures of resource scarcity, health status of the 
county, economic activity, health training programs, and socioeconomic and 
environmental characteristics. In addition, the basic file contains geographic codes and 
descriptors which enable it to be linked to many other files and to aggregate counties into 
various geographic groupings.
159
 ARF 2004 release was be used to obtain hospital‟s 
major metropolitan area variable for the study purposes. 
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CMS Physician Fee Schedule Relative Value Files (RVF)   
 The relative value file contains information on services covered by the Medicare 
Physician Fee Schedule (MPFS) from years 2003-2008.  For more than 10,000 physician 
services, the file contains the CMS HealthCare Common Procedure Coding System 
(HCPCS) that includes American Medical Association‟s Current Procedural Terminology 
(CPT) codes that are used primarily to identify medical services and procedures 
performed by physicians and other health care professionals, the associated relative value 
units (RVUs), a fee schedule status indicator, and various payment policy indicators 
needed for payment adjustment (i.e., payment of assistant at surgery, team surgery, 
bilateral surgery, etc.). The Medicare physician fee schedule amounts are adjusted to 
reflect the variation in practice costs from area to area.  A geographic practice cost index 
(GPCI) has been established for every Medicare payment locality for each of the three 
components of a procedure‟s relative value unit (i.e., the RVUs for work, practice 
expense, and malpractice).  The GPCIs are applied in the calculation of a fee schedule 
payment amount by multiplying the RVU for each component times the GPCI for that 
component.
160
  
 This study used 2003-2005 RVF files to obtain work RVUs associated with CPT 
codes.
132
 The 2005 file is incorporated to obtain work RVUs for new procedures, for 
example, laparoscopic gastric bypass. The ICD-9-CM procedure codes for laparoscopic 
gastric bypass were available in 2004 in the Florida Hospital inpatient discharge. 
However, the work RVUs for laparoscopic gastric bypass procedure is available only in 
2005 RVF. 
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ICD-9-CM procedure/CPT crosswalk  
The crosswalk between CPT codes and ICD-9-CM procedure codes for years 
2004 and 2005, obtained from a commercial organization, EMC Captiva, was used to link 
Florida hospital inpatient discharge data (IPF) to the CMS relative value file (RVF).
161
 
CMS Florida Carrier Specific - Part B Physician/Supplier Procedure Summary Master 
Record (PSMR) 
 
One ICD-9-CM procedure code is associated with more than one CPT codes. 
Therefore, Florida specific Part B summary master record (PSMR) for year 2004 was 
obtained from CMS to compute weighted average of work RVU, so that each ICD-9-CM 
procedure is assigned a unique weighted work RVU value. This PSMR file is a 100% 
summary of all Part B Carrier and DMERC Claims processed through the Common 
Working File and stored in the National Claims History Repository. The file is arrayed by 
carrier, pricing locality, HCPCS codes, modifier 1, modifier 2, specialty, type of service, 
and place of service. The summarized fields are total submitted services and charges, 
total allowed services and charges, total denied services and charges, and total payment 
amounts. This file is produced annually (1991-2007) and is usually available in July. The 
main variables used to obtain weighted average work RVU values for each HCPCS/CPT 
code included physician supplier specialty code for providing the service, type of service, 
place of service, and the total services count.
162
 
Ethical Considerations 
Permission for the use of the secondary sources of information which contain de-
identified patient-discharge data in the Florida hospital in-patient database, Florida 
physician profile data, and Florida hospital characteristics data was obtained from the 
Committee of Use of Human Subjects in Research at University of North Carolina at 
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Charlotte, Charlotte, North Carolina, USA. 
Study Population 
The study population included patient-discharges (n=11,897) undergoing gastric 
bypass surgeries using a two-year (2003-2004) Florida hospital inpatient discharge data. 
Figure 2 represents the inclusion/exclusion for the study. 
Inclusion 
The study population included patient-discharges undergoing gastric bypass as a 
principal procedure performed for morbid obesity in Florida (ICD-9-CM principal 
procedure codes 44.31 or 44.39 with primary diagnosis ICD-9-CM codes 278.0, 278.00, 
278.01, 278.1, V85.35, V85.36, V85.37, V85.38, V85.39, or V85.4)
163 
 or DRG code 
288.
4, 120, 164
 
Exclusion
 
i) To increase the homogeneity of gastric bypass patient cohort, discharges that were 
unlikely to be elective weight-loss procedures based on diagnosis codes for 
gastrointestinal tract neoplasm (150.0-159.9), inflammatory bowel disease (555.0-
556.9), or noninfectious colitis (557.0-558.9) were excluded,
4, 120, 164
 
ii) Discharges less than 18 years of age, “new born”, “urgent”/ “emergent” admit-type, 
and/or hospital transfer or emergency room as the admit-source was excluded from the 
analysis.
4, 120, 164
 
As gastric bypass procedures among other gastrointestinal procedures are 
typically performed by general surgeons, this study considered only those patients on 
whom gastric bypass procedures are performed by board certified general surgeons only. 
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Table 3 represents the distribution of gastric bypass patients treated by surgeons at 
hospitals in Florida in 2003 and 2004. 
 
TABLE 3: Distribution of gastric bypass patients, surgeons, and hospitals by year in 
Florida, 2003-2004 
 
Year 
Number of patients/ surgeons/ hospitals                                                         
(all age groups) 
Number of patients/ surgeons/ hospitals 
 (patient age ≥18 years) 
2003 6,714/ 121/ 70 6,690/ 120/ 70 
2004 5,183/ 129/ 76 5,167/ 128/ 76 
 
 
For the two-year period (2003-2004), there were 11,857 gastric bypass patients (age ≥18 
years) operated by 160 surgeons and 81 hospitals.  
Note: Gastric bypass patient-discharges were also referred to as gastric bypass patients in 
this dissertation.  
Identification of Surgeons 
The study identified an operating surgeon for gastric bypass procedures using the 
unique provider identification number listed in the “MD_operating” field of the inpatient 
file. Previous research has indicated the reliability of this approach in identifying 
operating surgeons.
165
 The unique operating surgeon identifier in the hospital discharge 
database was further linked to Florida practitioners profile information to obtain the 
board certification information for each surgeon.
166
 A surgeon was determined to be a 
general surgeon if the practitioners profile database indicated that he/she was certified by 
the American Board of Surgery or had “general surgery” as a specialty program area 
during his/her graduate medical education. Surgeon records containing no information 
regarding board certification were verified for general surgery board/specialty using the 
American Board of Medical Specialties (ABMS) database.
167
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The ABMS was established in 1933. It is a not-for-profit organization comprising 
24 medical specialty Member Boards and it oversees the certification of physician 
specialists in the United States.
168 
The primary function of ABMS is to assist its Member 
Boards in developing and implementing educational and professional standards to 
evaluate and certify physician specialists. The official 24 ABMS Member Boards and 
Associate Members are (year approved in parentheses):
 
 (1) Allergy and Immunology 
(1971), (2) Anesthesiology (1941), (3) Colon and Rectal Surgery (1949), (4) 
Dermatology (1932), (5)  Emergency Medicine (1979), (6) Family Medicine (1969), (7) 
Internal Medicine (1936), (8) Medical Genetics (1991), (9) Neurological Surgery (1940), 
(10) Nuclear Medicine (1971), (11) Obstetrics and Gynecology (Incorporated 1930) , 
(12) Ophthalmology (Incorporated 1916), (13) Orthopedic Surgery (1935), (14) 
Otolaryngology (Incorporated 1924), (15) Pathology (1936), (16) Pediatrics (1935), (17) 
Physical Medicine and Rehabilitation (1947), (18) Plastic Surgery (1941), (19)  
Preventive Medicine (1949), (20) Psychiatry and Neurology (1935), (21)  Radiology 
(1935), (22) Surgery (1937), (23) Thoracic Surgery (1971), and (24)  Urology (1935).
168
 
Assignment of Work Relative Value Units (RVUs) to Each Inpatient Discharge Record 
 
Description of Work RVU 
 
The Resource-Based Relative Value Scale (RBRVS), implemented in 1992 as a 
payment system for physician services provided to Medicare beneficiaries, is used by 
Medicare and many other third-party payers is a common source of RVUs.
169-171
 The 
RVUs were first developed by Hsiao et al. for fair reimbursement purposes, as certain 
evaluation- and-management services (for example, outpatient clinic visits, inpatient 
consultation, etc.) used same resource inputs as certain invasive procedures but under the 
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customary and prevailing charge-based system, such invasive procedures were typically 
reimbursed at much higher rates than the evaluation- and-management services.
171, 172
 
The RVUs are considered as the measure of physicians‟ productivity, as these are values 
assigned to each CPT code based on the amount of physician work, practice expense, and 
malpractice expense involved in that CPT code.  
Hsiao and colleagues conducted a telephone survey of a stratified random sample 
of physicians from the 1986 Physician Masterfile from American Medical Association 
(AMA) to determine the relative work involved in providing physician services.
173
 The 
researchers conducted both a pilot survey and a national survey. A pilot survey had an 
overall response rate of 73.1% among 90 physicians surveyed and a national survey had 
an overall response rate of 62.5% among 3,164 physicians surveyed.
171
 The dimensions 
of work included in the work-based scale are (1) time required to perform the procedure, 
(2) mental effort and judgment, (3) technical skill and physical effort, and (4) 
psychological stress associated with the physician's concern about the iatrogenic risk to 
the patient.
169-171, 174-176
 Work RVUs are assigned to physicians‟ services in relation to 
standard reference procedures designed to link the scale across subspecialties.
171, 175-177
 
Hsiao et al. found that physicians could rate the relative amount of work of the services 
within their specialty directly, taking into account all the dimensions of work. 
Additionally, the work RVU ratings were shown to be reproducible and consistent among 
physicians.
171
 
Previous studies have used work RVU as proxy measure for procedural 
complexity. For example, Davenport et al. applied the work component of RVUs as a 
proxy measure of operation complexity to the National Surgical Quality Improvement 
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Program (NSQIP) data to study whether the preoperative factors and surgical complexity 
are predictors of hospital costs.
131
  The current study, thus, assessed the complexity of 
procedures performed by board certified surgeons using work RVUs. 
Assignment of Work RVUs to Each ICD-9-CM Procedural Code and Discharge Record 
        The work RVUs were assigned to each ICD-9-CM procedural code as follows: 
1) Dataset 1: The Florida hospital in-patient discharge data contains ICD-9-CM 
diagnostic and procedure codes but not CPT codes. Thus, the EMC Captiva ICD-
9-CM Procedures/ CPT
®
 crosswalk was used to assign CPTs to each ICD-9-CM 
procedure code. Dataset 1 contained all ICD-9-CM procedure codes and CPT 
codes associated with each ICD-9-CM procedural code from the crosswalk. 
2) Dataset 2: The CMS physician fee schedule RVU files contained a unique work 
RVU associated with a unique CPT code.  
From datasets 1 and 2: As more than one CPT codes and thus more than one work 
RVUs were matched with one ICD-9-CM procedure code, a weighted average of 
work RVU was assigned to each ICD-9-CM procedural code. The weighted average 
of work RVU was computed below: 
3) Dataset 3: The number of times each unique CPT code performed as an inpatient 
surgery in Florida was obtained from Florida carrier specific PSMR file from 
CMS. 
4) The above CPT frequency data were then linked with the ICD-9-CM codes/ CPT 
matched dataset containing work RVU values for each CPT codes (using 
combined dataset 1 and 2) to obtain a dataset containing ICD-9-CM codes, CPT 
codes, work RVUs, frequency for each CPT code. 
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5) Finally, a weighted average of work RVU was computed for each ICD-9-CM 
procedural code, as the frequency of CPT code procedures performed in Florida 
could vary. 
The above steps were performed using years 2003, 2004, and 2005 work RVU 
data files. The 2005 RVU data file is incorporated to obtain work RVU‟s for new 
procedures, for example- laparoscopic gastric bypass. The ICD-9-CM procedure codes 
for laparoscopic gastric bypass were available in 2004 in Florida Hospital inpatient 
discharge. However, the work RVUs for laparoscopic gastric bypass procedure is 
available only in 2005 RVF. 
The ICD-9-CM and CPT coding schemes are similar for most common 
procedures. However, if there are coding differences (e.g., specification of surgical detail 
within the CPT scheme, which is not encoded in the ICD-9-CM codes) then those CPTs 
were not assigned to ICD-9-CM codes.
177
 Given that the ICD-9-CM/CPT procedural 
code crosswalk is not a one-to-one crosswalk, approximately 29.47% (913 of 3,098 ICD-
9-CM codes) of missing weighted work RVU values were generated for at least one 
particular year. Thus, imputation of missing work RVUs was performed as follows: 
1) If the weighted work RVU value was available in only one particular year (say 
2005), then the same value was applied to the ICD-9-CM codes for two other 
years (i.e., 2003 and 2004). 
2) If the weighted work RVU value was available for any two years (say 2003 and 
2005), then an average work RVU value was obtained for the remaining year (i.e., 
2004). 
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After the missing value imputation process, only 21.76% (674 of 3,098) ICD-9-
CM codes with missing weighted work RVU information remained. These procedures 
were confirmed, for having at least equivalent complexity as gastric bypass, with Dr. 
Keith Gersin, a board certified general surgeon (bariatric surgeon), from Carolinas 
Medical Center, Charlotte, North Carolina. 
Finally, the weighted work RVU for year 2003 was assigned to each Florida 
hospital inpatient record from 2003 and the weighted work RVU for year 2004 was 
assigned to each Florida hospital inpatient record from 2004. 
There were 128 types of non-GBC procedures and 341 types of non-GBNC 
procedures done by general surgeons who performed gastric bypass as a primary 
procedure. The examples of non-GBC procedures are listed below:  
(1) upper gastrointestinal procedures - for example- esophagectomy not specified, 
partial esophagectomy, total esophagectomy, esophagostomy, pyloromyotomy, 
pyloroplasty, thoracic interposition, suture esophageal laceration, etc.,  
(2) gastrointestinal procedures- for example- partial hepatectomy, hepatic 
lobectomy, choledocoenterostomy, partial gastrectomy, total gastrectomy, 
abdominal perineal resection, splenectomy, partial pancreatectomy, total 
pancreatectomy, radical pancreaticoduodenectomy, etc.,  
(3) lower gastrointestinal procedures- for example- duodenal fistula closure, anal 
anastomosis, small bowel segment isolation, permanent ileostomy, colostomy, 
rectal resection, large bowel to large bowel anastomosis, etc., 
(4) other procedures- This set included few procedures related to heart (heart and 
pericardium repair, aorta resection and anastomosis), lung (lung lobectomy), 
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thyroid (for example- thyroidectomy), kidney (for example- 
nephroureterectomy, removal of renal dialysis shunt, etc.), vessels (for example- 
abdominal endarterectomy, abdominal vessel resection/anastomosis, etc.), 
urinary procedures (for example- bladder repair), hip procedures (for example- 
disarticulation of hip), oopherectomy, and musculoskeletal procedure (for 
example- finger reattachment). 
  The examples of non-GBNC procedures are listed below:  
(1) upper gastrointestinal procedures - for example- endoscope dilate pylorus, 
gastrostomy closure, replace gastrostomy tube, esophagoscopy, gastroscopy, 
etc.,  
(2) gastrointestinal procedures- for example- mesenteric repair, cholecystostomy, 
cholecystectomy, peritoneal incision, etc.,  
(3) lower gastrointestinal procedures- for example- dilation of anal sphincter etc., 
laser destruction of rectal lesion, dilation of rectum, small bowel incision, large 
bowel incision, etc., 
(4) diagnostic procedures- for example- diagnostic ultrasound digestive, open lung 
biopsy, open liver biopsy, bronchoscopy through stoma, chest wall biopsy, 
mediastinoscopy, open mediastinal biopsy, tibia fibula biopsy, pericardial 
biopsy, blood vessel biopsy, open peripheral nerve biopsy,  open pancreatic 
biopsy, etc., 
(5) other procedures- This set included few procedures related to heart (open chest 
cardiac massage), lung (exploratory thoracotomy), trachea procedures (for 
example- tracheostomy), thyroid (for example- excision thyroid lesion), 
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parathyroid (for example- parathyroid reimplant), breast (for example- 
aspiration of breast, mastotomy, etc.), vessels (for example- freeing of vessel, 
suture of vein, suture of artery, etc.), pacemaker (revise or remove pacemaker, 
etc.), and muscle procedures (for example- myotomy, tendon sheath suture, 
fasciotomy, etc.) 
Similarly, there were 441 types of non-GBC procedures and 1,630 types of non-
GBNC procedures done in hospitals where gastric bypass was performed as a primary 
procedure. 
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Main Independent Variables: Volume Assessment 
Descriptions of the volume variables are given below (Table 4a). 
1. Surgeon Volume of Non-gastric Bypass Procedures: 
a) Surgeon‟s volume of non-gastric bypass complex procedures (Non-GBC Volume): 
was measured as the total number of non-gastric bypass procedures having at least 
equivalent complexity (work RVU ≥ 16.21) as gastric bypass performed by each 
board certified general surgeon per year.  
b) Surgeon‟s volume of non-gastric bypass non-complex procedures (Non-GBNC 
Volume): was measured as the total number of non-gastric bypass procedures 
with complexity value less than gastric bypass (work RVU < 16.21) performed by 
each board certified general surgeon per year.  
Only primary non-gastric bypass complex and non-complex procedures were 
included for computing surgeon‟s non-GBC and non-GBNC volume. This is because an 
operating surgeon can be associated only to primary procedure in the hospital discharge 
data. 
Surgeon‟s non-GBC and non-GBNC volume was assessed using varied cut points 
shown below; as there is no evidence in the literature to use a specific recommended 
surgeon‟s non-GBC and non-GBNC volume cut point(s): 
Dichotomous (top-tertile approach): 
(1) low non-GBC volume (bottom 66
th
 percentile- reference category) vs. high volume 
(top 33
rd
 percentile). 
(2) low non-GBNC volume (bottom 66
th
 percentile- reference category) vs. high 
volume (top 33
rd
 percentile). 
4
0
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For sensitivity analysis, the surgeon‟s non-GBC and non-GBNC volume was 
divided into tertiles:  low, medium and high volume groups. The volume groups were 
created by ranking surgeons in order of increasing total volume and selecting cutoff 
points that most closely sort patients into three evenly sized groups with low, medium, 
and high volume.
12
 
2. Hospital‟s Volume of Non-Gastric Bypass Procedures:  
a) Hospital‟s non-GBC volume: was measured as the total number of non-gastric 
bypass procedures having at least equivalent complexity (work RVU ≥ 16.21) as 
gastric bypass performed at each hospital per year.  
b) Hospital‟s non-GBNC volume: was measured as the total number of non-gastric 
bypass procedures with complexity value lesser than gastric bypass (work RVU < 
16.21) performed at each hospital per year.  
Hospital‟s non-GBC volume and non-GBNC volume was computed based on the 
primary non-gastric bypass complex and non-complex procedures done in hospital per 
year for the analysis purposes, as primary procedure is typically associated with the 
reason for hospital admission. For the additional analysis, hospital‟s non-GBC volume 
and non-GBNC volume was computed based on both primary (i.e., principal procedure) 
and secondary (i.e., up to nine non-principal procedures) non-gastric bypass complex and 
non-complex procedures done in hospital per year. This is because a hospital can be 
associated with any procedure (primary/secondary) performed within the same hospital in 
the hospital discharge data. Hospital‟s non-GBC and non-GBNC volume were assessed 
using similar measurements as those used for evaluating surgeon‟s non-GBC and non-
GBNC volume, respectively.  
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Outcomes Assessment 
Descriptions of the outcome/dependent variables are given below (Table 4b). 
In-hospital mortality- The reported in-hospital mortality after gastric bypass ranges from 
0.1 to 0.2%
37
. In-hospital mortality, defined as the mortality at any time during the 
hospital admission after gastric bypass procedure, was identified from discharge status 
variable as discharge status= 20. In the current study, the overall in-hospital mortality for 
gastric bypass was 0.18% (n=21 of 11,857). In addition, there were only 3 (out of 21) 
deaths with no complications. Thus, in-hospital mortality was not modeled either as a 
separate outcome variable or as a composite measure of death and/or any complications. 
Postoperative In-Hospital Complications 
Based on the review of previous studies related to gastric bypass complications,
4, 117, 134-
146
 and Agency for Healthcare Research and Quality (AHRQ) patient safety indicators,
147
  
the in-hospital complications based on ICD-9-CM codes were categorized into Technical 
and Systemic complications. 
Technical Complications included unexpected reoperations for surgical complications,
4, 
147
 postoperative hemorrhage or hematoma,
4, 147
 anastomotic complications,
4, 137, 147 
small 
bowel obstruction,
4
 splenic complications,
4
 and/ or wound: postoperative infection, 
seroma, or dehiscence.
4, 137, 147
 Technical complications variable was measured as a 
dichotomous variable (1= technical complication, 0= none) for the analysis purposes. 
Unexpected reoperations for surgical complications- The rate of unexpected reoperations 
for surgical complications
 
ranges from 6 to 9%.
37
 Reoperations were identified as 
secondary procedure codes for wound dehiscence, lysis of adhesions, removal of foreign 
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body, laparotomy or drainage of intraperitoneal abscess (ICD-9-CM codes: 54.61, 54.51, 
54.59, 54.92, 54.12 or 54.19).
37
 The variable was denoted as reoperation. 
Hemorrhagic complication – Hemorrhage is one of the potential complications of Roux-
en-Y gastric bypass, with an incidence ranging from 0.6% to 4.4%.
75-78
 Hemorrhagic 
complications were identified as secondary diagnosis and/or procedure codes for 
hemorrhage, hematoma, or blood transfusion (ICD-9-CM codes: 998.11, 998.12, 99.04, 
or 99.09).
37
 The variable was denoted as hem. 
Anastomotic complications- The incidence of leak has varied (0%–5%) in both open and 
laparoscopic gastric bypass.
33,85,91
 For surgeons performing beyond 75 to 100 cases, the 
likelihood of gastrointestinal leak may be significantly reduced (0% to 1.6%).
80,33
 
Anastomotic complications were identified as secondary diagnosis codes for intestinal 
(internal) anastomosis and bypass, not elsewhere classified, persistent postoperative 
fistula (leak), percutaneous abdominal drainage, surgical operation with anastomosis, 
bypass, or graft, or other gastric/duodenal prolapse and/or  rupture (ICD-9-CM codes: 
997.4, 998.6, 54.91, E878.2, or 537.89).
34,37,79
 The variable was denoted as leak. 
Small bowel obstruction- The incidence of small bowel obstruction is up to 0.7% for 
open gastric bypass procedures.
4, 178
 Small bowel obstruction was identified as secondary 
diagnosis codes in the discharge data (ICD-9-CM codes: 560, 560.0, 560.1, 560.2, 560.8, 
560.81, 560.9).
4, 179
 The variable was denoted as smbowel_obst. 
Splenic complications- The incidence of iatrogenic splenic injuries leading to 
splenectomy after open gastric bypass is quite low (up to 0.41%).
4, 180
 Splenic 
complications were identified as secondary diagnosis codes for splenic injury, and 
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partial/complete splenectomy (ICD-9-CM codes: 412, 414.3, 415).
4
 The variable was 
denoted as splenic_comp. 
Wound infection- The rate of wound infection following open gastric bypass may 
approach 25% .
83
 Infection was identified as secondary diagnosis codes for postoperative 
infection, seroma, and dehiscence (ICD-9-CM codes: 998.5, 998.51, 998.59, 998.13, 
998.3).
37
 This variable was denoted as infect. 
Systemic complications included pulmonary complications: respiratory failure or 
postoperative pneumonia (aspiration),
4, 147
 cardiac complications: cardiac arrest or 
insufficiency, cardiorespiratory failure or heart failure during or resulting from a 
procedure,
4, 147
 thromboembolism: deep vein thrombosis (DVT) and/or pulmonary 
embolism,
117, 137, 146
  postoperative shock,
4, 147
 and/ or genitourinary complications.
4, 147
 
Systemic complications variable was measured as a dichotomous variable (1= systemic 
complication, 0= none) for the analysis purposes. 
Pulmonary complications- Pulmonary complications following gastric bypass are 
frequent (1.4–5.8%).
80,81
 Respiratory complications including prolonged mechanical 
ventilation for more than 96 hours (ICD-9-CM code 96.72), tracheostomy (519.0, 519.00, 
519.01, 519.02, 519.09, 31.1, 31.2, 31.21, 31.29, 96.55, 97.23), pneumonia or aspiration 
(519.8, 997.3), respiratory failure (518.5, 518.81, 518.82, 518.84), postoperative acute 
pneumothorax (512.1), respiratory arrest (799.1), pulmonary edema (514, 518.4), and 
collapsed lung (518.0) were identified as secondary diagnosis/procedure codes for 
patient-discharges after gastric bypass.
37,44,79,82
 The variable was denoted as resp_comp. 
Cardiac complications- Cardiac complications are rare after gastric bypass. Cardiac 
complications were identified as secondary diagnosis codes for cardiac 
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arrest/insufficiency during or resulting from a procedure, acute myocardial infarction, 
postoperative stroke, phlebitis or thrombophlebitis from a procedure (ICD-9-CM codes: 
997.1, 410, 410.0-410.9, 997.02, or 997.2).
37,79
 The variable was denoted as cardiac. 
Thromboembolism- Pulmonary embolus remains a leading cause of mortality following 
gastric bypass.
32
 Studies involving open gastric bypass have demonstrated an incidence 
of pulmonary embolus and venous thromboembolism in the range of 0.25% to 3%.
85-90
 
Thromboembolism was identified as secondary diagnosis codes for acute deep vein 
thrombosis (DVT) and/or acute pulmonary embolism, or vascular complications for other 
vessels (ICD-9CM codes: 453.8, 453.9, 415.1, 415.11, 415.19, or 997.79).
37,79
 The 
variable was denoted as pe_dvt. 
Postoperative shock- Although postoperative shock is a rare outcome after open gastric 
bypass, previous studies and AHRQ has considered it as one of the patient safety 
indicators.
4, 147
 Postoperative shock was identified as secondary diagnosis code (ICD-9-
CM codes: 998.0) in the discharge data. 
4, 147
 The variable was denoted as shock. 
Genitourinary complications- Although genitourinary is a rare outcome after open gastric 
bypass, previous studies and AHRQ has considered it as one of the patient safety 
indicators.
4, 147
 Genitourinary complications were identified as secondary diagnosis codes 
for urinary tract complications, acute renal failure, acute dialysis, and/or insertion of 
dialysis catheter (ICD-9-CM codes: 997.5, 584, 584.5, 584.6, 584.7, 584.8,or 584.9) in 
the discharge data. 
4, 147
 The variable was denoted as genito_comp. 
Composite Complications- Composite measure included one or more complications (both 
technical and/or systemic). Composite complications variable was measured as a 
dichotomous variable (1= any complication, 0= none) for the analysis purposes. 
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LOS- The reported means for LOS ranged from 2 to 4.5 days.
4, 117, 146, 181
 LOS was 
defined as the number of days elapsed from the admission date to the discharge date. 
LOS was measured as a count variable for the analysis purposes. 
Covariate Assessment 
Factors known or suspected to be related to both provider (hospital and surgeon) 
volume and clinical and resource use outcomes were identified in the dataset.  
1) Patient-discharge demographic factors included: age, sex, race/ethnicity, and payer 
type.  
2) Patient-discharge comorbidities- The Elixhauser
 
comorbidity algorithm was used for 
identifying relevant comorbid conditions.
133
 The comorbidity software, version 3.0, was 
obtained from the Agency
 
for Healthcare Research and Quality (http://www.hcup-
us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp#download).
 
 In the health services 
literature, there is an extensive review of the adequacy of claims data for measurement of 
comorbidity and risk adjustment.
182-185
 Most of the concern involves accuracy and 
completeness of the coding of diagnoses. Although primary data collection has 
advantages, the enormous expense associated with it makes it infeasible for this study.
185
  
Several of the 30 comorbidities were excluded for the analysis purposes because 
they were the focus of the study (obesity, weight loss), or could be the result of surgery 
rather than a condition existing before the gastric bypass surgery (renal failure, anemia 
from blood loss, deficiency anemias, fluid and electrolyte disorders), or had total sample 
sizes less than 20 (AIDS, metastatic cancer, lymphoma, solid tumor without metastasis, 
peptic ulcer, alcohol abuse, drug abuse, and paralysis). In addition to Elixhauser 
comorbidities, sleep apnea, one of the major comorbidities for morbidly obese patients
35, 
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36
, was included in the analysis. Sleep apnea was identified using secondary diagnosis 
codes in the Florida hospital discharge data (ICD-9-CM codes: 780.51, 780.53, or 
780.57).  
2) Surgeon factors included surgeon gastric bypass volume. Surgeon‟s gastric bypass 
volume was measured as total number of gastric bypass procedures performed by each 
board certified general surgeon in a year. 
3) Hospital factors included hospital gastric bypass volume, bed size, major metropolitan 
area (hospital county with population at least 1 million was defined as major metropolitan 
area), teaching status (teaching and non-teaching), and ownership status (private, 
government, and not-for-profit).  
 Hospital‟s gastric bypass volume was measured as the total number of primary 
gastric bypass procedures done in a hospital in a year.  Hospital‟s gastric bypass volume 
was also measured as the total number of primary or secondary gastric bypass procedures 
done in a hospital in a year for the additional analysis purposes. 
 The hospital- and surgeon- gastric bypass volume were assessed as dichotomous 
variables (low vs. high) using Leapfrog Group provider volume guideline cut points.
88
  
Furthermore, year as a binary variable was considered as an additional covariate in the 
model. This is because the overall patient discharges after open gastric bypass have 
decreased from 2003 to 2004 (shown in the Study Population section above) in Florida, 
indicating the shift to laparoscopic gastric bypass surgeries. The definition and 
measurement of covariates incorporated in the analysis is presented in Table 4c-4e. 
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Data Analysis Plan 
All analyses were conducted with the individual patient as the unit of analysis. 
Patients are nested within hospitals, patients are nested within surgeons, and a surgeon 
can have privileges at more than one hospital. Analyses of all clinical and resource use 
outcomes used the non-nested Generalized Estimating Equation (GEE) model which 
adjusted for the non-nested effects (surgeons and hospitals).
186-190
 SAS 9.1.3 was used for 
data management and creating variables and STATA 10 was used for analyses purposes. 
For all analyses an a priori alpha value of 5% was considered. 
For hypotheses H1.1 through H2.2, the common variables considered in the models were: 
Dependent variables: technical complications, systemic complications, composite 
complications, and LOS. 
Control variables: age, sex, race/ethnicity, payer type, Elixhauser comorbidities, year, 
surgeon GB volume, hospital GB volume, hospital bed size, hospital major metropolitan 
area status, teaching status, and ownership status. 
For hypotheses H1.1 and H1.2 
Main Independent variables: surgeon non-GBC volume and surgeon non-GBNC volume. 
For hypotheses H2.1 and H2.2: 
Main Independent variables: hospital non-GBC volume and hospital non-GBNC volume. 
Descriptive Statistics 
For hypotheses H1.1 through H2.2: 
Summary statistics including frequencies n (%) and means (SD) were calculated 
for selected characteristics for all patient-discharges, year, surgeon volumes, and hospital 
characteristics. 
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Outcomes: n (%) were for technical complications, systemic complications, composite 
complications, and mean (SD) as well as n (%) was computed for LOS.  
Comparison of Patient-, Surgeon-, and Hospital- Characteristics by Provider Non-GB 
Volume 
 
For hypotheses H1.1 through H2.4: 
 The comparison of baseline patient demographic, patient comorbidities, year, 
surgeon GB volume, and hospital characteristics by surgeon volume (both non-GBC and 
non-GBNC) categories was performed for hypotheses H1.1 to H1.4. Similarly, the 
comparison of baseline patient demographic, patient comorbidities, year, surgeon GB 
volume, and hospital characteristics by hospital volume (both non-GBC and non-GBNC) 
categories was performed for hypotheses H2.1 to H2.4. Chi-square statistics for categorical 
variables and t-test for continuous variables was used for the comparison purposes for all 
hypotheses. 
Comparison of In-Hospital Complications and LOS Across Patient-, Surgeon-, and 
Hospital Characteristics 
  
For hypotheses H1.1 through H2.4: 
 To compare the adverse outcomes across each independent variable, chi-square 
statistics for categorical variables and t-test for continuous variables were used. 
Additionally, one-way ANOVAs were used to obtain the mean LOS across independent 
variables with more than two categories.  
Unadjusted Association Between Provider Non-GB Volume and Adverse Outcomes 
For hypotheses H1.1 through H2.4: 
 To obtain the unadjusted association between provider (i.e., hospital and/or 
surgeon) non-GBC and non-GBNC volume and each adverse outcome for gastric bypass, 
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GEE model with binomial distribution and logit link function was used for dichotomous 
outcomes (technical complications, systemic complications, and composite 
complications) to obtain unadjusted odds ratios (OR) and 95% confidence intervals (CI). 
Likewise, unadjusted association was also obtained between each selected covariate and 
each adverse outcome for gastric bypass. For LOS outcome, GEE model with log link 
and negative binomial distribution was used to obtain unadjusted beta estimates and 95% 
CI for LOS.  
Additionally for the sensitivity analysis purposes (for all hypotheses H1.1 to H2.4), 
the unadjusted associations between provider non-GB (both complex and non-complex 
procedures) volume and each adverse outcomes were obtained using the provider non-
GB volume categorized as tertiles: low, medium, and high volume. 
 All regression analyses used surgeon and hospital non-nested clustering to obtain 
unadjusted effect of surgeon non-GBC and non-GBNC volume, and hospital non-GBC and 
non-GBNC volume on adverse outcomes.  
Confounding 
For hypotheses H1.1 through H2.4: 
 The known and potential confounders for the association between surgeon 
volume (both non-GBC and non-GBNC) and/or hospital volume (both non-GBC and non-
GBNC) and the risk of adverse outcomes were selected based on the literature review. The 
selected confounders used in previous gastric bypass provider volume studies were 
reflected in the adjusted model of association
191
 and are addressed in the “covariate 
assessment” section above. 
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Multivariate Analysis 
For hypotheses H1.1 through H2.4: 
Separate generalized estimating equation (GEE) regression models, adjusting 
standard errors for the non-nested surgeon and hospital cluster effect, were constructed to 
examine the effect of surgeon‟s non-GBC and non-GBNC volumes on technical 
complications, systemic complications, and composite complications, controlling for the 
patient-level, surgeon-level, hospital-level, and year as covariates in the model. Similarly, 
a multivariate GEE model with log link and negative binomial distribution was used to 
model the association between surgeon volume (both non-GBC  and non-GBNC ) and 
hospital volume (non-GBC  and non-GBNC) and LOS, controlling for the patient-level, 
surgeon-level, and hospital-level  and year as covariates in the model.  
For hypotheses H1.1 and H2.4, a generic marginal regression GEE model structure 
can be represented as
192
: 
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i
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i
E  
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Where, 
y
i
= outcome 
xi = vector of covariates associated with the parameter vector β 
 
 
 
 
53 
PA = marginal outcome averaged over the population of individuals and 
PA
have an 
interpretation in terms of the response averaged over the population 
V = variance matrix 
i
= marginal expectation of the outcome 
)(a = scale parameter  
g = link function 
i = patient-discharge 
For hypotheses H1.1 through H1.4, the general form of equation is given below: 
g (mean Outcome) = β0 + β1* (surgeon non-GBC volume) + β2* (surgeon non-GBNC 
volume) + β3*(patient-level covariates) + β4*(surgeon-level covariates) +  
β5*(hospital-level covariates excluding hospital non-GBC volume and hospital non-GBNC 
volume) ----(I) 
For hypotheses H2.1 through H2.4, the general form of equation is given below: 
g (mean Outcome) = β0 + β1* (hospital non-GBC volume) + β2*(hospital non-GBNC 
volume) + β3*(patient-level covariates) + β4*(hospital-level covariates) +  
β5*(surgeon-level covariates excluding surgeon non-GBC volume and surgeon non-GBNC 
volume) ----(II) 
For equations (I) and (II), logit link: logit P(Yi=1|Xi) with binomial distribution was used 
for dichotomous outcome, and log link: log (Yi|Xi) with negative binomial distribution 
was employed for LOS. 
In all adjusted analyses, the assessment of working correlation structure and the 
model fit for the GEE models was based on the quasilikelihood under independence 
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criterion (QIC).
193
 The robust standard errors, 95% CI, and p-values were computed 
accounting for non-nested surgeon-hospital cluster effect. 
 Additionally for the sensitivity analysis purposes (for all hypotheses H1.1 to H2.4), 
separate adjusted GEE regression models for each outcome were developed using the 
provider (hospital and surgeon) non-GB (both complex and non-complex procedures) 
volume as tertiles: low, medium, and high volume. 
 Sub-Analysis 
For hypotheses H1.1 and H1.4: 
 Stratified analysis was conducted to obtain the association between surgeon non-
GB volume (both non-GBC and non-GBNC) and adverse outcomes (composite measure 
for one or complications and LOS) by surgeon GB volume (used as a dichotomous 
variable with Leapfrog Group cut points) in the study population. The Breslow-Day test 
for homogeneity of effects (i.e., Odds Ratios) was performed for one or more 
complications outcome. 
For hypotheses H2.1 and H2.4: 
 Stratified analysis was conducted to obtain the association between hospital non-
GB volume (both non-GBC and non-GBNC) and adverse outcomes (composite measure 
for one or complication and LOS) by hospital GB volume (used as a dichotomous 
variable with Leapfrog Group cut points) in the study population. The Breslow-Day test 
for homogeneity of effects (i.e., Odds Ratios) was performed for one or more 
complications outcome. 
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TABLE 4a: Primary independent variables for the gastric bypass study in Florida, 2003- 
2004 
 
Variable Name Description Type 
Surgeon non-GBC volume 
Number of non-gastric bypass procedures of at least 
equivalent complexity than gastric bypass performed 
by a general surgeon in a year 
dichotomous/ 
categorical 
  0=low (≤66th percentile), 1= high (>66th percentile)   
  
0=low volume (<33rd percentile), 1= medium volume 
(between 33rd and 66th percentile), 2=high volume 
(>66th percentile)   
Surgeon non-GBNC volume 
Number of non-gastric bypass procedures with lower 
complexity than gastric bypass performed by a general 
surgeon in a year 
dichotomous/ 
categorical 
  0=low (≤66th percentile), 1= high (>66th percentile)   
  
0=low volume (<33rd percentile), 1= medium volume 
(between 33rd and 66th percentile), 2=high volume 
(>66th percentile)   
      
Hospital non-GBC volume* 
Number of non-gastric bypass procedures of at least 
equivalent complexity than gastric bypass performed in 
hospital in a year 
dichotomous/ 
categorical 
  0=low (≤66th percentile), 1= high (>66th percentile)   
  
0=low volume (<33rd percentile), 1= medium volume 
(between 33rd and 66th percentile), 2=high volume 
(>66th percentile)   
Hospital non-GBNC volume* 
Number of non-gastric bypass procedures with lower 
complexity than gastric bypass performed in hospital in 
a year 
dichotomous/ 
categorical 
  0=low (≤66th percentile), 1= high (>66th percentile)   
  
0=low volume (<33rd percentile), 1= medium volume 
(between 33rd and 66th percentile), 2=high volume 
(>66th percentile)   
*For main analysis, only primary procedures were counted towards volume computation. For 
additional analysis, primary/secondary procedures were counted towards volume computation. 
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TABLE 4b: Dependent variables for the gastric bypass study in Florida, 2003- 2004 
 
Variable Name Description Type 
technical technical complications Nominal 
  1= yes, 0= no   
      
systemic systemic complications Nominal 
  1= yes, 0= no   
      
any_comp composite: one or more complications Nominal 
  1= yes, 0= no   
LOS length of stay Count 
 
TABLE 4c: Patient demographics for the gastric bypass study in Florida, 2003- 2004 
 
Patient-level Demographics Description Type 
Age Patient's age                                                                                                                                                                                                                                                                   continuous 
Sex Patient's sex Nominal 
  1= Male, 0= Female   
Race Patient's race/ethnicity Nominal 
  
1= Non-Hispanic White, 2= Non-Hispanic Black, 
3=Hispanic, 4= Other   
Payer Principal payer type Nominal 
  
1=Medicare, 2= Medicaid, 3= Commercial, 4= 
Selfpay/underinsured, 5= other   
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TABLE 4d: Patient comorbidities for the gastric bypass study in Florida, 2003- 2004 
 
Patient-level Comorbidities Description Type 
Elixhauser Comorbidities Based on ICD-9-CM codes   
chf congestive heart failure Nominal 
  1= Yes, 0= No   
arryth cardiac arrythmia Nominal 
  1= Yes, 0= No   
valve valvular disease Nominal 
  1= Yes, 0= No   
pulmcirc pulmonary circulation disease Nominal 
  1= Yes, 0= No   
perivasc peripheral vascular disease Nominal 
  1= Yes, 0= No   
htn_c hypertension Nominal 
  1= Yes, 0= No   
neuro other neurologic disorder Nominal 
  1= Yes, 0= No   
chrnlung chronic pulmonary disease Nominal 
  1= Yes, 0= No   
dm diabetes mellitus without chronic complications Nominal 
  1= Yes, 0= No   
dmcx diabetes mellitus with chronic complications Nominal 
  1= Yes, 0= No   
hypothy hypothyroidism Nominal 
  1= Yes, 0= No   
liver liver disease Nominal 
  1= Yes, 0= No   
arth rheumatoid arthritis Nominal 
  1= Yes, 0= No   
coag coagulopathy Nominal 
  1= Yes, 0= No   
psych psychoses Nominal 
  1= Yes, 0= No   
depress depression Nominal 
  1= Yes, 0= No   
sleep_apnea sleep apnea Nominal 
  1= Yes, 0= No   
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TABLE 4e: Surgeon, hospital, and year variables for the gastric bypass study in Florida, 
2003-2004 
 
Variables Description Type 
Surgeon-level    
surgeon GB volume 
surgeon's gastric bypass volume/year based on Leapfrog 
group standards dichotomous 
  1= high (>50 procs/yr), 0= low (≤50 procs/yr)   
Hospital-level    
hospital GB volume 
hospital's gastric bypass volume/year  based on Leapfrog 
group standards dichotomous 
  1= high (>125 procs/yr), 0= low (≤125 procs/yr)   
bed size number of beds in a hospital continuous 
      
teaching hospital teaching status dichotomous 
  1=teaching, 0=non-teaching    
hospital location major metropolitan area dichotomous 
  
1=hospital county population<1 million, 0=hospital 
county population≥1 million   
ownership ownership status categorical 
  1= not-for-profit/government, 0=for-profit   
Year_dummy Year dichotomous 
  1=2004, 0=2003   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4: RESULTS 
 
 
Descriptive Statistics 
Tables 5-7 present the summary statistics for gastric bypass patients used in the 
analyses of general surgeon non-GB (both non-GBC and non-GBNC) volume effect 
(hypotheses H1.1 through H1.4) and hospital non-GB (both non-GBC and non-GBNC) 
volume effect (hypotheses H2.1 through H2.4). A total of 11,363 and 11,857 patients were 
used in the analyses of general surgeon non-GB volume effect and hospital non-GB 
volume effect, respectively. 
Demographic Characteristics 
The demographic characteristics – age, sex, race/ethnicity, and insurance- of the 
study population used in the analyses are described below (table 5). 
For hypotheses H1.1 through H1.4: 
Overall, the gastric bypass patients operated by board certified general surgeons 
had a mean (Standard Deviation: SD) age of 42.5 (10.8) years, and a majority (71.35%) 
of patients were less than 50 years of age. In addition, a majority of gastric bypass 
patients were females (81.38%), white (69.82%), and had private insurance (80.32%).  
For hypotheses H2.1 through H2.4: 
Overall, the gastric bypass patients operated at hospital had a mean (Standard 
Deviation: SD) age of 42.5 (10.8) years, and a majority (71.58%) of patients were less 
than 50 years of age. In addition, a majority of gastric bypass patients were females
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 (81.25%), white (69.22%), and had private insurance (79.83%).  
Patient Comorbidities 
The patient comorbidities- selected Elixhauser comorbidities- for the study 
population used in analyses are described below (Table 5). 
For hypotheses H1.1 through H1.4: 
 Overall, 79.00% of gastric bypass patients operated by general surgeons had at 
least one comorbidity among the selected comorbidities determined by Elixhauser et 
al.
133
 The major comorbidities for gastric bypass patients operated by board certified 
general surgeons were hypertension (51.08%), sleep apnea (32.76%), and diabetes 
mellitus both with and without chronic complications (26.27%), depression (15.22%), 
chronic pulmonary disease (14.60%), and liver disease (9.82%). 
For hypotheses H2.1 through H2.4: 
Overall, 79.24% of gastric bypass patients operated at hospitals had at least one 
comorbidity among the selected comorbidities determined by Elixhauser et al.
133
 The 
major comorbidities for gastric bypass patients operated at hospitals were hypertension 
(51.24%), sleep apnea (33.36%), diabetes mellitus- both with and without chronic 
complications (26.28%), depression (15.43%), chronic pulmonary disease (14.71%), and 
liver disease (9.87%). These results were similar to the above analysis restricted only to 
patients operated by general surgeons. 
Year 
For hypotheses H1.1 through H2.4: 
Approximately a higher proportion of gastric bypass patients (56.60% and 
56.42%) were operated in 2003 when considering surgeon non-GB volume analysis 
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(hypotheses H1.1 through H1.4)  and  hospital non-GB volume analysis (hypotheses H2.1 
through H2.4) respectively (Table 5). 
Surgeon Volume Characteristics (at patient-level)  
 The surgeon volume characteristics - non-GBC, non-GBNC, and GB volume- of 
the study population used in analyses are described below (Table 6). 
For hypotheses H1.1 through H1.4: 
Overall, the gastric bypass patients were operated by board certified general 
surgeons who had a non-GBC volume with a mean (SD) of 41.51 (31.45) non-GBC 
procedures per year, non-GBNC volume with a mean (SD) of 112.08 (81.65) non-GBNC 
procedures per year and GB volume with a mean (SD) of 174.63 (107.66) GB procedures 
per year. A majority of patients were operated by general surgeon with low non-GBC 
volume with ≤50 procedures per year (73.84%), low non-GBNC volume with ≤142 
procedures per year (75.72%), and high GB volume with >50 procedures per year 
(85.05%).   
Note- The surgeon‟s  non-GBC and non-GBNC volume (low vs. high) cut-points were 
based on top-tertile (upper 33
rd
 percentile) approach and the GB volume cut-points were 
based on volume standards indicated by Leapfrog Group.
194
 
For hypotheses H2.1 through H2.4: 
Overall, the gastric bypass patients were operated by surgeons in hospitals having 
a mean (SD) GB volume of 169.10 (108.81) procedures per year. A majority (83.36%) of 
patients were operated by surgeons in hospitals with high GB volume (>50 GB 
procedures per year).   
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Note- The hospital‟s  non-GBC and non-GBNC volume (low vs. high) cut-points were 
based on top-tertile (upper 33
rd
 percentile) approach and the GB volume cut-points were 
based on volume standards indicated by Leapfrog Group.
194
 
Hospital Characteristics (at patient-level)  
The hospital characteristics- hospital GB volume, teaching status, ownership 
status, major metropolitan area status, and bed size - of the study population used in 
analyses are described below (Table 6). 
For hypotheses H1.1 through H1.4: 
 Overall, the gastric bypass patients were operated by board certified general 
surgeons in hospitals having a mean (SD) GB volume of 240.80 (158.96) procedures per 
year. A majority (67.40%) of patients were operated by general surgeon in hospitals with 
high GB volume (>125 GB procedures per year).   
Note- The above results presents binary hospital volume cut-points for GB volume based 
on volume standards indicated by Leapfrog Group.
194
 
 In addition, a majority of gastric bypass patients were operated at non-teaching 
hospitals (94.53%), hospitals with county population ≥1 million (65.10%), and those 
hospitals with for-profit ownership status (56.35%), and had mean (SD) bed size of 
389.26 (213.72) beds. 
For hypotheses H2.1 through H2.4: 
 The results presented for hospital volumes were computed using principal 
procedures only.          
Overall, the gastric bypass patients were operated at hospitals having a mean (SD) 
non-GBC volume of 2,766.10 (1970.93) non-GBC procedures per year, non-GBNC volume 
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of 6,178.16 (3411.02) non-GBNC procedures per year and GB volume of 234.58 (159.90) 
GB procedures per year. A majority of patients were operated at hospitals with low non-
GBC volume with ≤2,743 procedures per year (61.33%), low non-GBNC volume with 
≤6,478 procedures per year (59.53%), and high GB volume with >125 procedures per 
year (65.46%).  The results were similar when hospital volumes computed using both 
principal and secondary procedures were considered. 
  In addition, a majority of gastric bypass patients were operated at non-teaching 
hospitals (94.55%), hospitals with county population ≥1 million (66.44%), and those 
hospitals with for-profit ownership status (56.51%), and had mean (SD) bed size of 
386.83 (211.10) beds. 
Outcomes 
For hypotheses H1.1 through H1.4: 
 Overall, the in-hospital mortality for gastric bypass patients operated by general 
surgeon was low (0.18%). There were considerable composite (one or more 
complications), technical, and systemic complications (18.13%, 10.95%, and 9.97% 
respectively) and a mean (SD) length of stay of 3.41 (3.40) observed for gastric bypass 
patients operated by general surgeons (Table 7). 
For hypotheses H2.1 through H2.4: 
Likewise, the overall in-hospital mortality for gastric bypass patients operated at 
hospitals was low (0.19%). There were considerable composite (one or more 
complications), technical, and systemic complications (18.39%, 11.24%, and 9.97% 
respectively) and a mean (SD) length of stay of 3.45 (3.49) observed for gastric bypass 
patients operated by general surgeons (Table 7). 
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Comparison of Patient-Discharge Characteristics, Surgeon Gastric Bypass Volume, and 
Hospital Characteristics, by Surgeon Volume of Non-Gastric Bypass Procedures 
(Hypotheses H1.1 through H1.4) 
 
Demographic Characteristics 
Tables 8 and 10 represent the comparison of demographic characteristics by 
surgeon volume of non-GB procedures. 
Among gastric bypass patients operated by surgeons with high non-GBC volume 
(>50 non-GBC procedures/year), approximately 81.80% were females and had mean±SE 
age 43.12±0.20 years. Approximately 69.61% (vs. 71.97%, p=0.029) patients operated by 
low (vs. high) non-GBC volume were less than 50 years of age. Compared to gastric 
bypass patients operated by surgeons with low non-GBC volume, those operated by 
surgeons with high non-GBC volume were more likely to be non-Hispanic White 
(74.53% vs. 68.16%, p<0.0001) and insured (91.76% vs. 88.75%, p<0.0001) (Table 8). 
While a greater percentage of gastric bypass patients operated by surgeons with 
high (vs. low) non-GBNC volume (>142 non-GBNC procedures/year) were females 
(81.23%), younger having mean±SE age of 42.57±0.21 years with 71.51% of patients 
having less than 50 years of age, the results were not statistically significant. Compared 
to gastric bypass patients operated by surgeons with low non-GBNC volume, those 
operated by surgeons with high non-GBNC volume were more likely to be Hispanic 
(23.09% vs. 13.74%, p<0.0001) and insured (93.48% vs. 88.27%, p<0.0001) (Table 10). 
Patient Comorbidities  
Tables 8 and 10 represent the comparison of patient comorbidities by surgeon 
volume of non-GB procedures. 
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Among gastric bypass patients operated by surgeons with high non-GBC volume, 
approximately 79.34% had the presence of one or more comorbidities. Compared to 
gastric bypass patients operated by surgeons with low non-GBC volume, those operated 
by surgeons with high non-GBC volume were more likely to have congestive heart failure 
(2.02% vs. 0.85%, p<0.0001), peripheral vascular disease (2.05% vs. 0.94%, p<0.0001), 
diabetes mellitus without chronic complications (26.65% vs. 24.61%, p=0.028), liver 
disease (2.12% vs. 1.55%, p<0.0001), and psychoses (1.11% vs. 0.69%, p=0.028) (Table 
8). 
Among gastric bypass patients operated by surgeons with high non-GBNC volume, 
approximately 78.76% had presence of one or more comorbidities. Compared to gastric 
bypass patients operated by surgeons with low non-GBNC volume, those operated by 
surgeons with high non-GBNC volume were more likely to have congestive heart failure 
(1.88% vs. 0.92%, p<0.0001), hypertension (53.46% vs. 50.31%, p=0.004), diabetes 
mellitus without chronic complications (27.76% vs. 24.30%, p=0.028), psychoses (1.12% 
vs. 0.70%, p=0.029), sleep apnea (35.27% vs. 31.96%, p=0.001) and less likely to have 
peripheral vascular disease (0.51% vs. 1.46%, p<0.0001), liver disease (3.26% vs. 
11.92%, p<0.0001), and depression (10.08% vs. 16.88%, p<0.0001) (Table 10). 
Year 
Tables 8 and 10 represent the comparison of gastric bypass patients across year, 
by surgeon volume of non-GB procedures. 
 Approximately, 68.64% (vs. 52.33%, p<0.0001) of gastric bypass patients were 
operated by surgeons with high (vs. low) non-GBC volume in 2003 (Table 8). In contrast, 
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53.06% (vs. 40.31%, p<0.0001) of gastric bypass patients were operated by surgeons 
with high (vs. low) non-GBNC volume in 2004 (Table 10). 
Surgeon Volume Characteristics (at patient-level)  
Tables 9 and 11 represent the comparison of gastric bypass patients across 
surgeon GB volume, by surgeon volume of non-GB procedures. 
Among gastric bypass patients operated by surgeons with high (vs. low) non-GBC 
volume, 59.22% (vs. 11.91%, p <0.0001) of patients were operated by surgeons 
performing >142 non-GBNC procedures per year (Table 9). 
Likewise, among gastric bypass patients operated by surgeons with high (vs. low) 
non-GBNC volume, 63.79% (vs. 14.09%, p <0.0001) of patients were operated by 
surgeons performing >50 non-GBC procedures per year (Table 11). 
Hospital Characteristics (at patient-level)  
Tables 9 and 11 represent the comparison of gastric bypass patients across 
hospital characteristics, by surgeon volume of non-GB procedures. 
Compared to gastric bypass patients operated by surgeons with low non-GBC 
volume, those operated by surgeons with high non-GBC volume went to hospitals 
performing ≤125 GB as principal procedures per year (35.16% vs. 31.69%, p<0.0001) 
with mean±SE bed size of 355.96±3.21 (vs. 400.36±2.45, p<0.0001). When comparing 
the distribution of hospital beds, only 16.72% (vs. 29.65%, p<0.0001) of patients 
operated by surgeons with high (vs. low) non-GBC volume went to hospitals with 500+ 
beds. In addition, patients operated by surgeons with high non-GBC volume were less 
likely to go to teaching hospitals (2.79% vs. 6.43%, p<0.0001) and hospitals with county 
 
 
 
 
67 
population ≥1 million (57.57% vs. 67.76%) but more likely to go to hospitals having for-
profit ownership status (65.07% vs. 53.13%, p<0.0001) (Table 9). 
Similarly, compared to gastric bypass patients operated by surgeons with low 
non-GBNC volume, those operated by surgeons with high non-GBNC volume went to 
hospitals performing ≤125 GB as principal procedures per year (42.95% vs. 29.28%, 
p<0.0001) with mean±SE bed size of 423.14±5.24 (vs. 377.72±2.03, p<0.0001). When 
comparing the distribution of hospital beds, approximately 24.94% (vs. 26.70%, 
p<0.0001) of patients operated by surgeons with high (vs. low) non-GBNC volume went 
to hospitals with 500+ beds. In addition, patients operated by surgeons with high non-
GBNC volume were more likely to go to hospitals located in the major metropolitan area 
with county population ≥1 million (76.51% vs. 61.44%, p<0.0001) (Table 11).   
Comparison of Patient-Discharge Characteristics, Surgeon Gastric Bypass Volume, and 
Hospital Characteristics, by Hospital Volume of Non-Gastric Bypass Procedures 
(Hypotheses H2.1 through H2.4) 
 
Demographic Characteristics 
Tables 12 and 14 represent the comparison of demographic characteristics by 
hospital volume of non-GB procedures. 
Among gastric bypass patients operated at hospitals with high non-GBC volume 
(>2,743 non-GBC procedures/year), approximately 81.70% were females and had 
mean±SE age 42.37±0.16 years. Approximately 71.89% patients operated at hospitals 
with high non-GBC volume were younger (less than 50 years of age). Compared to 
gastric bypass patients operated at hospitals with low non-GBC volume, those operated at 
hospitals with high non-GBC volume were less likely to be non-Hispanic Black (10.53% 
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vs. 12.53%, p<0.0001) and more likely to be insured (92.83% vs. 87.80%, p<0.0001) 
(Table 12). 
While a greater percentage of gastric bypass patients operated at hospitals with 
high (vs. low) non-GBNC volume (>142 non-GBNC procedures/year) were females 
(81.33%), with mean±SE age of 42.57±0.16 years and with70.74%  of patients having 
less than 50 years of age, the result was not statistically significant. Compared to gastric 
bypass patients operated at hospitals with low non-GBNC volume, those operated at 
hospitals with high non-GBNC volume were less likely to be non-Hispanic Black (10.71% 
vs. 12.47%, p<0.0001) and insured (92.67% vs. 87.74%, p<0.0001) (Table 14). 
Patient Comorbidities  
Tables 12 and 14 represent the comparison of patient comorbidities by hospital 
volume of non-GB procedures. 
Among gastric bypass patients operated at hospitals with high non-GBC volume, 
approximately 81.66% had the presence of one or more comorbidities. Compared to 
gastric bypass patients operated by surgeons with low non-GBC volume, those operated 
by surgeons with high non-GBC volume were more likely to have valvular disease 
(2.09% vs. 1.49%, p=0.013), peripheral vascular disease (2.51% vs. 0.36%, p<0.0001), 
depression (17.56% vs. 14.10%, p<0.0001) and sleep apnea (38.65% vs. 30.03%, 
p<0.0001) (Table 12). 
Among gastric bypass patients operated at hospitals with high non-GBNC volume, 
approximately 82.08% had presence of one or more comorbidities. Compared to gastric 
bypass patients operated at hospitals with low non-GBNC volume, those operated at 
hospitals with high non-GBNC volume were more likely to have arrythmia (3.65% vs. 
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2.75%, p<0.0001), peripheral vascular disease (2.38% vs. 0.38%, p<0.0001), liver 
disease (14.82% vs. 6.50%, p<0.0001), depression (16.76% vs. 14.53%, p=0.001) and 
sleep apnea (35.64% vs. 31.82%, p<0.0001) (Table 14). 
Year 
Tables 12 and 14 represent the comparison of gastric bypass patients across year, 
by hospital volume of non-GB procedures. 
Approximately, 63.90% (vs. 51.71%, p<0.0001) of gastric bypass patients were 
operated at hospitals with high (vs. low) non-GBC volume in 2003 (Table 12). Likewise, 
61.80% (vs. 52.77%, p<0.0001) of gastric bypass patients were operated at hospitals with 
high (vs. low) non-GBNC volume in 2003 (Table 14). 
Surgeon Volume Characteristics (at patient-level)  
Tables 13 and 15 represent the comparison of gastric bypass patients across 
surgeon GB volume, by hospital volume of non-GB procedures. 
Among gastric bypass patients operated at hospitals with high (vs. low) non-GBC 
volume, a higher proportion (19.50% vs. 14.84%, p <0.0001) of patients were operated 
by surgeons with low GB volume (≤50 GB procedures per year) (Table 13). 
Likewise, among gastric bypass patients operated at hospitals with high (vs. low) 
non-GBNC volume, a higher proportion (17.51% vs. 16.05%, p <0.0001) of patients were 
operated by surgeons with low GB volume (≤50 GB procedures per year) (Table 15). 
Hospital Characteristics (at patient-level)  
Tables 13 and 15 represent the comparison of gastric bypass patients across 
hospital characteristics, by hospital volume of non-GB procedures. 
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Compared to gastric bypass patients operated at hospitals with low non-GBC 
volume, a higher proportion of those operated at hospitals with high non-GBC volume 
went to hospitals performing high volume of non-GBNC  procedures (>6,478 procedures) 
per year (87.31% vs. 10.93%, p<0.0001) and having large hospital bed size (mean±SE) 
530.58±1.57 (vs. 296.20±3.39, p<0.0001). When comparing the distribution of hospital 
beds, a larger proportion of patients operated at hospitals with high (vs. low) non-GBC 
volume went to hospitals with 500+ beds (50.40% vs. 10.48%, p<0.0001). In addition, 
patients operated at hospitals with high non-GBC volume were less likely (64.89% vs. 
67.42%) to go to hospitals in the major metropolitan area with county population ≥ 1 
million and hospitals having for-profit ownership status (22.49% vs. 77.96%, p<0.0001) 
(Table 13). 
Similarly, compared to gastric bypass patients operated at hospitals with low non-
GBNC volume, a higher proportion of those operated at hospitals with high non-GBNC 
volume went to hospitals performing high volume of non-GBC procedures (>2,743 
procedures) per year (83.43% vs. 8.24%, p<0.0001) hospitals performing >125 GB as 
principal procedures per year (69.38% vs. 62.80%, p<0.0001), and large hospital bed size 
(mean±SE) 536.51±3.19 (vs. 285.09±1.50, p<0.0001). When comparing the distribution 
of hospital beds, a larger proportion of patients operated at hospitals with high (vs. low) 
non-GBNC volume went to hospitals with 500+ beds (53.86% vs. 6.93%, p<0.0001). In 
addition, the patients operated at hospitals with high non-GBC volume were less likely to 
go to hospitals with for-profit ownership status (31.18% vs. 73.72%, p<0.0001) (Table 
15). 
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Comparison of In-Hospital Complications and LOS Across Patient-, Surgeon-, and 
Hospital-Characteristics (Hypotheses H1.1 through H2.4) 
 
Tables 16 – 19 present the comparisons of the independent variables for each 
outcome of interest. 
Composite Complications 
For hypotheses H1.1 through H1.4: 
A greater proportion of patients having a composite complication (vs. no 
complication) was non-Hispanic White (71.50% vs. 69.45%, p=0.042), had Medicare 
(10.19% vs. 6.11%, p<0.0001), had at least one of the selected Elixhauser 
comorbidities
133
 (85.78% vs. 77.50%, p<0.0001), and were operated in the year 2003 
(59.51% vs. 55.95%, p=0.003). In addition, compared to patients with no complications, 
those having a composite complication were operated by high non-GBC, high non-GBNC, 
and low GB volume surgeons (28.93% vs. 25.54%, p=0.002; 33.11% vs. 22.33%, 
p<0.0001; 18.88% vs. 14.08%, p<0.0001, respectively). Furthermore, the patients having 
a composite complication (vs. no complication) were operated at hospitals with low GB 
volume with GB as a principal procedure, teaching hospital, hospitals with county 
population≥1 million, and hospitals with not-for-profit or government status (37.09% vs. 
31.60%, p<0.0001; 7.6% vs. 5.00%, p<0.0001; 73.98% vs. 63.13%, p<0.0001; 49.13% 
vs. 42.56%, p<0.0001, respectively) (Tables 16 and 17).  
For hypotheses H2.1 through H2.4: 
A greater proportion of patients having a composite complication (vs. no 
complication) had Medicare (10.73% vs. 6.21%, p<0.0001), had at least one of the 
selected Elixhauser comorbidities
133
 (85.97% vs. 77.73%, p<0.0001),  was operated by 
surgeons with low GB volume (20.82% vs. 15.70%, p<0.0001), was operated at hospitals 
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with high non-GBC, low non-GBNC, and low GB volume- based on principal procedures 
(40.76% vs. 38.20%, p=0.026; 61.90% vs. 59.00%, p=0.013; and 39.11%  vs. 33.51%, 
p<0.0001, respectively), teaching hospital (7.87% vs. 4.91%, p<0.0001), hospital county 
population≥1 million (75.24% vs. 64.46%, p<0.0001), and with not-for-profit or 
government status (48.56% vs. 42.35%), (Tables 18 and 19).   
Technical Complications 
For hypotheses H1.1 through H1.4:           
A greater proportion of patients having a technical complication (vs. no 
complication) was non-Hispanic White (72.59% vs. 69.48%, p=0.016), had Medicare 
(9.73% vs. 6.49%, p<0.0001), and had at least one of the selected Elixhauser 
comorbidities
133
 (83.36% vs. 78.47%, p<0.0001). In addition, compared to patients with 
no complications, those having a technical complication were operated by high non-
GBNC and low GB volume surgeons (28.22% vs. 23.80%, p=0.001; 19.29% vs. 14.42%, 
p<0.0001, respectively). Furthermore, the patients having a technical complication (vs. 
no complication) were operated at hospitals with low GB volume with GB as a principal 
procedure, teaching hospital, and hospitals with county population≥1 million (40.76% vs. 
31.59%, p<0.0001; 9.69% vs. 4.95%, p<0.0001; 71.38% vs. 64.32%, p<0.0001, 
respectively) (Tables 16 and 17).  
For hypotheses H2.1 through H2.4:           
A greater proportion of patients having a technical complication (vs. no 
complication) was non-Hispanic White (71.27% vs. 68.97%, p=0.031), had Medicare 
(10.28% vs. 6.63%, p<0.0001), and had at least one of the selected Elixhauser 
comorbidities
133
 (83.57% vs. 78.70%, p<0.0001). Additionally compared to patients with 
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no complications, those having a technical complication were operated by surgeons with 
low GB volume (21.16% vs. 16.07%, p<0.0001) and at hospitals with low non-GBNC and 
low GB volume- based on principal procedures (63.92% vs. 58.98%, p=0.001; 43.44% 
vs. 33.41%, p<0.0001, respectively). Furthermore, patients having a technical 
complication (vs. no complication) were operated at teaching hospitals (10.11% vs. 
4.86%, p<0.0001), hospitals with county population ≥1 million (73.29% vs. 65.57%, 
p<0.0001), and hospitals having not-for-profit or government status (45.54% vs. 
43.23%), (Tables 18 and 19).  
Systemic Complications 
For hypotheses H1.1 through H1.4:           
A greater proportion of patients having a systemic complication (vs. no 
complication) was non-Hispanic White (71.67% vs. 69.62%, p=0.016), had Medicare 
(11.21% vs. 6.36%, p<0.0001), had at least one of the selected Elixhauser 
comorbidities
133
 (88.08% vs. 78.00%, p<0.0001), and were operated in 2003 (63.64% vs. 
55.82%, p<0.0001). In addition, compared to patients with no complications, those 
having a systemic complication were operated by high non-GBC, high non-GBNC, and 
low GB volume surgeons (33.19% vs. 25.38%, p<0.0001; 37.61% vs. 22.80%, p<0.0001; 
19.42% vs. 14.46%, p<0.0001, respectively). Furthermore, the patients having a systemic 
complication (vs. no complication) were operated at hospitals with larger bed size, 
hospitals with county population≥1 million, and not-for-profit or government status 
(mean±SD: 417.63±211.51 vs. 385.55±213.34, p<0.0001; 77.05% vs. 663.77%, 
p<0.0001; 53.13% vs. 42.71%, p<0.0001, respectively) (Tables 16 and 17).  
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For hypotheses H2.1 through H2.4:           
A greater proportion of patients having a systemic complication (vs. no 
complication) was male (24.70% vs. 18.09%), but lesser proportion was non-Hispanic 
Black (8.04 % vs. 12.17%, p<0.0001), had Medicare (11.76% vs. 6.52%, p<0.0001), had 
at least one of the selected Elixhauser comorbidities
133
 (88.32% vs. 78.34%, p<0.0001). 
Additionally compared to patients with no in-hospital complications, those having a 
systemic complication were operated by surgeons with low GB volume (21.24% vs. 
16.13%, p<0.0001) and at hospitals with high non-GBC volume- based on principal 
procedures (45.09% vs. 37.96%, p<0.0001). Moreover, patients having a systemic 
complication (vs. no complication) were operated at hospitals with county population≥1 
million (77.66% vs. 65.20%, p<0.0001) and hospitals with not-for-profit or government 
status (52.54% vs. 42.49%) (Tables 18 and 19).         
LOS 
For hypotheses H1.1 through H1.4:           
Patients with higher LOS were females with mean (SD) of 3.36(3.36) days, non-
Hispanic White with mean (SD) of  3.52 (3.61) days, had Medicare with mean (SD) of  
4.59 (6.47) days , had at least one Elixhauser comorbidities
133
 with mean (SD) of 3.45 
(3.09) days, and were operated in the year 2003 with a mean (SD) of 3.53 (3.46) days. In 
addition, patients operated by surgeons with high non-GBC, high non-GBNC, and low GB 
had a higher mean (SD) LOS of 3.73 (2.50), 3.87 (3.36), and 3.79 (4.08) days 
respectively. Furthermore, those operated at hospitals with low volume GB as a principal 
procedure, teaching hospitals, hospitals with county population≥1 million, and hospitals 
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with not-for-profit or government status had a higher mean (SD) LOS of 3.44 (3.52), 4.86 
(6.19), 3.50 (3.14), and 3.62 (4.16) days respectively (Tables 16 and 17).  
For hypotheses H2.1 through H2.4:           
Patients with higher LOS were males with mean (SD) of  3.69 (3.51) days, non-
Hispanic White with mean (SD) of  3.54 (3.66) days, had Medicare with mean (SD) of 
4.68 (6.45) days, had at least one of the selected Elixhauser comorbidities
133
 with mean 
(SD) of 3.45 (3.09) days, were operated in the year 2003 with mean (SD) of 3.56 (3.51) 
days. In addition, patients operated by surgeons with low GB volume, hospitals with high 
non-GBC volume, and hospitals non-GBNC volume- based on principal procedures  had a 
high mean (SD) LOS of 3.80 (4.38) days, 3.77 (4.10) days, and  3.68 (3.75) respectively. 
Furthermore, those operated at teaching hospitals, hospitals with county population≥1 
million, hospitals with not-for-profit or government status had a high mean (SD) LOS of 
4.76 (6.10) days, 3.62 (3.14) days, and 3.62 (4.16) days respectively (Tables 18 and 19).  
Note- Appendix A shows the graphical representation of in-hospital complication rates 
and LOS for gastric bypass patients treated by general surgeons and hospitals with high 
(vs. low) GB, non-GBC, and non-GBNC volumes. 
Unadjusted Results for the Independent Variables and Each Outcome                       
(Hypotheses H1.1 through H2.4) 
 
Tables 20 – 27 present the unadjusted results for the independent variables and each 
outcome of interest. 
Composite Complications 
For hypotheses H1.1 through H1.4: 
The gastric bypass patients operated by general surgeons with high non-GBC 
volume had a slight increased odds of having a composite complication (OR=1.19, 95% 
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CI: 0.74 -1.91).  However,  gastric bypass patients operated by general surgeons with 
high non-GBNC volume had 1.72 times the odds of having a composite complication and 
this result was statistically significant (95% CI: 1.14-2.60) (Table 20).  
For hypotheses H2.1 through H2.4:           
The patients who had gastric bypass procedures done at hospitals with high non-
GBC volume had slight increased odds of having a composite complication (OR=1.11, 
95% CI: 0.71-1.74) and non-GBNC volume had slight decreased odds of having a 
composite complication (OR=0.89, 95% CI: 0.56-1.40) but neither of these results were 
statistically significant (Table 24).              
Technical Complications 
For hypotheses H1.1 through H1.4:           
The gastric bypass patients operated by general surgeons with high non-GBC 
volume had slight decreased odds of having a technical complication (OR=0.94, 95% CI: 
0.64-1.37).  However, gastric bypass patients operated by general surgeons with high 
non-GBNC volume had slight increased odds of having a technical complication 
(OR=1.26, 95% CI: 0.85-1.86) but this result was not statistically significant (Table 21).                       
For hypotheses H2.1 through H2.4:           
The patients who had gastric bypass procedures done at hospitals with high non-
GBC volume and non-GBNC volume had slight decreased odds of having a technical 
complication (OR=0.92, 95% CI: 0.63-1.34; OR=0.82, 95% CI: 0.54-1.22, respectively) 
but these results were not statistically significant (Table 25).              
Systemic Complications 
For hypotheses H1.1 through H1.4:          
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The gastric bypass patients operated by general surgeons with high non-GBC 
volume had a slight increased odds of having a systemic complication (OR=1.46, 95% 
CI: 0.80 -2.68).  However, patients operated by general surgeons with high non-GBNC 
volume had 2.05 times the odds of having a systemic complication and this result was 
statistically significant (95% CI: 1.11-3.77) (Table 22).                  
For hypotheses H2.1 through H2.4: 
The patients who had gastric bypass procedures done at hospitals with high non-
GBC volume and non-GBNC volume had slight increased odds of having a systemic 
complication (OR=1.34, 95% CI: 0.69-2.60; OR=1.03, 95% CI: 0.55-1.96, respectively) 
but neither of these results were statistically significant (Table 26).                                            
LOS 
For hypotheses H1.1 through H1.4:           
The patients who had gastric bypass procedures done by surgeons with high non-
GBC volume and non-GBNC volume had slight increased LOS (Parameter Estimate: 1.13, 
95% CI: 0.94-1.37 and Parameter Estimate: 1.18, 95% CI: 0.99-1.42, respectively) but 
these results were not statistically significant (Table 23). 
For hypotheses H2.1 through H2.4:            
The patients who had gastric bypass procedures done at hospitals with high non-
GBC volume and non-GBNC volume had slight increased LOS (Parameter Estimate: 1.16, 
95% CI: 0.98-1.39 and Parameter Estimate: 1.12, 95% CI: 0.91-1.37, respectively) but 
these results were not statistically significant (Table 27).                                    
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Model Working Correlation Fit Assessment (Hypotheses H1.1 through H2.4) 
Based on the relatively smaller values obtained using the quasilikelihood under 
independence criterion (QIC), independent working correlation structure was selected for 
the analysis purposes for all outcome variables -composite complications, technical 
complications, systemic complications, and LOS for both objective 1 (surgeon non-GB 
volume study), and objective 2 (hospital non-GB volume study) (Tables 28 and 29). 
Adjusted Results for the Association between Surgeon‟s Non-GB Volumes and Each 
Adverse Outcome (Hypotheses H1.1 through H1.4) 
 
Tables 30-33 present the results of multivariate analyses for the association 
between surgeon‟s high non-GB volumes and each outcome. In addition, Tables 30-33 
present adjusted results for the association of surgeon- and hospital-GB volume and each 
outcome of interest. 
The GEE model adjusting for age, sex, race/ethnicity, insurance status, presence 
of comorbidities, surgeon GB volume, hospital GB volume (based on principal 
procedures), hospital teaching status, bed size, ownership status, major metropolitan area 
status, and year, and adjusting standard errors for the non-nested clustering structure, 
showed no clear association between surgeon‟s high non-GBC volume and composite 
complications, technical complications, systemic complications, and LOS (OR: 0.91, 
95% CI: 0.66 - 1.27, p= 0.595; OR: 0.81, 95% CI: 0.63-1.05, p= 0.106; OR: 1.12, 95% 
CI: 0.70 - 1.80, p= 0.641; and Parameter Estimate: 1.05, 95% CI: 0.856 - 1.279, p= 0.656, 
respectively). However, after adjusting for covariates, patients who had gastric bypass 
procedures done by surgeons with high non-GBNC volume had 1.70 times increased odds 
of having a composite complication (95% CI: 1.16 - 2.51, p= 0.007) and 1.88 times 
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increased odds of having a systemic complication ( 95% CI: 1.13 - 3.13, p=0.016) 
(Model 3 in Tables 30 and 32).  
In contrast, the adjusted GEE model showed that patients who had gastric bypass 
procedures done by surgeons with high GB volume had odds of having a composite 
complication and a systemic complication decreased by 27% and 41% respectively (OR: 
0.73, 95% CI: 0.57 - 0.95, p=0.021; OR: 0.59, 95% CI: 0.36 -0.97, p=0.036, 
respectively), and these results were statistically significant. In addition, the adjusted 
GEE model showed that patients who had gastric bypass procedures done at hospitals 
with high GB volume (based on principal procedures) had odds of having a technical 
complication decreased by 28% (OR: 0.72, 95% CI: 0.52 - 0.98, p= 0.039) (Model 3 in 
Tables 30-32). 
For the additional analysis using hospital GB volume based on primary and 
secondary procedures in the model, the adjusted GEE model showed that patients who 
had gastric bypass procedures done by surgeons with high non-GBNC volume had 1.70 
times increased odds of having a composite complication (95% CI: 1.16 - 2.51, p= 0.007) 
and 1.88 times increased odds of having a systemic complication (95% CI: 1.13 - 3.13, 
p=0.015) (Model 4 in Tables 30 and 32). Similar to the results obtained by using hospital 
GB volume based on principal procedures, the adjusted GEE model using hospital GB 
volume based on principal and secondary procedures showed that patients who had 
gastric bypass procedures done by surgeons with high GB volume had odds of a 
composite complication and a systemic complication decreased by 27% and 42% (OR: 
0.73, 95% CI: 0.57 - 0.95, p=0.017; OR: 0.58, 95% CI: 0.36 -0.95, p=0.0290) (Model 4 
in Tables 30 and 32). In addition, the adjusted GEE model showed that patients who had 
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gastric bypass procedures done at hospitals with high GB volume (based on principal and 
secondary procedures) had odds of a technical complication decreased by 29% (OR: 0.71, 
95% CI: 0.51 - 0.98, p= 0.039) (Model 4 in Table 31). 
Adjusted Results for the Association between Hospital‟s Non-GB Volumes and Each 
Adverse Outcome (Hypotheses H2.1 through H2.4) 
 
Tables 34-37 present the results of multivariate analyses for the association 
between hospital‟s high non-GB volumes and each outcome. In addition, Tables 31-34 
present adjusted results for the association of surgeon- and hospital-GB volume and each 
outcome of interest. 
The GEE model adjusting for age, sex, race/ethnicity, insurance status, presence 
of comorbidities, surgeon GB volume, hospital GB volume (based on principal 
procedures), hospital teaching status, bed size, ownership status, major metropolitan area 
status, and year, and adjusting standard errors for the non-nested clustering structure, 
showed no clear association between hospital‟s high non-GBC volume (based on 
principal procedures) and composite complications, technical complications, systemic 
complications, and LOS. However, after adjusting for covariates, patients who had 
gastric bypass procedures done at hospitals with high non-GBNC volume (based on 
principal procedures) had odds of having a composite, technical and systemic 
complication decreased by 49%, 40%, 44% respectively (OR: 0.51, 95% CI: 0.33-0.80, 
p= 0.003; OR: 0.60, 95% CI: 0.42-0.88, p= 0.008; OR: 0.56, 95% CI: 0.28-1.07, p= 
0.077, respectively) but the effect did not reach the level of statistical significance for a 
systemic complication. There was no clear association between patients operated at 
hospitals with high non-GBNC volume (based on principal procedures) and LOS (Model 3 
in Tables 34-36).  
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In contrast, the adjusted GEE model showed that patients who had gastric bypass 
procedures done at hospitals with high GB volume had odds of having a technical 
complication decreased by 30% (OR: 0.70, 95% CI: 0.52 - 0.95, p=0.022). In addition, 
the adjusted GEE model showed that patients who had gastric bypass procedures done by 
surgeons with high GB volume had odds of having a composite and systemic 
complication decreased by 23% and 36% respectively (OR: 0.77, 95% CI: 0.61 - 0.98, p= 
0.032; OR: 0.64, 95% CI: 0.43 - 0.94, p= 0.024) (Model 3 in Table 34-36). 
For the additional analysis using hospital GB and non-GB volumes based on 
primary and secondary procedures in the model, the adjusted GEE model showed that 
patients who had gastric bypass procedures at hospitals with high non-GBNC volume had 
odds of a composite, technical, and systemic complication decreased by 49%, 38%, and 
48% respectively (OR: 0.51, 95% CI: 0.34 - 0.77, p= 0.001; OR: 0.62, 95% CI: 0.45 - 
0.85, p= 0.003; OR: 0.52, 95% CI: 0.28 - 0.98, p= 0.043, respectively) (Model 4 in Table 
31-33). Likewise, the patients who had gastric bypass procedures at hospitals with high 
GB volume (based on principal and secondary procedures) had odds of a technical 
complication decreased by 31% (OR: 0.69, 95% CI: 0.50-0.96, p=0.026) (Model 4 in 
Table 32). In addition, the adjusted GEE model showed that patients who had gastric 
bypass procedures done by surgeons with high GB volume had odds of a composite 
complication and a systemic complication decreased by 34% and 37% (OR: 0.76, 95% 
CI: 0.60 - 0.96, p=0.0215; OR: 0.63, 95% CI: 0.43 -0.92, p=0.018) (Model 4 in Tables 34 
and 37). Thus, the results were similar to those obtained by using hospital GB and non-
GB volumes based on principal procedures. In contrast, the adjusted GEE model using 
hospital GB and non-GB volumes based on principal and secondary procedures showed 
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that the patients who had gastric bypass procedures done at hospitals with high (vs. low) 
non-GBC volume had 1.55 and 1.90 times increased odds of having a composite and a 
systemic complication (95% CI: 1.09 - 2.20, p= 0.016; 95% CI: 1.09 – 3.30, p= 0.023, 
respectively). The gastric bypass patients operated at hospitals with high (vs. low) non-
GBC volume had 38% higher length of stay (Parameter Estimate: 1.38, 95% CI: 1.12-
1.70, p=0.002) (Model 4 in Tables 34, 36 and 37).  
Sub-Analysis 
Unadjusted Association between Surgeon’s Non-GB Volumes and Composite 
Complications and LOS Outcome, Stratified by Surgeon GB Volume - (Hypotheses H1.1 
through H1.4) 
 
The Breslow-Day statistic testing the null hypothesis of homogeneous odds ratio 
for composite complications stratified by surgeon‟s GB volume showed a significant 
result (chi-square value= 11.69, p= 0.0006). 
Within surgeon‟s low GB volume strata, although patients who had gastric bypass 
procedures done by high non-GBC volume surgeons had lower odds of a composite 
complication and had increased LOS than those patients who had their procedures done 
by low non-GBC volume surgeons, the results were not significant (OR: 0.78, 95% CI: 
0.53-1.15, p=0.218 and Parameter Estimate: 1.10, 95% CI: 0.90-1.35, p=0.336, 
respectively). Similarly, the patients who had gastric bypass procedures done by high 
non-GBNC volume surgeons had higher odds of a composite complication and had 
increased LOS than those patients who had their procedures done by low non-GBNC 
volume surgeons, the results were not significant (OR: 1.12, 95% CI: 0.78-1.60, p=0.537 
and Parameter Estimate: 1.02, 95% CI: 0.86-1.22, p=0.800, respectively) (Tables 38 and 
39). 
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Within Surgeon‟s high GB volume strata, although patients who had gastric 
bypass procedures done by high non-GBC volume surgeons had higher odds of a 
composite complication and had increased LOS than those patients who had their 
procedures done by low non-GBC volume surgeons, the results were not significant (OR: 
1.29, 95% CI: 0.72-2.29, p=0.390 and Parameter Estimate: 1.13, 95% CI: 0.90-1.44, 
p=0.293, respectively). In contrast, the patients who had gastric bypass procedures done 
by high non-GBNC volume surgeons had statistically significant higher odds of a 
composite complication (OR: 1.87, 95% CI: 1.12-3.15, p=0.018). However, although 
those patients who had gastric bypass procedures done by high non-GBNC volume 
surgeons had increased LOS, the results were not significant (Parameter Estimate: 1.22, 
95% CI: 0.97-1.52, p=0.086, respectively) (Tables 38 and 39). 
Unadjusted Association between Hospital’s Non-GB Volumes and Composite 
Complications and LOS Outcome, Stratified by Hospital GB Volume - (Hypotheses H2.1 
through H2.4) 
 
The Breslow-Day statistic testing the null hypothesis of homogeneous odds ratio 
for composite complications stratified by hospital‟s GB volume (based on principal 
procedures) did not show a significant result (chi-square value= 1.82, p= 0.1770). 
        For both hospital‟s low GB and high GB volume strata, there was no clear 
association between patients who had gastric bypass procedures done at hospitals with 
high (vs. low) non-GBC volume, high (vs. low) non-GBNC volume and composite 
complication as well as LOS outcomes (Tables 40 and 41). 
Adjusted Association between Surgeon’s Non-GB Volumes and Composite Complications 
and LOS Outcome, Stratified by Surgeon GB Volume - (Hypotheses H1.1 through H1.4) 
 
Within Surgeon‟s low GB volume strata, the GEE model adjusting for age, sex, 
race/ethnicity, insurance status, presence of comorbidities, surgeon GB volume, hospital 
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GB volume (based on principal procedures), hospital teaching status, bed size, ownership 
status, major metropolitan area status, and year, and adjusting standard errors for the non-
nested clustering structure, showed no clear association between surgeon‟s high non-GBC 
volume and composite complications (OR: 0.90, 95% CI: 0.64-1.25, p=0.515) and LOS 
(Parameter Estimate: 1.11, 95% CI: 0.89-1.38, p=0.374), and between surgeon‟s high 
non-GBNC volume and composite complications (OR: 0.91, 95% CI: 0.62-1.32, p=0.607) 
and LOS (Parameter Estimate: 1.03, 95% CI: 0.80-1.31, p=0.837) for gastric bypass 
patients (Tables 42 and 43). 
Within Surgeon‟s high GB volume strata, the adjusted GEE model showed no 
clear association between surgeon‟s high non-GBC volume and composite complications 
(OR: 0.91, 95% CI: 0.62-1.32, p=0.607) and LOS (Parameter Estimate: 1.03, 95% CI: 
0.80-1.31, p=0.837) for gastric bypass patients. In contrast, patients who had gastric 
bypass procedures done by surgeons with high non-GBNC volume had higher odds of a 
composite complication (OR: 1.97, 95% CI: 1.30-2.99, p=0.001) and had increased LOS 
(Parameter Estimate: 1.26, 95% CI: 1.02-1.55, p=0.032) (Tables 42 and 43). 
Adjusted Association between Hospital’s Non-GB Volumes and Composite Complications 
and LOS Outcome, Stratified by Hospital GB Volume - (Hypotheses H2.1 through H2.4) 
 
For both low GB volume and high GB volume hospital strata, the GEE model 
adjusting for age, sex, race/ethnicity, insurance status, presence of comorbidities, surgeon 
GB volume, hospital GB volume (based on principal procedures), hospital teaching 
status, bed size, ownership status, major metropolitan area status, and year, and adjusting 
standard errors for the non-nested clustering structure showed no clear association 
between hospital‟s high non-GBC volume and composite complication as well LOS 
outcomes (Table 44).  
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Within hospital‟s low GB volume strata, the adjusted GEE model showed that 
patients who had gastric bypass procedures done at hospitals with high non-GBNC volume 
had lower odds of a composite complication (OR: 0.56, 95% CI: 0.37-0.85, p=0.006). 
Likewise, within hospital‟s high GB volume strata, the adjusted GEE model showed that 
patients who had gastric bypass procedures done at hospitals with high non-GBNC volume 
had lower odds of a composite complication (OR: 0.42, 95% CI: 0.20-0.91, p=0.027) 
(Table 45). 
Sensitivity Analysis 
Adjusted Results for Surgeon’s Non-GB Volume Variables and Each Outcome- 
(Hypotheses H1.1 through H1.4) 
 
The sensitivity analysis was performed using both surgeon‟s non-GBC and non-GBNC 
volume as a categorical variable (low- referent, medium, and high volume) based on the 
volume tertile approach. 
Composite Complications 
The GEE model adjusting for age, sex, race/ethnicity, insurance status, presence 
of comorbidities, surgeon GB volume, hospital GB volume (based on principal 
procedures), hospital teaching status, bed size, ownership status, major metropolitan area 
status, and year, and adjusting standard errors for the non-nested clustering structure, 
showed no clear association between surgeon‟s high (vs. low) non-GBC volume, 
surgeon‟s medium (vs. low) non-GBC volume and composite complications for gastric 
bypass patients. 
However, the adjusted GEE model showed that patients who had gastric bypass 
procedures done by surgeons with high (vs. low) non-GBNC volume had higher odds of a 
composite complication (OR: 1.74, 95% CI: 1.10-2.78, p=0.018) (Table 46). 
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Technical Complications 
The GEE model adjusting for age, sex, race/ethnicity, insurance status, presence 
of comorbidities, surgeon GB volume, hospital GB volume (based on principal 
procedures), hospital teaching status, bed size, ownership status, major metropolitan area 
status, and year, and adjusting standard errors for the non-nested clustering structure, 
showed no clear association between surgeon‟s high (vs. low) non-GBC volume, 
surgeon‟s medium (vs. low) non-GBC volume, and technical complications for gastric 
bypass patients. In addition, there was no association between surgeon‟s high (vs. low) 
non-GBNC volume, surgeon‟s medium (vs. low) non-GBNC volume, and technical 
complications (Table 46). 
Systemic Complications 
The GEE model adjusting for age, sex, race/ethnicity, insurance status, presence 
of comorbidities, surgeon GB volume, hospital GB volume (based on principal 
procedures), hospital teaching status, bed size, ownership status, major metropolitan area 
status, and year, and adjusting standard errors for the non-nested clustering structure, 
showed no clear association between surgeon‟s high (vs. low) non-GBC volume, 
surgeon‟s medium (vs. low) non-GBC volume and systemic complications for gastric 
bypass patients. 
However, the adjusted GEE model showed that patients who had gastric bypass 
procedures done by surgeons with high (vs. low) non-GBNC volume had higher odds of a 
systemic complication (OR: 1.95, 95% CI: 1.08-3.50, p=0.025) (Table 46). 
LOS 
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The GEE model adjusting for age, sex, race/ethnicity, insurance status, presence 
of comorbidities, surgeon GB volume, hospital GB volume (based on principal 
procedures), hospital teaching status, bed size, ownership status, major metropolitan area 
status, and year, and adjusting standard errors for the non-nested clustering structure, 
showed no clear association between surgeon‟s high (vs. low) non-GBC volume, 
surgeon‟s medium (vs. low) non-GBC volume, and LOS for gastric bypass patients. In 
addition, although patients who had gastric bypass procedures done by surgeons with 
high (vs. low) non-GBNC volume had higher LOS, the results were not statistically 
significant (Parameter Estimate: 1.15, 95% CI: 0.81-1.61, p=0.435) (Table 46). 
Adjusted Results for Hospital’s non-GB Volume Variables and Each Outcome- 
(Hypotheses H2.1 through H2.4) 
 
The sensitivity analysis was performed using both hospital‟s non-GBC and non-
GBNC volume as a categorical variable (low- referent, medium, and high volume) based 
on the volume tertile approach. 
The  GEE model adjusting for age, sex, race/ethnicity, insurance status, presence 
of comorbidities, surgeon GB volume, hospital GB volume (based on principal 
procedures), hospital teaching status, bed size, ownership status, major metropolitan area 
status, and year, and adjusting standard errors for the non-nested clustering structure, 
showed that patients who had gastric bypass procedures done at hospitals with high (vs. 
low) non-GBNC volume had decreased odds of a composite, technical and systemic 
complication (OR: 0.46, 95% CI: 0.20-1.05, p=0.066; OR: 0.58, 95% CI: 0.33-1.03, 
p=0.062; OR: 0.46, 95% CI: 0.13-1.64, p=0.233). However, the results were not 
statistically significant for all three complications (Table 47). 
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TABLE 5: Patient characteristics for gastric bypass discharges in Florida, 2003-2004 
 
Patient Characteristics 
Objective 1                                                      
All Adults                                        
(n=11,363, s=108, h=73 ) 
n (%) 
Objective 2                                               
All Adults                                    
(n= 11,857, s=160, h=81) 
n (%) 
Age, mean (SD)*; Median (range) 42.5 (10.8); 42 (18-75) 42.5 (10.8);  42 (18-80) 
Age (in years)     
18-29  1,408 (12.39)    1,476 (12.45)   
30-39 3,257 (28.66) 3,426 (28.89) 
40-49 3,443 (30.30) 3,585 (30.24) 
50-59 2,592 (22.81) 2,680 (22.60) 
≥60 663 (5.83) 690 (5.82) 
Gender     
Male 2116 (18.62) 2,223 (18.75) 
Female  9247 (81.38) 9,634 (81.25) 
Race/Ethnicity     
Non-Hispanic White 7,934 (69.82) 8,208 (69.22) 
Non-Hispanic Black 1,302 (11.46) 1,394 (11.76) 
Hispanic 1,819 (16.01) 1,932 (16.29) 
Other 308 (2.71) 323 (2.72) 
Payer Type     
Medicare 778 (6.85) 835 (7.04) 
Medicaid 269 (2.37) 342 (2.88) 
Private 9,127 (80.32) 9,465 (79.83) 
Self pay/ underinsured 707 (6.22) 731 (6.17) 
Other 482 (4.24) 484 (4.08) 
Elixhauser Comorbidities     
Presence of comorbidities 8,977 (79.00) 9,396 (79.24) 
Congestive heart failure 131 (1.15) 140 (1.18) 
Arrythmia 352 (3.10) 369 (3.11) 
Valvular disease 197 (1.73) 204 (1.72) 
Peripheral vascular disease 140 (1.23) 141 (1.19) 
Hypertension 5,804 (51.08) 6,075 (51.24) 
Pulmonary circulation disease 36 (0.32) 38 (0.32) 
Other neurologic disorder 55 (0.48) 57 (0.48) 
Chronic pulmonary disease 1,659 (14.60) 1,744 (14.71) 
Diabetes mellitus without chronic 
complications 2,857 (25.14) 2,983 (25.16) 
Diabetes mellitus with chronic 
complications 128 (1.13) 133 (1.12) 
Hypothyroidism 1,016 (8.94) 1,063 (8.97) 
Liver disease 1,116 (9.82) 1,170 (9.87) 
Rheumatoid arthritis 126 (1.11) 132 (1.11) 
Coagulopathy 44 (0.39) 50 (0.42) 
Psychoses 91 (0.80) 99 (0.83) 
Depression 1,730 (15.22) 1,830 (15.43) 
Sleep apnea 3,723 (32.76) 3,956 (33.36) 
Year     
2003 6,431 (56.60) 6,690 (56.42) 
2004 4,932 (43.40) 5,167 (43.58) 
*SD= standard deviation; n= patients; s=surgeons; h=hospitals 
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TABLE 6: Distribution of gastric bypass discharges across provider characteristics in 
Florida, 2003-2004 
 
Characteristics 
Objective 1                                             
All Adults                        
(n=11,363, s=108, h=73 ) 
n (%) 
Objective 2                                              
All Adults                                         
(n= 11,857, s=160, h=81) 
n (%) 
Surgeon characteristics   
Surgeon non-GBC volume, 
mean(SD*); Median 
41.51 (31.45); 32.0 
(range=0-258) - 
≤50 procs/yr (lower 66th percentile) 8,391 (73.84) - 
>50 procs/yr (upper 33rd percentile) 2,972 (26.16) - 
low volume, <26 procs/yr (<33rd 
percentile)- complex procedure 4,182 (36.80) - 
medium volume, between 26 and 50 
procs/yr  (between 33rd and 66th  
percentile)- complex procedure 4,209 (37.04) - 
high volume, >50 procs/yr (>66th 
percentile)- complex procedure 2,972 (26.16) - 
Surgeon non-GBNC volume, mean, 
(SD); Median) 
112.08 (81.65); 92.0 
(range= 0-474) - 
≤142 procs/yr (lower 66th percentile) 8,604 (75.72) - 
>142 procs/yr (upper 33rd percentile) 2,759 (24.28) - 
low volume, <78 procs/yr (<33rd 
percentile)- complex procedure 4,925 (43.34) - 
medium volume, between 78 and 142 
procs/yr (between 33rd and 66th  
percentile)- complex procedure 3,679 (32.38) - 
high volume, >142 procs/yr (>66th 
percentile)- complex procedure 2,759 (24.28) - 
Surgeon GB volume (mean, 
SD*/Median)  
174.63 (107.66), 163.0 
(range= 1-377) 
169.10 (108.81), 155.0             
(range=1-377) 
≤50 procs/yr  1,699 (14.95) 1,973 (16.64) 
>50 procs/yr 9,664 (85.05) 9,884 (83.36) 
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TABLE 6 (continued)  
 
 Characteristics 
Objective 1                                                      
All Adults                                        
(n=11,363, s=108, h=73 ) 
n (%) 
Objective 2                                               
All Adults                                    
(n= 11,857, s=160, h=81) 
n (%) 
Hospital Characteristics     
Hospital volumes based on principal 
procedures   
Hospital non-GBC volume, mean(SD*); 
median (range) - 
2,766.10 (1,970.93), 
2,065.00                   
(range=7-11,425) 
≤2,743 procs/yr (lower 66th percentile) - 7,272 (61.33) 
>2,743 procs/yr (upper 33rd percentile) - 4,585 (38.67) 
low volume, <1,271 procs/yr (<33rd 
percentile)- complex procedure - 2,234 (18.84) 
medium volume, between 1,271 and 
2,743 procs/yr (between 33rd and 66th  
percentile)- complex procedure - 5,038 (42.49) 
high volume,>2,743 procs/yr (>66th 
percentile)- complex procedure - 4,585 (38.67) 
Hospital non-GBNC volume, mean(SD*); 
median (range) - 
6,178.16 (3411.02), 5,458 
(range=138-20,372) 
≤6,478 procs/yr (lower 66th percentile) - 7,059 (59.53) 
>6,478 procs/yr (upper 33rd percentile) - 4,798 (40.47) 
low volume, <3,376 (<33rd percentile)- 
complex procedure - 2,710 (22.86) 
medium volume, between 3,376 and 
6,478 procs/yr (between 33rd and 66th  
percentile)- complex procedure - 4,349 (36.68) 
high volume, >6,478 procs/yr (>66th 
percentile)- complex procedure - 4,798 (40.47) 
Hospital GB volume, mean(SD*); median 
(range) 
240.80 (158.96), 225.0 
(range=1-643) 
234.58 (159.90), 213.0 
(range=1-643) 
≤125 procs/yr 3,704 (32.60) 4,095 (34.54) 
>125 procs/yr 7,659 (67.40) 7,762 (65.46) 
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TABLE 6 (continued)  
 
 Characteristics 
Objective 1                                                      
All Adults                                        
(n=11,363, s=108, h=73 ) 
n (%) 
Objective 2                                               
All Adults                                    
(n= 11,857, s=160, h=81) 
n (%) 
Hospital volumes based on 
principal and secondary 
procedures     
Hospital non-GBC volume, 
mean(SD*); median (range) - 
4,586.97(3,190.35), 3,365 
(range=29-18,196) 
≤4,617 procs/yr (lower 66th 
percentile) - 7,246 (61.11) 
>4,617 procs/yr (upper 33rd 
percentile) - 4,611 (38.89) 
Hospital non-GBNC volume, 
mean(SD*); median (range) - 
17,594.80 (10,931.91), 15,257 
(range=1189-69,468) 
≤18,082 procs/yr (lower 66th 
percentile) - 7,354 (62.02) 
>18,082 procs/yr (upper 33rd 
percentile) - 4,503 (37.98) 
Hospital GB volume, mean(SD*); 
median (range)  
240.80 (158.96), 225.0 
(range=1-643) 
238.39 (159.68), 219.0 
(range=1-647) 
≤125 procs/yr  3,704 (32.60) 3,922 (33.08) 
>125 procs/yr 7,659 (67.40) 7,935 (66.92) 
Bed size (mean [SD], median) 389.26 (213.72), 378 386.83 (211.10), 353 
Bed size, categorical     
less than 200 2, 072 (18.23) 2,111 (17.8) 
200-299 2, 497 (21.97) 2,722 (22.96) 
300-399 1,789 (15.74) 1,895 (15.98) 
400-499 2,020 (17.78) 2,056 (17.34) 
500+ 2,985 (26.27) 3,073 (25.92) 
Teaching status     
Teaching  619 (5.47) 643 (5.45) 
Non-teaching 10,692 (94.53) 11,149 (94.55) 
Major metropolitan area     
Hospital county population≥1 
million 7,397 (65.10) 7,878 (66.44) 
Hospital county population<1 
million 3,966 (34.90) 3,979 (33.56) 
Ownership     
Categorical     
For profit 6,392 (56.51) 6,700 (56.51) 
Government 448 (3.96) 448 (3.78) 
Not-for-profit 4,471 (39.53) 4,709 (39.71) 
Dichotomous     
For profit 6,392 (56.25) 6,700 (56.51) 
Not-for-profit or government 4,971 (43.75) 5,157 (43.49) 
*SD= standard deviation; n= patients; s=surgeons; h=hospitals 
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TABLE 7: In-hospital outcomes for gastric bypass discharges in Florida, 2003-2004 
 
Outcomes 
Objective 1                                                      
All Adults                                        
(n=11,363, s=108, h=73 ) 
n (%) 
Objective 2                                               
All Adults                                    
(n= 11,857, s=160, h=81) 
n (%) 
In-hospital mortality 21 (0.18) 22 (0.19) 
Complications     
Technical 1,244 (10.95) 1,333 (11.24) 
Small bowel obstruction 168 (1.48) 172 (1.45) 
Splenic 35 (0.31) 35 (0.30) 
Unexpected reoperations 620 (5.46) 670 (5.65) 
Wound 83 (0.73) 92 (0.78) 
Hemorrhage/hematoma 354 (3.12) 384 (3.24) 
Anastomotic leak 317 (2.79) 326 (2.75) 
Systemic 1,133 (9.97) 1,182 (9.97) 
Thromboembolism (PE/DVT) 24 (0.21) 24 (0.20) 
Pulmonary 979 (8.62) 1,019 (8.59) 
Cardiac 101 (0.89) 112 (0.94) 
Postoperative shock 8 (0.07) 8 (0.07) 
Genitourinary 120 (1.06) 128 (1.08) 
Composite- Any complications 2,060 (18.13) 2,181 (18.39) 
Composite- death/any complication 2,063 (18.16) 2,184 (18.42) 
LOS in days, mean(SD*); median 3.41 (3.40), 3.0 3.45 (3.49), 3.0 
*SD= standard deviation; n= patients; s=surgeons; h=hospitals 
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TABLE 8: Comparison of patient characteristics, according to surgeon volume of non-
gastric bypass complex procedures in Florida, 2003-2004 
 
  Surgeon non-GBC volume 
Patient Characteristics 
Low (≤50 procs/year)                        
(n=8,391) 
High (>50 procs/year)                          
(n= 2,972 ) p-value 
Age, mean(SE*) 42.31±0.12 43.12±0.20 0.0005 
Age, yrs n (%)   0.029 
18-29 1,075 (12.81) 333 (11.20)   
30-39 2,436 (29.03) 821 (27.62)   
40-49 2,528 (30.13) 915 (30.79)   
 50-59 1,877 (22.37) 715 (24.06)   
≥ 60 475 (5.66) 188 (6.33)   
Gender, n (%)   0.495 
Male 1,575 (18.77) 541 (18.20)   
Female  6,816 (81.23) 2,431 (81.80)   
Race/Ethnicity, n (%)   <0.0001 
Non-Hispanic White 5,719 (68.16) 2,215 (74.53)   
Non-Hispanic Black 989 (11.79) 313 (10.53)   
Hispanic 1,473 (17.55) 346 (11.64)   
Other 210 (2.50) 98 (3.30)   
Payer Type, n (%)   <0.0001 
Medicare 521 (6.21) 257 (8.65)   
Medicaid 174 (2.07) 95 (3.20)   
Commercial 6,752 (80.47) 2,375 (79.91)   
Self pay/ uninsured 563 (6.71) 144 (4.85)   
Other 381 (4.54) 101 (3.40)   
Elixhauser Comorbidities, n (%)     
Presence of comorbidities 6,619 (78.88) 2,358 (79.34) 0.598 
Congestive heart failure 71 (0.85) 60 (2.02) <0.0001 
Arrythmia 251 (2.99) 101 (3.40) 0.271 
Valvular disease 151 (1.80) 146 (1.55) 0.366 
Peripheral vascular disease 79 (0.94) 61 (2.05) <0.0001 
Hypertension 4,246 (50.60) 1,558 (52.42) 0.088 
Pulmonary circulation disease 27 (0.32) 9 (0.30) 0.874 
Other neurologic disorder 38 (0.45) 17 (0.57) 0.421 
Chronic pulmonary disease 1,231 (14.67) 428 (14.40) 0.721 
Diabetes mellitus without chronic 
complications 2,065 (24.61) 792 (26.65) 0.028 
Diabetes mellitus with chronic 
complications 92 (1.10) 36 (1.21) 0.61 
Hypothyroidism 743 (8.85) 273 (9.19) 0.587 
Liver disease 1,053 (1.55) 63 (2.12) <0.0001 
Rheumatoid arthritis 89 (1.06) 37 (1.24) 0.41 
Coagulopathy 32 (0.38) 12 (0.40) 0.866 
Psychoses 58 (0.69) 33 (1.11) 0.028 
Depression 1,257 (14.98) 473 (15.92) 0.223 
Sleep apnea 2,779 (33.12) 944 (31.76) 0.176 
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TABLE 8 (continued) 
 
  Surgeon non-GBC volume 
Patient Characteristics 
Low (≤50 procs/year)                        
(n=8,391) 
High (>50 procs/year)                          
(n= 2,972 ) p-value 
Year   <0.0001 
2003 4,391 (52.33) 2,040 (68.64)  
2004 4,000 (47.67) 932 (31.36)  
*SE= standard error; total number of surgeons=108; total number of hospitals=73 
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TABLE 9: Comparison of provider characteristics (at patient-level), according to surgeon 
volume of non-gastric bypass complex procedures in Florida, 2003-2004 
 
  Surgeon non-GBC volume 
  
Low                                 
(≤50 procs/year)                        
(n=8,391) 
High                       
(>50 procs/year)                          
(n= 2,972 ) p-value 
Surgeon Characteristics    
Surgeon GB volume, n(%)   0.051 
>50 procs/yr 7,169 (85.44) 2,495 (83.95)  
≤50 procs/yr  1,222 (14.56) 477 (16.05)  
Surgeon non-GBNC volume, n(%)   <0.0001 
≤142 procs/yr (lower 66th percentile) 7,392 (88.09) 1,212 (40.78)  
>142 procs/yr (upper 33rd percentile) 999 (11.91) 1,760 (59.22)  
Hospital Characteristics    
Hospital GB volume (principal 
procedures), n(%)   0.001 
>125 procs/yr 5,732 (68.31) 1,927 (64.84)  
≤125 procs/yr 2,659 (31.69) 1,045 (35.16)  
Hospital GB volume (all procedures), 
n(%)   0.069 
>125 procs/yr 5,823 (69.40) 2,009 (67.60)  
≤125 procs/yr 2,568 (30.60) 963 (32.40)  
Bed size, mean±SE 400.36±2.45 355.96±3.21 <0.0001 
Bed size, n(%)   <0.0001 
less than 200 1,467 (17.48) 605 (20.36)  
200-299 1,769 (21.08) 728 (24.50)  
300-399 1,139 (13.57) 650 (21.87)  
400-499 1,528 (18.21) 492 (16.55)  
500+ 2,488 (29.65) 497 (16.72)  
Teaching hospital, n(%) 536 (6.43) 83 (2.79) <0.0001 
Major metropolitan area, n(%) 5,686 (67.76) 1,711 (57.57) <0.0001 
Ownership, n(%)   <0.0001 
For profit 4,458 (53.13) 1,934 (65.07)  
Government 434 (5.17) 14 (0.47)  
Not-for-profit 3,499 (41.70) 1,024 (34.45)  
Dichotomous   <0.0001 
For profit 4,458 (53.13) 1,934 (65.07)  
Not-for-profit or government 3,933 (46.87) 1,038 (34.93)  
*SE= standard error; total number of surgeons=108; total number of hospitals=73 
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TABLE 10: Comparison of patient characteristics, according to surgeon volume of non-
gastric bypass non-complex procedures in Florida, 2003-2004 
 
  Surgeon non-GBNC volume 
Patient Characteristics 
Low (≤142 procs/year)                        
(n=8,604 ) 
High (>142 procs/year)                          
(n=2,759 ) p-value 
Age, mean(SE*) 42.51±0.12 42.57±0.21 0.7873 
Age, yrs n(%)   0.805 
18-29 1,054 (12.25) 354 (12.83)   
30-39 2,480 (28.82) 777 (28.16)   
40-49 2,601 (30.23) 842 (30.52)   
 50-59 1,974 (22.94) 618 (22.40)   
≥ 60 495 (5.75) 168 (6.09)   
Gender, n(%)   0.812 
Male 1,598 (18.57) 518 (18.77)   
Female  7,006 (81.43) 2,241 (81.23)   
Race/Ethnicity, n(%)   <0.0001 
Non-Hispanic White 6,205 (72.12) 1,729 (62.67)   
Non-Hispanic Black 1,016 (11.81) 286 (10.37)   
Hispanic 1,182 (13.74) 637 (23.09)   
Other 201 (2.34) 107 (3.88)   
Payer Type, n(%)   <0.0001 
Medicare 524 (6.09) 254 (9.21)   
Medicaid 159 (1.85) 110 (3.99)   
Private 6,912 (80.33) 2,215 (80.28)   
Self pay/ underinsured 574 (6.67) 133 (4.82)   
Other 435 (5.06) 47 (1.70)   
Elixhauser Comorbidities, n(%)     
Presence of comorbidities 6,804 (79.08) 2,173 (78.76) 0.72 
Congestive heart failure 79 (0.92) 52 (1.88) <0.0001 
Arrythmia 256 (2.98) 96 (3.48) 0.184 
Valvular disease 143 (1.66) 54 (1.96) 0.301 
Peripheral vascular disease 126 (1.46) 14 (0.51) <0.0001 
Hypertension 4,329 (50.31) 1,575 (53.46) 0.004 
Pulmonary circulation disease 26 (0.30) 10 (0.36) 0.624 
Other neurologic disorder 42 (0.49) 13 (0.47) 0.911 
Chronic pulmonary disease 1,245 (14.47) 414 (15.01) 0.488 
Diabetes mellitus without chronic 
complications 2,091 (24.30) 766 (27.76) <0.0001 
Diabetes mellitus with chronic 
complications 98 (1.14) 30 (1.09) 0.823 
Hypothyroidism 777 (9.03) 239 (8.66) 0.555 
Liver disease 1026 (11.92) 90 (3.26) <0.0001 
Rheumatoid arthritis 97 (1.13) 29 (1.05) 0.739 
Coagulopathy 33 (0.38) 11 (0.40) 0.911 
Psychoses 60 (0.70) 31 (1.12) 0.029 
Depression 1,452 (16.88) 278 (10.08) <0.0001 
Sleep apnea 2,750 (31.96) 973 (35.27) 0.001 
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TABLE 10 (continued) 
 
  Surgeon non-GBNC volume 
Patient Characteristics 
Low (≤142 procs/year)                        
(n=8,604 ) 
High (>142 procs/year)                          
(n=2,759 ) p-value 
Year   <0.0001 
2003 5,136 (59.69) 1,295 (46.94)  
2004 3,468 (40.31) 1,464 (53.06)  
*SE= standard error; total number of surgeons=108; total number of hospitals=73 
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TABLE 11: Comparison of provider characteristics and year (at patient-level), according 
to surgeon volume of non-gastric bypass non-complex procedures in 
Florida, 2003-2004 
 
  Surgeon non-GBNC volume 
  
Low                       
(≤142 procs/year)                        
(n=8,604 ) 
High                          
(>142 procs/year)                          
(n=2,759 ) p-value 
Surgeon Characteristics    
Surgeon GB volume, n(%)   <0.0001 
>50 procs/yr 7,394 (85.94) 2,270 (82.28)  
≤50 procs/yr  1,210 (14.06) 489 (17.72)  
Surgeon non-GBC volume, n(%)   <0.0001 
≤50procs/yr (lower 66th percentile) 7,392 (85.91) 999 (36.21)  
>50 procs/yr (upper 33rd percentile) 1,212 (14.09) 1,760 (63.79)  
Hospital Characteristics    
Hospital GB volume (principal 
procedures), n(%)   <0.0001 
>125 procs/yr 6,085 (70.72) 1,574 (57.05)  
≤125 procs/yr 2,519 (29.28) 1,185 (42.95)  
Hospital GB volume (all procedures), 
n(%)   <0.0001 
>125 procs/yr 6,220 (72.29) 1,612 (58.43)  
≤125 procs/yr 2,384 (27.71) 1,147 (41.57)  
Bed size, mean±SE 377.72±2.03 423.14±5.24 <0.0001 
Bed size, n(%)   <0.0001 
less than 200 1,713 (19.91) 359 (13.01)  
200-299 2,027 (23.56) 470 (17.04)  
300-399 992 (11.53) 797 (28.89)  
400-499 1,575 (18.31) 445 (16.13)  
500+ 2,297 (26.70) 688 (24.94)  
Teaching hospital, n(%) 468 (5.47) 151 (5.47) 0.999 
Major metropolitan area, n(%) 5,286 (61.44) 2,111 (76.51) <0.0001 
Ownership, n(%)   0.002 
For profit 4,828 (56.11) 1,564 (56.69)  
Government 310 (3.60) 138 (5.00)  
Not-for-profit 3,466 (40.28) 1,564 (56.29)  
Dichotomous   0.597 
For profit 4,828 (56.11) 1,564 (56.69)  
Not-for-profit or government 3,776 (43.89) 1,195 (43.31)  
*SE= standard error; total number of surgeons=108; total number of hospitals=73 
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TABLE 12: Comparison of patient characteristics, according to hospital volume of non-
gastric bypass complex procedures in Florida, 2003-2004 
 
  Hospital non-GBC volume 
Patient Characteristics 
Low                            
(≤2,743 procs/yr)                        
(n=7,272) 
High                
(>2,743 procs/yr)                          
(n= 4,585) p-value 
Age, mean±SE* 42.52 ±0.13 42.37±0.16 0.4791 
Age, yrs n (%)   0.309 
18-29 904 (12.43) 572 (12.48)  
30-39 2099 (28.86) 1,372 (28.94)  
40-49 2,188 (30.09) 1,397 (30.47)  
 50-59 1,631 (22.43) 1,049 (22.88)  
≥ 60 450 (6.19) 240 (5.23)  
Gender, n (%)   0.319 
Male 1,384 (19.03)) 839 (18.30)  
Female  5,888 (80.97) 3,746 (81.70)  
Race/Ethnicity, n (%)   <0.0001 
Non-Hispanic White 4,999 (68.74) 3,209 (69.99)  
Non-Hispanic Black 911 (12.53) 483 (10.53)  
Hispanic 1,115 (15.33) 817 (17.82)  
Other 247 (3.40) 76 (1.66)  
Payer Type, n (%)   <0.0001 
Medicare 532 (7.32) 303 (6.61)  
Medicaid 230 (3.16) 112 (2.44)  
Private 5,623 (77.32) 3,842 (83.78)  
Self pay/ uninsured 472 (6.49) 259 (5.65)  
Other 415 (5.71) 69 (1.50)  
Elixhauser Comorbidities, n(%)   <0.0001 
Presence of comorbidities 5,652 (77.72) 3,744 (81.66)   
Congestive heart failure 87 (1.20) 53 (1.16) 0.843 
Arrythmia 220 (3.03) 149 (3.25) 0.493 
Valvular disease 108 (1.49) 96 (2.09) 0.013 
Peripheral vascular disease 26 (0.36) 115 (2.51) <0.0001 
Hypertension 3,702 (50.91) 2,373 (51.76) 0.368 
Pulmonary circulation disease 18 (0.25) 20 (0.44) 0.077 
Other neurologic disorder 32 (0.44) 25 (0.55) 0.420 
Chronic pulmonary disease 1,063 (14.62) 681 (14.85) 0.725 
Diabetes mellitus without chronic complications 1,823 (25.07) 1,160 (25.30) 0.778 
Diabetes mellitus with chronic complications 93 (1.28) 40 (0.87) 0.041 
Hypothyroidism 634 (8.72) 429 (9.36) 0.236 
Liver disease 723 (9.94) 447 (9.75) 0.731 
Rheumatoid arthritis 83 (1.14) 49 (1.07) 0.713 
Coagulopathy 31 (0.43) 19 (0.41) 0.922 
Psychoses 61 (0.84) 38 (0.83) 0.953 
Depression 1,025 (14.10) 805 (17.56) <0.0001 
Sleep apnea 2,184 (30.03) 1,772 (38.65) <0.0001 
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TABLE 12 (continued) 
 
  Hospital non-GBC volume 
Patient Characteristics 
Low                            
(≤2,743 procs/yr)                                         
(n=7,272) 
High                  
(>2,743 procs/yr)                                            
(n= 4,585) p-value 
Year   <0.0001 
2003 3,760 (51.71) 2,930 (63.90)   
2004 3,512 (48.29) 1,655 (36.10)  
*SE= standard error; total number of surgeons=160; total number of hospitals=81 
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TABLE 13: Comparison of gastric bypass provider characteristics (at patient-level), 
according to hospital volume of non-gastric bypass complex procedures in 
Florida, 2003-2004 
 
  Hospital non-GBC volume 
  
Low                            
(≤2,743 procs/yr)                        
(n=7,272) 
High                           
(>2,743 procs/yr)                          
(n=  4,585) p-value 
Surgeon Characteristics     
Surgeon GB volume, n(%)   <0.0001 
>50 procs/yr 6,193 (85.16) 3,691 (80.50)   
≤50 procs/yr  1,079 (14.84) 894 (19.50)   
Hospital Characteristics     
Hospital volume based on principal 
procedures     
Hospital non-GBNC volume, n(%)   <0.0001 
>6,478 procs/yr 795 (10.93) 4,003 (87.31)   
≤6,478 procs/yr 6,477 (89.07) 582 (12.69)   
Hospital GB volume, n(%)   0.565 
>125 procs/yr 4,746 (65.26) 3,016 (65.78)   
≤125 procs/yr 2,526 (34.74) 1,569 (34.22)   
Bed size, Mean±SE 296.20 (3.39) 530.58 (1.57)   
Bed size, n(%)   <0.0001 
Less than 200 2,111 (29.03) 0 (0.00)  
200-299 1,897 (26.09) 825 (17.99)   
300-399 1,534 (21.09) 361 (7.87)   
400-499 968 (13.31) 1,088 (23.73)   
500+ 762 (10.48) 2,311 (50.40)   
Teaching hospital, n(%) 0 (0.00) 643 (14.02) <0.0001 
Major metropolitan area- county 
population ≥1 million, n(%) 4,903 (67.42) 2,975 (64.89) 0.004 
Ownership, n(%)   <0.0001 
For profit 5,699 (77.96) 1,031 (22.49)   
Government 264 (3.63) 184 (4.01)   
Not-for-profit 1,339 (18.41) 3,370 (73.50)   
Dichotomous   <0.0001 
For profit 5,669 (77.96) 1,031 (22.49)   
Not-for-profit or government 1,603 (22.04) 3, 554 (77.51)   
*SE= standard error; total number of surgeons=160; total number of hospitals=81 
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TABLE 14: Comparison of patient characteristics, according to hospital volume of non-
gastric bypass non-complex procedures in Florida, 2003-2004 
 
  Hospital non-GBNC volume 
Patient Characteristics 
Low                        
(≤6,478 procs/yr)                        
(n=7,059) 
High                     
(> 6,478 procs/yr)                          
(n=4,798  ) p-value 
Age, mean(SE*) 42.38±0.13 42.57±0.16 0.341 
Age, yrs n(%)   0.201 
18-29 860 (12.18) 616 (12.84)   
30-39 2,088 (29.58) 1,338 (27.89)   
40-49 2,145 (30.39) 1,440 (30.01)   
 50-59 1,562 (22.13) 1,118 (23.30)   
≥ 60 404 (5.72) 286 (5.96)   
Gender, n(%)   0.865 
Male 1327 (18.8) 896 (18.67)   
Female  5,732 (81.20) 3,902 (81.33)   
Race/Ethnicity, n(%)   <0.0001 
Non-Hispanic White 4,816 (68.22) 3,392 (70.70)   
Non-Hispanic Black 880 (12.47) 514 (10.71)   
Hispanic 1,119 (15.85) 813 (16.94)   
Other 244 (3.46) 79 (1.65)   
Payer Type, n(%)   <0.0001 
Medicare 490 (6.94) 345 (7.19)   
Medicaid 227 (3.22) 115 (2.40)   
Private 5,479 (77.62) 3,986 (83.08)   
Self pay/ uninsured 470 (6.66) 261 (5.44)   
Other 393 (5.57) 91 (1.90)   
Elixhauser Comorbidities, n(%)     
Presence of comorbidities 5,458 (77.32) 3,938 (82.08) <0.0001 
Congestive heart failure 85 (1.20) 55 (1.15) 0.775 
Arrythmia 194 (2.75) 175 (3.65) 0.006 
Valvular disease 111 (1.57) 93 (1.94) 0.133 
Peripheral vascular disease 27 (0.38) 114 (2.38) <0.0001 
Hypertension 3,590 (50.86) 2,485 (51.79) 0.317 
Pulmonary circulation disease 17 (0.24) 21 (0.44) 0.063 
Other neurologic disorder 29 (0.41) 28 (0.58) 0.182 
Chronic pulmonary disease 1,029 (14.58) 715 (14.90) 0.624 
Diabetes mellitus without chronic 
complications 1,767 (25.03) 1,216 (25.34) 0.701 
Diabetes mellitus with chronic complications 88 (1.25) 45 (0.94) 0.117 
Hypothyroidism 624 (8.84) 439  (9.15) 0.562 
Liver disease 459 (6.5) 711 (14.82) <0.0001 
Rheumatoid arthritis 78 (1.10) 54 (1.13) 0.917 
Coagulopathy 36 (0.51) 14 (0.29) 0.072 
Psychoses 66 (0.93) 33 (0.69) 0.147 
Depression 1,026 (14.53) 804 (16.76) 0.001 
Sleep apnea 2,246 (31.82) 1,710 (35.64) <0.0001 
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TABLE 14 (continued) 
 
  Hospital non-GBNC volume 
Patient Characteristics 
Low                        
(≤6,478 procs/yr)                        
(n=7,059) 
High                     
(>6,478 procs/yr)                          
(n=4,798  ) p-value 
Year     <0.0001 
2003 3,725 (52.77) 2,965 (61.80)   
2004 3,334 (47.23) 1,833 (38.20)  
*SE= standard error; total number of surgeons=160; total number of hospitals=81 
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TABLE 15: Comparison of provider characteristics (at patient-level), according to 
hospital volume of non-gastric bypass non-complex procedures in Florida, 
2003-2004 
 
  Hospital non-GBNC volume 
  
Low                         
(≤6,478 procs/yr)                        
(n=7,059) 
High                   
(>6,478 procs/yr)                          
(n=4,798  ) p-value 
Surgeon Characteristics     
Surgeon GB volume, n (%)   0.037 
>50 procs/yr 5,926 (83.95) 3,958 (82.49)   
≤50 procs/yr  1,133 (16.05) 840 (17.51)   
Hospital Characteristics     
Hospital volume based on principal 
procedures     
Hospital non-GBC volume, n (%)   <0.0001 
>2,743 procs/yr 582 (8.24) 4,003 (83.43)   
≤2,743 procs/yr 6,477 (91.76) 795 (16.57)   
Hospital GB volume, n (%)   <0.0001 
>125 procs/yr 4,433 (62.80) 3,329 (69.38)   
≤125 procs/yr 2,626 (37.20) 1,469 (30.62)   
Bed size, mean±SE 285.09±1.50 536.51±3.19 <0.0001 
Bed size, n (%)   <0.0001 
less than 200 2,111 (29.91) 0 (0.00)   
200-299 2,016 (28.56) 706 (14.71)   
300-399 1,506 (21.33) 389 (8.11)   
400-499 937 (13.27) 1,1119 (23.32)   
500+ 489 (6.93) 2,584 (53.86)   
Teaching hospital, n (%) 0 (0.00) 643 (13.40) <0.0001 
Major metropolitan area- county 
population ≥1 million, n (%) 4,703 (66.62) 3,175 (66.17) 0.610 
Ownership, n (%)   <0.0001 
For profit 5,204 (73.72) 1,496 (31.18)   
Government 192 (2.72) 256 (5.34)   
Not-for-profit 1,663 (23.56) 3,046 (63.48)   
Dichotomous   <0.0001 
For profit 5,204 (73.72) 1,496 (31.18)   
Not-for-profit or government 1,855 (26.28) 3,302 (68.82)   
*SE= standard error; total number of surgeons=160; total number of hospitals=81 
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TABLE 20: Unadjusted association between each independent variable and composite 
complications among patients undergoing gastric bypass in Florida, 2003 – 
2004 (for the surgeon volume study) 
 
  Composite Complications  
  Odds Ratio 95% CI, p-value 
Patient Characteristics     
Age 1.03 1.02-1.03, <0.0001 
Gender     
Female 1.00 referent 
Male  1.09 0.91-1.32, 0.352 
Race/Ethnicity     
Non-Hispanic White 1.00 referent 
Non-Hispanic Black 0.83 0.70-0.99, 0.041 
Hispanic 0.94 0.49-1.79, 0.851 
Other 1.21 0.77-1.91, 0.399 
Payer Type     
Medicare 1.75 1.19-2.56, 0.004 
Medicaid 0.78 0.50-1.24,0.297 
Private 1.00 referent 
Self pay/ underinsured 0.82 0.59-1.15, 0.253 
Other 0.59 0.39-0.91, 0.017 
Elixhauser Comorbidities     
No 1.00 referent 
Yes 1.75 1.24-2.46, 0.001 
Year     
2003 1.00 referent 
2004 0.98 0.71-1.36, 0.912 
Surgeon Characteristics     
Surgeon non-GBC volume      
≤50 procs/yr (lower 66th percentile) 1.00 referent 
>50 procs/yr (upper 33rd percentile) 1.19 0.74-1.91, 0.480 
Surgeon non-GBNC volume      
≤142 procs/yr (lower 66th percentile) 1.00 referent 
>142 procs/yr (upper 33rd percentile) 1.72 1.14-2.60, 0.009 
Surgeon GB volume     
≤50 procs/yr (lower 66th percentile) 1.00 referent 
>50 procs/yr (upper 33rd percentile) 0.70 0.53-0.94, 0.017 
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TABLE 20 (continued) 
 
  Composite Complications  
  Odds Ratio 95% CI, p-value 
Hospital Characteristics     
Hospital GB volume (based on 
principal procedures)    
≤125 procs/yr  1.00 referent 
>125 procs/yr 0.78 0.53-1.16, 0.221 
Hospital GB volume (based on 
principal and secondary procedures)      
≤125 procs/yr  1.00 referent 
>125 procs/yr 0.79 0.53-1.16, 0.225 
Bed size  1.00 0.1.00-1.001, 0.036 
Teaching status     
Non-teaching  1.00 referent 
Teaching 1.56 1.11-2.20, 0.009 
Major metropolitan area     
Hospital county population≥1 million 1.00 referent 
Hospital county population<1 million 0.60 0.37-0.97, 0.036 
Ownership     
For profit 1.00 referent 
Not-for-profit or government 1.30 0.86-1.98, 0.217 
total number of surgeons=108; total number of hospitals=73; CI= confidence interval 
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TABLE 21: Unadjusted association between each independent variable and technical 
complications among patients undergoing gastric bypass in Florida, 2003 – 
2004 (for the surgeon volume study) 
 
  Technical Complications  
  Odds Ratio 95% CI, p-value 
Patient Characteristics     
Age 1.03 1.025-1.04, p<0.0001 
Gender   
Female 1.00 referent 
Male  0.87 0.71-1.07, 0.179 
Race/Ethnicity   
Non-Hispanic White 1.00 referent 
Non-Hispanic Black 1.03 0.85-1.25, 0.757 
Hispanic 0.75 0.50-1.14, 0.181 
Other 1.04 0.66-1.64, 0.85 
Payer Type   
Medicare 1.55 1.09-2.21, 0.015 
Medicaid 0.76 0.43-1.32, 0.324 
Private 1.00 referent 
Self pay/ underinsured 0.84 0.59-1.21, 0.353 
other 0.73 0.59-1.21, 0.353 
Elixhauser Comorbidities   
No 1.00 referent 
Yes 1.37 0.98-1.93, 0.068 
Year   
2003 1.00 referent 
2004 1.05 0.89-1.23, 0.559 
Surgeon Characteristics   
Surgeon non-GBC volume    
≤50 procs/yr (lower 66th percentile) 1.00 referent 
>50 procs/yr (upper 33rd percentile) 0.94 0.64-1.37, 0.744 
Surgeon non-GBNC volume    
≤142 procs/yr (lower 66th percentile) 1.00 referent 
>142 procs/yr (upper 33rd percentile) 1.26 0.85-1.86, 0.247 
Surgeon GB volume   
≤50 procs/yr (lower 66th percentile) 1.00 referent 
>50 procs/yr (upper 33rd percentile) 0.70 0.53-0.95, 0.019 
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TABLE 21 (continued) 
 
  Technical Complications  
  Odds Ratio 95% CI, p-value 
Hospital Characteristics     
Hospital GB volume (based on 
principal procedures)    
≤125 procs/yr  1.00 referent 
>125 procs/yr 0.67 0.46-0.97, 0.035 
Hospital GB volume (based on 
principal and secondary procedures)      
≤125 procs/yr  1.00 referent 
>125 procs/yr 0.68 0.47-0.99, 0.045 
Bed size  1.00 0.99-1.001, 0.167 
Teaching status     
Non-teaching  1.00 referent 
Teaching 2.03 1.51-2.81, <0.0001 
Major metropolitan area     
Hospital county population≥1 million 1.00 referent 
Hospital county population<1 million 0.72 0.45-1.16, 0.177 
Ownership     
For profit 1.00 referent 
Not-for-profit or government 1.10 0.76-1.61, 0.611 
total number of surgeons=108; total number of hospitals=73; CI= confidence 
interval 
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TABLE 22: Unadjusted association between each independent variable and systemic 
complications among patients undergoing gastric bypass in Florida, 2003 – 
2004 (for the surgeon volume study) 
 
  Systemic Complications  
  Odds Ratio 95% CI, p-value 
Patient Characteristics     
Age 1.02 1.01-1.03, 0.0003 
Gender   
Female 1.00 referent 
Male  1.45 1.18-1.80, 0.0006 
Race/Ethnicity   
Non-Hispanic White 1.00 referent 
Non-Hispanic Black 0.62 0.49-0.77, <0.0001 
Hispanic 1.12 0.50-2.49, 0.787 
Other 1.24 0.78-1.96, 0.357 
Payer Type   
Medicare 1.86 1.21-2.85, 0.005 
Medicaid 0.76 0.49-1.18, 0.225 
Private 1.00 referent 
Self pay/ underinsured 0.77 0.49-1.19, 0.230 
Other 0.57 0.25-1.27, 0.167 
Elixhauser Comorbidities   
No 1.00 referent 
Yes 2.09 1.40-3.10, 0.0003 
Year   
2003 1.00 referent 
2004 0.72 0.64-0.82, <0.0001 
Surgeon Characteristics   
Surgeon non-GBC volume    
≤50 procs/yr (lower 66th percentile) 1.00 referent 
>50 procs/yr (upper 33rd percentile) 1.46 0.80-2.68, 0.221 
Surgeon non-GBNC volume    
≤142 procs/yr (lower 66th 
percentile) 1.00 referent 
>142 procs/yr (upper 33rd 
percentile) 2.05 1.11-3.77, 0.021 
Surgeon GB volume   
≤50 procs/yr (lower 66th percentile) 1.00 referent 
>50 procs/yr (upper 33rd percentile) 0.70 0.48-1.03, 0.069 
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TABLE 22 (continued) 
 
  Systemic Complications  
  Odds Ratio 95% CI, p-value 
Hospital Characteristics     
Hospital GB volume (based on 
principal procedures)    
≤125 procs/yr  1.00 referent 
>125 procs/yr 0.96 0.57-1.63, 0.885 
Hospital GB volume (based on 
principal and secondary procedures)      
≤125 procs/yr  1.00 referent 
>125 procs/yr 0.96 0.57-1.63, 0.892 
Bed size  1.00 0.99-1.001, 0.172 
Teaching status     
Non-teaching  1.00 referent 
Teaching 1.10 0.72-1.68, 0.652 
Major metropolitan area     
Hospital county population≥1 
million 1.00 referent 
Hospital county population<1 
million 0.52 0.29-0.95, 0.032 
Ownership     
For profit 1.00 referent 
Not-for-profit or government 1.52 0.79-2.93, 0.211 
total number of surgeons=108; total number of hospitals=73; CI= confidence interval 
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TABLE 23: Unadjusted association between each independent variable and length of stay 
among patients undergoing gastric bypass in Florida, 2003 – 2004 (for the 
surgeon volume study) 
 
  Length of Stay 
  Parameter Estimate§ 95% CI, p-value 
Patient Characteristics     
Age 1.01 1.007-1.011, <0.0001 
Gender     
Female 1.00 referent 
Male  1.09 1.04-1.14, 0.0004 
Race/Ethnicity     
Non-Hispanic White 1.00 referent 
Non-Hispanic Black 0.96 0.90-1.02, 0.164 
Hispanic 0.87 0.71-1.06, 0.171 
Other 1.03 0.84-1.27 
Payer Type     
Medicare 1.38 1.20-1.58, <0.0001 
Medicaid 1.03 0.87-1.22, 0.729 
Private 1.00 referent 
Self pay/ underinsured 0.90 0.81-0.99, 0.031 
Other 0.88 0.71-1.10, 0.268 
Elixhauser Comorbidities     
No 1.00 referent 
Yes 1.06 0.94-1.20, 0.342 
Year     
2003 1.00 referent 
2004 0.92 0.86-0.98, 0.007 
Surgeon Characteristics     
Surgeon non-GBC volume      
≤50 procs/yr (lower 66th percentile) 1.00 referent 
>50 procs/yr (upper 33rd percentile) 1.13 0.94-1.37, 0.201 
Surgeon non-GBNC volume      
≤142 procs/yr (lower 66th percentile) 1.00 referent 
>142 procs/yr (upper 33rd percentile) 1.18 0.99-1.42, 0.068 
Surgeon GB volume     
≤50 procs/yr (lower 66th percentile) 1.00 referent 
>50 procs/yr (upper 33rd percentile) 0.88 0.75-1.03, 0.115 
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TABLE 23 (continued) 
 
  Length of Stay 
  
Parameter 
Estimate
§
 95% CI, p-value 
Hospital Characteristics     
Hospital GB volume (based on 
principal procedures)    
≤125 procs/yr  1.00 referent 
>125 procs/yr 0.99 0.82-1.18, 0.879 
Hospital GB volume (based on 
principal and secondary 
procedures)      
≤125 procs/yr  1.00 referent 
>125 procs/yr 1.04 0.88-1.23, 0.644 
Bed size  1.00 0.99-1.00, 0.086 
Teaching status     
Non-teaching  1.00 referent 
Teaching 1.46 1.19-1.79, 0.0002 
Major metropolitan area     
Hospital county population≥1 
million 1.00 referent 
Hospital county population<1 
million 0.93 0.70-1.23, 0.604 
Ownership     
For profit 1.00 referent 
Not-for-profit or government 1.11 0.93-1.34, 0.253 
total number of surgeons=108; total number of hospitals=73; CI= confidence interval; 
§Parameter Estimate= incidence rate ratio 
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TABLE 24: Unadjusted association between each independent variable and composite 
complications among patients undergoing gastric bypass in Florida, 2003-
2004 (for the hospital volume study) 
 
  Composite Complications  
  Odds Ratio 95% CI, p-value 
Patient Characteristics     
Age 1.03 1.02-1.03,<0.0001 
Gender     
Female 1.00 referent 
Male  1.11 0.93-1.33, 0.256 
Race/Ethnicity     
Non-Hispanic White 1.00 referent 
Non-Hispanic Black 0.87 0.73-1.04, 0.130 
Hispanic 0.97 0.52-1.79, 0.912 
Other 1.17 0.75-1.82, 0.5003 
Payer Type     
Medicare 1.81 1.28-2.57,0.0007 
Medicaid 0.96 0.66-1.41, 0.842 
Private 1.00 referent 
Self pay/ underinsured 0.79 0.57-1.09, 0.161 
Other 0.59 0.38-0.92, 0.019 
Elixhauser Comorbidities     
No 1.00 referent 
Yes 1.76 1.26-2.45, 0.0009 
Year     
2003 1.00 referent 
2004 0.87 0.77-0.98, 0.020 
Surgeon Characteristics     
Surgeon GB volume     
≤50 procs/yr (lower 66th percentile) 1.00 referent 
>50 procs/yr (upper 33rd percentile) 0.71 0.54-0.93, 0.013 
Hospital Characteristics     
Hospital Volumes - based on principal 
procedures     
Hospital non-GBC volume      
≤2,743 procs/yr (lower 66th percentile) 1.00 referent 
>2,743 procs/yr (upper 33rd percentile) 1.11 0.71-1.74, 0.636 
Hospital non-GBNC volume      
≤6,478 procs/yr (lower 66th percentile) 1.00 referent 
>6,478 procs/yr (upper 33rd percentile) 0.89 0.56-1.40, 0.601 
Hospital GB volume (based on principal 
procedures)      
≤125 procs/yr  1.00 referent 
>125 procs/yr 0.78 0.53-1.15, 0.217 
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TABLE 24 (continued) 
 
  Composite Complications  
  Odds Ratio 95% CI, p-value 
Hospital Volumes - based on principal 
and secondary procedures     
Hospital non-GBC volume      
≤4,617 procs/yr (lower 66th percentile) 1.00 referent 
>4,617 procs/yr (upper 33rd percentile) 1.19 0.75-1.86, 0.459 
Hospital non-GBNC volume      
≤18,082 procs/yr (lower 66th percentile) 1.00 referent 
>18,082 procs/yr (upper 33rd percentile) 0.95 0.61-1.46, 0.809 
Hospital GB volume       
≤125 procs/yr  1.00 referent 
>125 procs/yr 0.79 0.54-1.15, 0.218 
Bed size  1.00 1.000-1.001, 0.028 
Teaching status     
Non-teaching  1.00 referent 
Teaching 1.66 1.17-2.36, 0.004 
Major metropolitan area     
Hospital county population≥1 million 1.00 referent 
hospital county population<1 million 0.60 0.38-0.94, 0.029 
Ownership     
For profit 1.00 referent 
Not-for-profit or government 1.28 0.85-1.93, 0.228 
total number of surgeons=160; total number of hospitals=81; CI= confidence interval 
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TABLE 25: Unadjusted association between each independent variable and technical 
complications among patients undergoing gastric bypass in Florida, 2003-
2004 (for the hospital volume study) 
 
  Technical Complications  
  Odds Ratio 95% CI, p-value 
Patient Characteristics     
Age 1.03 1.02-1.04, <0.0001 
Gender     
Female 1.00 referent 
Male  0.88 0.73-1.07, 0.2001 
Race/Ethnicity     
Non-Hispanic White 1.00 referent 
Non-Hispanic Black 1.09 0.91-1.30, 0.372 
Hispanic 0.78 0.52-1.17, 0.230 
Other 0.99 0.63-1.55, 0.965 
Payer Type     
Medicare 1.61 1.16-2.24, 0.004 
Medicaid 0.96 0.62-1.47, 0.839 
Private 1.00 referent 
Self pay/ underinsured 0.81 0.57-1.56, 0.248 
other 0.72 0.49-1.06, 0.0969 
Elixhauser Comorbidities     
no 1.00 referent 
yes 1.38 0.98-1.93, 0.062 
Year     
2003 1.00 referent 
2004 1.06 0.908-1.24, 0.458 
Surgeon Characteristics     
Surgeon GB volume     
≤50 procs/yr (lower 66th percentile) 1.00 referent 
>50 procs/yr (upper 33rd percentile) 0.71 0.53-0.95, 0.023 
Hospital Characteristics     
Hospital Volumes - based on principal 
procedures     
Hospital non-GBC volume      
≤2,743 procs/yr (lower 66th percentile) 1.00 referent 
>2,743 procs/yr (upper 33rd percentile) 0.92 0.63-1.34, 0.650 
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TABLE 25 (continued) 
 
  Technical Complications  
  Odds Ratio 95% CI, p-value 
Hospital non-GBNC volume      
≤6,478 procs/yr (lower 66th percentile) 1.00 referent 
>6,478 procs/yr (upper 33rd percentile) 0.82 0.54-1.22, 0.312 
Hospital GB volume (based on 
principal procedures)    
≤125 procs/yr  1.00 referent 
>125 procs/yr 0.65 0.46-0.94, 0.026 
Hospital Volumes - based on principal 
and secondary procedures   
Hospital non-GBC volume    
≤4,617 procs/yr (lower 66th percentile) 1.00 referent 
>4,617 procs/yr (upper 33rd percentile) 0.98 0.66-1.45, 0.910 
Hospital non-GBNC volume    
≤18,082 procs/yr (lower 66th 
percentile) 1.00 referent 
>18,082 procs/yr (upper 33rd 
percentile) 0.87 0.59-1.27, 0.466 
Hospital GB volume     
≤125 procs/yr  1.00 referent 
>125 procs/yr 0.66 0.46-0.95, 0.026 
Bed size  1.00 0.99-1.001, 0.122 
Teaching status   
non-teaching  1.00 referent 
teaching 2.20 1.56-3.10, <0.0001 
Major metropolitan area   
hospital county population≥1 million 1.00 referent 
hospital county population<1 million 0.69 0.44-1.10, 0.121 
Ownership   
for profit 1.00 referent 
not-for-profit or government 1.10 0.76-1.58, 0.613 
total number of surgeons=160; total number of hospitals=81; CI= confidence interval 
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TABLE 26: Unadjusted association between each independent variable and systemic 
complications among patients undergoing gastric bypass in Florida, 2003-
2004 (for the hospital volume study) 
 
  Systemic Complications  
  Odds Ratio 95% CI, p-value 
Patient Characteristics     
Age 1.02 1.01-1.03, <0.0001 
Gender     
Female 1.00 referent 
Male  1.49 1.21-1.82, 0.0001 
Race/Ethnicity     
Non-Hispanic White 1.00 referent 
Non-Hispanic Black 0.63 0.51-0.79, <0.0001 
Hispanic 1.13 0.52-2.45, 0.755 
Other 1.21 0.77-1.91, 0.412 
Payer Type     
Medicare 1.91 1.30-2.81, 0.0009 
Medicaid 0.93 0.63-1.38, 0.718 
Private 1.00 referent 
Self pay/ underinsured 0.74 0.48-1.13, 0.164 
Other 0.56 0.25-1.26, 0.164 
Elixhauser Comorbidities     
No 1.00 referent 
Yes 2.10 1.43-3.09, 0.0001 
Year     
2003 1.00 referent 
2004 0.72 0.64-0.82, <0.0001 
Surgeon Characteristics     
Surgeon GB volume     
≤50 procs/yr (lower 66th percentile) 1.00 referent 
>50 procs/yr (upper 33rd percentile) 0.71 0.50-1.10, 0.0614 
 
 
 
 
 
 
 
 
 
 
 
128 
TABLE 26 (continued) 
 
  Systemic Complications  
  Odds Ratio 95% CI, p-value 
Hospital Characteristics     
Hospital Volumes - based on principal 
procedures     
Hospital non-GBC volume      
≤2,743 procs/yr (lower 66th percentile) 1.00 referent 
>2,743 procs/yr (upper 33rd percentile) 1.34 0.69-2.60, 0.383 
Hospital non-GBNC volume      
≤6,478 procs/yr (lower 66th percentile) 1.00 referent 
>6,478 procs/yr (upper 33rd percentile) 1.03 0.55-1.96, 0.917 
Hospital GB volume (based on principal 
procedures)      
≤125 procs/yr  1.00 referent 
>125 procs/yr 1.01 0.60-1.69, 0.961 
Hospital Volumes - based on principal 
and secondary procedures     
Hospital non-GBC volume      
≤4,617 procs/yr (lower 66th percentile) 1.00 referent 
>4,617 procs/yr (upper 33rd percentile) 1.46 0.75-2.84, 0.262 
Hospital non-GBNC volume      
≤18,082 procs/yr (lower 66th percentile) 1.00 referent 
>18,082 procs/yr (upper 33rd percentile) 1.10 0.59-2.06, 0.756 
Hospital GB volume       
≤125 procs/yr  1.00 referent 
>125 procs/yr 1.01 0.60-1.70, 0.962 
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TABLE 26 (continued) 
 
  Systemic Complications  
  Odds Ratio 95% CI, p-value 
Bed size  1.00 0.99-1.001, 0.158 
Teaching status     
Non-teaching  1.00 referent 
Teaching 1.09 0.72-1.65, 0.680 
Major metropolitan area     
Hospital county population≥1 
million 1.00 referent 
Hospital county population<1 
million 0.54 0.30-0.96, 0.036 
Ownership     
For profit 1.00 referent 
Not-for-profit or government 1.50 0.79-2.84, 0.215 
 total number of surgeons=160; total number of hospitals=81; CI= confidence interval 
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TABLE 27: Unadjusted association between each independent variable and length of stay 
among patients undergoing gastric bypass in Florida, 2003-2004 (for the 
hospital volume study) 
 
  Length of Stay 
  
Parameter 
Estimate
§
 95% CI, p-value 
Patient Characteristics     
Age 1.01 1.007-1.011, <0.0001 
Gender   
Female 1.00 referent 
Male  1.09 1.04-1.14, 0.0003 
Race/Ethnicity   
Non-Hispanic White 1.00 referent 
Non-Hispanic Black 0.97 0.92-1.03, 0.325 
Hispanic 0.88 0.73-1.07, 0.201 
Other 1.03 0.85-1.25, 0.785 
Payer Type   
Medicare 1.40 1.23-1.59, <0.0001 
Medicaid 1.08 0.92-1.28, 0.342 
Private 1.00 referent 
Self pay/ underinsured 0.89 0.81-0.98, 0.017 
Other 0.87 0.70-1.09, 0.229 
Elixhauser Comorbidities   
No 1.00 referent 
Yes 1.07 0.95-1.09, 0.229 
Year   
2003 1.00 referent 
2004 0.93 0.88-0.98, 0.006 
Surgeon Characteristics   
Surgeon GB volume   
≤50 procs/yr (lower 66th percentile) 1.00 referent 
>50 procs/yr (upper 33rd percentile) 0.89 0.76-1.03, 0.115 
Hospital Characteristics   
Hospital Volumes - based on principal 
procedures   
Hospital non-GBC volume    
≤2,743 procs/yr (lower 66th percentile) 1.00 referent 
>2,743 procs/yr (upper 33rd percentile) 1.16 0.98-1.39, 0.089 
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TABLE 27 (continued) 
 
  Length of Stay 
  
Parameter 
Estimate
§
 95% CI, p-value 
Hospital non-GBNC volume      
≤6,478 procs/yr (lower 66th percentile) 1.00 referent 
>6,478 procs/yr (upper 33rd percentile) 1.12 0.91-1.37, 0.283 
Hospital GB volume (based on principal 
procedures)    
≤125 procs/yr  1.00 referent 
>125 procs/yr 0.97 0.81-1.16, 0.739 
Hospital Volumes - based on principal and 
secondary procedures   
Hospital non-GBC volume    
≤4,617 procs/yr (lower 66th percentile) 1.00 referent 
>4,617 procs/yr (upper 33rd percentile) 1.26 1.06-1.49, 0.008 
Hospital non-GBNC volume  1.00 referent 
≤18,082 procs/yr (lower 66th percentile) 1.00 referent 
>18,082 procs/yr (upper 33rd percentile) 1.17 0.98-1.40, 0.082 
Hospital GB volume     
≤125 procs/yr  1.00 referent 
>125 procs/yr 1.02 0.86-1.20, 0.840 
Bed size  1.00 0.99-1.00, 0.1005 
Teaching status   
Non-teaching  1.00 referent 
Teaching 1.41 1.15-1.73, 0.0008 
Major metropolitan area   
Hospital county population≥1 million 1.00 referent 
Hospital county population<1 million 0.92 0.70-1.21, 0.561 
Ownership   
For profit 1.00 referent 
Not-for-profit or government 1.09 0.92-1.30, 0.329 
total number of surgeons=160; total number of hospitals=81; CI=confidence interval; §Parameter 
Estimate= incidence rate ratio 
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TABLE 28: Model fit assessment for the surgeon volume study 
 
Outcomes 
GEE model 
Link, Variance 
Function 
Patients 'p'  and 
no. of groups- 
hospitals 'h' used 
in the model 
Working 
correlation 
structure Cluster QIC* 
Composite 
Complications                                                                                                      
logit,  binomial p=11,363, h=73 exchangeable hospital 10,526.47 
logit,  binomial p=11,363, h=73 independent hospital 10,510.64 
Technical 
Complications                                                                                                      
logit,  binomial p=11,363, h=73 exchangeable hospital 7,752.22 
logit,  binomial p=11,363, h=73 independent hospital 7,728.01 
Systemic 
Complications                                                                                                      
logit,  binomial p=11,363, h=73 exchangeable hospital 7,224.07 
logit,  binomial p=11,363, h=73 independent hospital 7,183.46 
Length of Stay                                                                                                        
log , negative 
binomial p=11,363, h=73 exchangeable hospital 2,652.26 
log , negative 
binomial p=11,363, h=73 independent hospital 2,597.10 
log , Poisson p=11,363, h=73 independent hospital 15,451.57 
log , Gaussian p=11,363, h=73 independent hospital 126,184.43 
identity , 
Gaussian p=11,363, h=73 independent hospital 126,169.44 
*QIC= Quasi-likelihood under the independence model criterion, Lower QIC value better is the model 
fit; GEE Model - Surgeon non-GBC volume + Surgeon non-GBNC volume + Surgeon GB volume  + 
Hospital GB volume (principal procedures) + age + male + Black + Hispanic + other race + Medicare + 
Medicaid + self/uninsured + other insurance + presence of comorbidities + year + teaching + not-for-
profit or government + county population less than 1million + beds 
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TABLE 29: Model fit assessment for the hospital volume study 
 
Outcomes 
GEE model Link, 
Variance Function 
Patients 'p'  and 
no. of groups- 
hospitals 'h' used 
in the model 
Working 
correlation 
structure Cluster QIC* 
Composite 
Complications                                                                                                      
logit,  binomial p=11,857, h=81 exchangeable hospital 11083.11 
logit,  binomial p=11,857, h=81 independent hospital 11,064.38 
Technical 
Complications                                                                                                      
logit,  binomial p=11,857, h=81 exchangeable hospital 8,194.87 
logit,  binomial p=11,857, h=81 independent hospital 8,147.64 
Systemic 
Complications                                                                                                      
logit,  binomial p=11,857, h=81 exchangeable hospital 7,601.47 
logit,  binomial p=11,857, h=81 independent hospital 7,577.59 
Length of Stay                                                                                                        
log , negative 
binomial p=11,857, h=81 exchangeable hospital 2,940.20 
log , negative 
binomial p=11,857, h=81 independent hospital 2,876.68 
log , Poisson p=11,857, h=81 independent hospital 17,161.30 
log , Gaussian p=11,857, h=91 independent hospital 140,242.04 
identity , Gaussian p=11,857, h=91 independent hospital 140,262.23 
*QIC= Quasi-likelihood under the independence model criterion, Lower QIC value better is the model fit;  
GEE Model - Hospital non-GBC volume (based on principal procedures) + Hospital non-GBNC volume 
(based on principal procedures) + Surgeon GB volume + Hospital GB volume (based on principal 
procedures) + age + male + Black + Hispanic + other race + Medicare + Medicaid + self/uninsured + other 
insurance + presence of comorbidities + year + teaching + not-for-profit or government + county population 
less than 1million + beds 
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TABLE 38: Unadjusted association between each independent variable and composite 
complications among patients undergoing gastric bypass in Florida, 2003-
2004 (stratified by surgeon gastric bypass volume) 
 
  Surgeon Gastric Bypass Volume 
Characteristics 
Low (≤50 procs/yr)                                  
n=1,699 
High (>50 procs/yr)                                                    
n=9,664 
Odds Ratio 95% CI, p-value Odds Ratio 95% CI, p-value 
Patient Characteristics       
Age 1.04 
1.03-1.05, 
p<0.0001 1.025 
1.02-1.03, 
p<0.0001 
Gender       
Female 1.00 referent 1.00 referent 
Male  1.09 1.61-1.93, 0.774 1.11 0.92-1.34, 0.280 
Race/Ethnicity       
Non-Hispanic White 1.00 referent 1.00 referent 
Non-Hispanic Black 0.93 0.63-1.97, 0.704 0.82 0.72-0.94, 0.004 
Hispanic 0.84 0.43-1.63, 0.598 0.98 0.51-1.87, 0.945 
Other 0.92 0.41-2.06, 0.847 1.28 0.88-1.87, 0.198 
Payer Type       
Medicare 2.15 1.42-2.34, 0.0003 1.61 1.06-2.45, 0.027 
Medicaid 0.40 0.18-0.97, 0.027 0.89 0.54-1.46, 0.641 
Private 1.00 referent 1.00 referent 
Self pay/ underinsured 1.01 0.61-1.69, 0.954 0.77 0.52-1.12, 0.170 
Other 0.81 0.50-1.31, 0.395 0.59 0.27-1.28, 0.181 
Elixhauser Comorbidities       
No 1.00 referent 1.00 referent 
Yes 1.70 1.16-2.49, 0.007 1.76 1.26-2.45, 0.0008 
Year       
2003 1.00 referent 1.00 referent 
2004 0.98 0.71-1.36, 0.912 0.8 0.69-0.93, 0.004 
Surgeon Characteristics       
Surgeon non-GBC volume        
≤50 procs/yr (lower 66th 
percentile) 1.00 referent 1.00 referent 
>50 procs/yr (upper 33rd 
percentile) 0.78 0.53-1.15, 0.218 1.29 0.72-2.29, 0.390 
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TABLE 38 (continued) 
 
  Surgeon Gastric Bypass Volume 
Characteristics 
Low (≤50 procs/yr)                  
(n=1,699) 
High (>50 procs/yr)               
(n=9,664) 
Odds Ratio 95% CI, p-value Odds Ratio 95% CI, p-value 
Surgeon non-GBNC volume        
≤142 procs/yr (lower 66th 
percentile) 1.00 referent 1.00 referent 
>142 procs/yr (upper 33rd 
percentile) 1.12 0.78-1.60, 0.537 1.87 1.12-3.15, 0.018 
Hospital Characteristics       
Hospital GB volume (based 
on principal procedures)        
≤125 procs/yr  1.00 referent 1.00 referent 
>125 procs/yr 1.16 0.67-2.01, 0.588 0.79 0.54-1.17, 0.240 
Hospital GB volume (based 
on principal and secondary 
procedures)          
≤125 procs/yr  1.00 referent 1.00 referent 
>125 procs/yr 1.06 0.65-1.73, 0.810 0.80 0.54-1.19, 0.274 
Bed size  1.00 0.99-1.001, 0.491 1.00 1.00-1.001, 0.001 
Teaching status       
Non-teaching  1.00 referent 1.00 referent 
Teaching 1.01 0.65-1.58, 0.958 1.77 1.29-2.43, 0.0004 
Major metropolitan area       
Hospital county population≥1 
million 1.00 referent 1.00 referent 
Hospital county population<1 
million 0.68 0.45-1.01, 0.058 0.57 0.34-0.95, 0.032 
Ownership       
For profit 1.00 referent 1.00 referent 
Not-for-profit or government 1.13 0.75-1.70, 0.548 1.33 0.81-2.17, 0.257 
total number of surgeons=108; total number of hospitals=73; CI= confidence interval 
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TABLE 39: Unadjusted association between each independent variable and length of stay 
among patients undergoing gastric bypass in Florida, 2003 – 2004 (stratified 
by surgeon gastric bypass volume) 
 
  Surgeon  Gastric Bypass Volume 
Characteristics 
Low (≤50 procs/yr)                   
(n=1,699) 
High (>50 procs/yr)                
(n=9,664) 
Parameter 
Estimate
§
 95% CI, p-value 
Parameter 
Estimate
§
 95% CI, p-value 
Patient Characteristics         
Age 1.01 
1.005-1.014, 
<0.0001 1.009 
1.007-1.011, 
<0.0001 
Gender         
Female 1.00 referent 1.00 referent 
Male  1.08 0.923-1.25, 0.349 1.09 1.04-1.15, 0.0006 
Race/Ethnicity         
Non-Hispanic White 1.00 referent 1.00 referent 
Non-Hispanic Black 0.92 0.83-1.101, 0.088 0.97 0.92-1.03, 0.280 
Hispanic 0.90 0.70-1.16, 0.420 0.87 0.71-1.06, 0.186 
Other 1.03 0.70-1.52, 0.862 1.03 0.85-1.23, 0.790 
Payer Type         
Medicare 1.44 1.17-1.77, 0.0005 1.35 1.17-1.56, <0.0001 
Medicaid 1.17 0.81-1.69, 0.405 0.99 0.84-1.18, 0.950 
Private 1.00 referent 1.00 referent 
Self pay/ underinsured 0.79 0.70-0.9, 0.0004 0.92 0.83-1.02, 0.127 
Other 1.14 0.72-1.78, 0.580 0.86 0.70-1.07, 0.189 
Elixhauser Comorbidities         
No 1.00 referent 1.00 referent 
Yes 1.08 0.88-1.33, 0.441 1.05 0.93-1.19, 0.403 
Year         
2003 1.00 referent 1.00 referent 
2004 0.88 0.76-1.02, 0.088 0.92 0.86-0.99, 0.020 
Surgeon Characteristics         
Surgeon non-GBC volume          
≤50 procs/yr (lower 66th 
percentile) 1.00 referent 1.00 referent 
>50 procs/yr (upper 33rd 
percentile) 1.10 0.90-1.35, 0.336 1.13 0.90-1.44, 0.293 
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TABLE 39 (continued) 
 
  Surgeon  Gastric Bypass Volume 
Characteristics 
Low (≤50 procs/yr)                  
(n=1,699) 
High (>50 procs/yr)               
(n=9,664) 
Parameter 
Estimate
§
 95% CI, p-value 
Parameter 
Estimate
§
 95% CI, p-value 
Surgeon non-GBNC volume          
≤142 procs/yr (lower 66th 
percentile) 1.00 referent 1.00 referent 
>142 procs/yr (upper 33rd 
percentile) 1.02 0.86-1.22, 0.800 1.22 0.97-1.52, 0.086 
Hospital Characteristics         
Hospital GB volume (based 
on principal procedures)          
≤125 procs/yr  1.00 referent 1.00 referent 
>125 procs/yr 1.18 0.96-1.46, 0.118 0.99 0.84-1.18, 0.957 
Hospital GB volume (based 
on principal and secondary 
procedures)          
≤125 procs/yr  1.00 referent 1.00 referent 
>125 procs/yr 1.13 1.09-1.58, 0.004 1.03 0.88-1.22, 0.709 
Bed size  1.00 0.99-1.00, 0.110 1.00  0.99-1.00, 0.227 
Teaching status         
Non-teaching  1.00 referent 1.00 referent 
Teaching 1.29 1.01-1.65, 0.038 1.51 1.19-1.91, 0.0006 
Major metropolitan area         
Hospital county population≥1 
million 1.00 referent 1.00 referent 
Hospital county population<1 
million 1.19 0.95-1.50, 0.129 0.87 0.64-1.18, 0.371 
Ownership         
For profit 1.00 referent 1.00 referent 
Not-for-profit or government 1.15 0.90-1.46, 0.270 1.1 0.90-1.34, 0.339 
total number of surgeons=108; total number of hospitals=73; CI= confidence interval; §Parameter 
Estimate= incidence rate ratio 
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TABLE 40: Unadjusted association between each independent variable and composite 
complications among patients undergoing gastric bypass in Florida, 2003 – 
2004 (stratified by hospital gastric bypass volume) 
 
  Hospital Gastric Bypass Volume 
Characteristics 
Low (≤125 procs/yr)  
n=4,095 
High (>125 procs/yr)  
n=7,762 
Odds 
Ratio 
95% CI, p-
value 
Odds 
Ratio 95% CI, p-value 
Patient Characteristics         
Age 1.04 
1.028-1.042, 
<0.0001 1.02 1.01-1.03, <0.0001 
Gender         
Female 1.00 referent 1.00 referent 
Male  0.94 0.74-1.18, 0.714 1.23 0.97-1.55, 0.085 
Race/Ethnicity         
Non-Hispanic White 1.00 referent 1.00 referent 
Non-Hispanic Black 0.95 0.70-1.28, 0.740 0.84 0.68-1.04, 0.104 
Hispanic 1.04 0.67-1.62, 0.87 0.99 0.46-2.16, 0.982 
Other 0.78 0.44-1.39, 0.407 1.45 0.88-2.40, 0.1445 
Payer Type         
Medicare 2.21 
1.72-2.84, 
<0.0001 1.63 0.97-2.73, 0.063 
Medicaid 0.62 0.32-1.19, 0.152 1.19 0.80-1.77, 0.387 
Private 1.00 referent 1.00 referent 
Self pay/ underinsured 0.71 0.50-1.02, 0.061 0.84 0.52-1.36, 0.473 
Other 0.96 0.58-1.59, 0.887 0.42 0.25-0.71, 0.001 
Elixhauser 
Comorbidities         
No 1.00 referent 1.00 referent 
Yes 1.82 
1.29-2.58, 
0.0007 1.69 1.07-2.66, 0.024 
Year         
2003 1.00 referent 1.00 referent 
2004 0.95 0.77-1.18, 0.667 0.75 0.62-0.91, 0.004 
Surgeon 
Characteristics         
Surgeon GB volume         
≤50 procs/yr (lower 66th 
percentile) 1.00 referent 1.00 referent 
>50 procs/yr (upper 33rd 
percentile) 0.90 0.69-1.17, 0.423 0.57 0.39-0.81, 0.002 
 
 
 
 
 
 
 
 
 
 
 
 
155 
TABLE 40 (continued) 
 
  Hospital Gastric Bypass Volume 
Characteristics 
Low (≤125 procs/yr)  
n=4,095 
High (>125 procs/yr)  
n=7,762 
Odds 
Ratio 
95% CI, p-
value 
Odds 
Ratio 95% CI, p-value 
Hospital Characteristics         
Hospital Volumes - based 
on principal procedures         
Hospital non-GBC volume          
≤2,743 procs/yr (lower 66th 
percentile) 1.00 referent 1.00 referent 
>2,743 procs/yr (upper 33rd 
percentile) 1.06 0.73-1.53, 0.760 1.15 0.60-2.22, 0.676 
Hospital non-GBNC volume      
≤6,478 procs/yr (lower 66th 
percentile) 1.00 referent 1.00 referent 
>6,478 procs/yr (upper 33rd 
percentile) 0.88 0.62-1.25, 0.489 0.91 0.46-1.78, 0.780 
Bed size  1.00 
1.00-1.001, 
0.033 1.001 0.99-1.002, 0.087 
Teaching status     
Non-teaching  1.00 referent 1.00 referent 
Teaching 1.37 
0.84-2.22, 
0.205 1.87 1.27-2.76, 0.002 
Major metropolitan area     
Hospital county 
population≥1 million 1.00 referent 1.00 referent 
Hospital county 
population<1 million 0.83 
0.56-1.23, 
0.354 0.44 0.25-0.76, 0.003 
Ownership     
For profit 1.00 referent 1.00 referent 
Not-for-profit or 
government 1.00 
0.70-1.43, 
0.999 1.44 0.78-2.66, 0.242 
total number of surgeons=160; total number of hospitals=81; CI= confidence interval 
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TABLE 41: Unadjusted association between each independent variable and length of stay 
among patients undergoing gastric bypass in Florida, 2003 – 2004 (stratified 
by hospital gastric bypass volume) 
 
  Hospital Gastric Bypass Volume 
Characteristics 
Low (≤125 procs/yr)          
(n=4,095) 
High (>125 procs/yr)             
(n=7,762) 
Parameter 
Estimate
§
 95% CI, p-value 
Parameter 
Estimate
§
 95% CI, p-value 
Patient Characteristics         
Age 1.01 1.00-1.01, <0.0001 1.01 1.00-1.01, <0.0001 
Gender         
Female 1.00 referent 1.00 referent 
Male  1.17 1.04-1.20, 0.003 1.08 1.01-1.14, 0.018 
Race/Ethnicity         
Non-Hispanic White 1.00 referent 1.00 referent 
Non-Hispanic Black 0.92 0.85-1.00, 0.051 0.99 0.93-1.07, 0.936 
Hispanic 1.01 0.84-1.22, 0.926 0.85 0.67-1.07, 0.936 
Other 0.88 0.78-1.00, 0.050 1.12 0.88-1.43, 0.363 
Payer Type         
Medicare 1.56 1.25-1.94, <0.0001 1.32 1.14-1.52, 0.0001 
Medicaid 1.22 0.96-1.57, 0.118 1.06 0.86-1.20, 0.855 
Private 1.00 referent 1.00 referent 
Self pay/ underinsured 0.90 0.81-0.99, 0.037 0.89 0.77-1.03, 0.105 
other 1.10 0.93-1.32, 0.267 0.77 0.60-0.97, 0.028 
Elixhauser Comorbidities         
No 1.00 referent 1.00 referent 
Yes 1.11 1.01-1.23, 0.038 1.05 0.89-1.24, 0.594 
Year         
2003 1.00 referent 1.00 referent 
2004 0.91 0.83-1.00, 0.055 0.92 0.83-1.03, 0.141 
Surgeon Characteristics         
Surgeon GB volume         
≤50 procs/yr (lower 66th 
percentile) 1.00 referent 1.00 referent 
>50 procs/yr (upper 33rd 
percentile) 0.96 0.84-1.08, 0.464 1.22 0.97-1.54, 0.093 
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TABLE 41 (continued) 
 
  Hospital Gastric Bypass Volume 
Characteristics 
Low (≤125 procs/yr)          
(n=4,095) 
High (>125 procs/yr)             
(n=7,762) 
Parameter 
Estimate
§
 95% CI, p-value 
Parameter 
Estimate
§
 95% CI, p-value 
Hospital Characteristics         
Hospital Volumes - based 
on principal procedures         
Hospital non-GBC volume          
≤2,743 procs/yr (lower 
66th percentile) 1.00 referent 1.00 referent 
>2,743 procs/yr (upper 
33rd percentile) 1.06 0.86-1.32, 0.564 1.22 0.97-1.54, 0.093 
Hospital non-GBNC volume      
≤6,478 procs/yr (lower 
66th percentile) 1.00 referent 1.00 referent 
>6,478 procs/yr (upper 
33rd percentile) 1.17 0.89-1.53, 0.253 1.03 0.89-1.35, 0.405 
Bed size  1.00 1.00-1.00, 0.047 1.00 0.99-1.00, 0.435 
Teaching status     
Non-teaching  1.00 referent 1.00 referent 
Teaching 1.46 1.09-1.95, 0.011 1.36 1.14-1.62, 0.0006 
Major metropolitan area     
Hospital county 
population≥1 million 1.00 referent 1.00 referent 
Hospital county 
population<1 million 1.05 0.85-1.30, 0.648 0.84 0.55-1.29, 0.433 
Ownership     
For profit 1.00 referent 1.00 referent 
Not-for-profit or 
government 1.09 0.91-1.31, 0.327 1.09 0.84-1.40, 0.520 
total number of surgeons=160; total number of hospitals=81; CI= confidence interval; §Parameter 
Estimate= incidence rate ratio 
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CHAPTER 5: DISCUSSION 
 
 
This population-based study investigated the effect of surgeon and hospital 
volume of non-gastric bypass surgeries (both complex and non-complex) on in-hospital 
complications and LOS outcomes after gastric bypass surgery using 2003-2004 Florida 
hospital discharge data.  
Overall Findings 
This study provides insight into the specificity aspect of procedure volume–
outcome associations for gastric bypass procedures. The patients treated by general 
surgeons with high non-GBNC volume had a higher likelihood of in-hospital composite 
(one or more) complications and systemic complications than those treated by general 
surgeons with low non-GBNC volume. Although the effect of general surgeon‟s non-
GBNC volume was attenuated after accounting for general surgeon GB volume and 
hospital GB volume, the non-GBNC volume effect remained significant for both 
composite and systemic complications. Overall, general surgeon‟s non-GB (both 
complex and non-complex procedures) volume did not show statistically significant 
effects for technical complications or LOS after gastric bypass surgery. However, the 
effect of general surgeon‟s non-GBNC volume was more pronounced for composite 
complication and LOS when surgeons with high GB volume also performed high non-
GBNC procedures.
 
 
 
 
165 
The current study demonstrated that patients treated by general surgeons with 
high GB volume had a notably lower likelihood of an in-hospital composite (one or 
more) complication and a systemic complication. This finding is consistent with previous 
studies examining effect of surgeon volume on gastric bypass complications.
117, 119, 121, 123
 
The apparent effect of general surgeon‟s gastric bypass volume for composite 
complications after gastric bypass was slightly pronounced when accounting for hospital 
GB volume. Although the effect of general surgeon‟s GB volume was attenuated after 
accounting for hospital GB volume, the surgeon‟s GB volume effect remained significant 
for systemic complications (Table 48). 
The general surgeon‟s non-GB volume study results suggest that while general 
surgeon GB volume matters for in-hospital complications, the complexity of their overall 
surgical load also matters. The benefits of high volume of a procedure are restricted to 
that particular specific procedure performed by a general surgeon. In particular, the 
outcomes may improve if gastric bypass patients avoided surgeons with a high volume of 
non-complex procedures. As presented in the theoretical framework in Chapter 2 of this 
study, procedure-specific volume – a structural component of care- is an important 
determinant of short-term outcomes. It is possible that GB-specific volume is correlated 
with processes of care, for example, in the context of the theoretical framework: 
structure-process-outcomes, general surgeons performing large number of GB procedures 
could be more familiar with providing optimal treatment for in-hospital complications.
148, 
195
  
Alternatively, high GB volume general surgeons may work with well-experienced 
operating staff, for example, nurses play an important role in the early identification of 
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postoperative complications and previous studies have demonstrated that the patterns of 
nurse staffing might influence patient mortality from a surgery.
196, 197
 Thus, the operating 
team might influence the effect of general surgeon‟s procedure specific volume-outcome 
association, especially for those general surgeons who perform large number of both GB 
and non-GB non-complex procedures. Most patients undergoing gastric bypass do not 
require very intensive postoperative management, and the length of stay is typically 
around 3 days. Thus, the role of surgeon procedure-specific volume in the outcome of 
this procedure is intuitively congruent.  
The findings for the hospital‟s non-GB volume (based on principal procedures) 
study indicated that the patients treated at hospitals with high non-GBNC volume had a 
lower likelihood of in-hospital composite (one or more) complications and technical 
complications than those treated at hospitals with low non-GBNC volume. This protective 
effect of hospital‟s non-GBNC volume did not change even after accounting for hospital 
GB volume and surgeon GB volume for both composite and technical complications. 
Although the protective effect for patients treated at hospitals with high non-GBNC 
volume on composite complications remained significant when stratified by hospitals 
with high (vs. low) GB volume, the effect was more pronounced for composite 
complications when hospitals with high GB volume also performed high non-GBNC 
procedures. However, the study did not find any significant association between 
hospital‟s non-GBC volume and in-hospital complications or LOS. This result is 
consistent with earlier observations for other complex procedures shown in the study by 
Allareddy et al., where the researchers found that hospital volume levels for pancreatic 
resection or esophagectomy did not influence in-hospital mortality following CABG, 
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PCI, and AAA. Similarly, hospital volumes for CABG, PCI, and AAA did not influence 
the outcomes for pancreatic resection or esophagectomy. The intermediate outcomes such 
as in-hospital complications are correlated with in-hospital mortality, which is an ultimate 
outcome
126
  Overall, hospital‟s non-GB (both complex and non-complex procedures) 
volume did not show statistically significant effect for systemic complications and LOS 
after gastric bypass surgery (Table 49). 
In addition, the study demonstrated that the patients treated at hospitals with high 
GB volume had a notably lower likelihood of an in-hospital technical complication 
(Table 49). This finding is consistent with previous studies examining effect of hospital 
GB volume on bariatric surgical complications including wound infection.
120, 121, 123
 The 
apparent effect of hospital‟s gastric bypass volume on gastric bypass technical 
complications was slightly pronounced when accounting for surgeon‟s GB volume. 
Likewise, the patients treated by surgeons with high GB volume had a notably lower 
likelihood of an in-hospital composite and systemic complication. This result is 
consistent with the gastric bypass volume-outcome association studies in the literature.
121, 
123
 
When considering hospital‟s non-GB volume based on principal and secondary 
procedures, the findings of hospitals with high non-GBNC volume showing a protective 
effect on composite and technical complications were consistent with the results using 
hospital‟s non-GB volume based on principal procedures only. In contrast to the results 
using hospital‟s non-GB volume based on principal procedures only, the patients 
operated at hospitals with high non-GBC volume showed a higher likelihood of a 
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composite complication and increased LOS outcome when hospital‟s non-GB volume 
was based on principal and secondary procedures (Table 49). 
Thus, the hospital‟s non-GB volume study results suggest that while complexity 
of hospital volume may not matter so much, the overall hospital procedural volume, i.e., 
hospital scale, matters. When considering the total hospital volume, the proportion of 
non-GBC and GB volume is relatively small compared to the proportion of non-complex 
procedures performed at a hospital. This indicates that economies of scale achieved 
through overall larger volume could possibly be associated with better outcomes for 
gastric bypass. This could explain the protective effect of hospital‟s non-GB NC volume 
on in-hospital complications for gastric bypass found in the study.  
The focus of this study is limited to examining the overall hospital volume 
segregated into three components: GB volume, non-GBC volume, and non-GBNC volume. 
This absolute hospital volume is possibly a product of procedures performed by surgeons, 
surgical staff including anesthesiologists, and nursing staff. Therefore, for gastric bypass 
procedure, the absolute hospital volume measure may be limited in explaining the effect 
of non-GBC volume on increased likelihood of composite complication and increased 
LOS outcomes, when hospital volume was computed based on principal and secondary 
procedures. For example, consider hospitals „A‟ and „B‟ performing the same total 
number of procedures (i.e., same total volume- say 1,000 procedures) and same 
proportion of complex procedures (say 300 procedures) and non-complex procedures 
(say 700 procedures). Only a small number of surgeons are performing those 300 
complex procedures at hospital „A‟ indicating larger volume per surgeon, while a large 
number of surgeons are performing those 300 complex procedures at hospital „B‟ 
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indicating smaller volume per surgeon. Thus, it is possible that the hospitals with non-
GBC volume in this study reflect the group of those hospitals performing large number of 
complex procedures but having smaller non-GBC volume per surgeon- similar to hospital 
„B‟ described in the above example. The GB, non-GBC, and non-GBNC hospital volume 
per surgeon could possibly be a better measure that would capture the volume and 
complexity effect together. Another plausible explanation at patient-level could be that 
although comorbidities were accounted for in the model, the level of severity of the 
illness could not be adjusted in the model due to the non-availability of patient severity or 
acuity data. Accounting for this unmeasured patient acuity might attenuate the effect for 
patients operated at hospitals that perform high non-GBC volume. 
Limitations and Strengths 
There were several limitations for the studies in this dissertation. 
1) Non-differential Misclassification - Surgeon volume (GB as well as non-GB) and 
hospital volume (GB as well as non-GB) were abstracted from the Florida hospital 
discharge data. Although it does not appear that there would be any misclassification 
regarding the exposure (i.e. volume) status, coding errors could lead to possible 
misclassification. Thus, low volume surgeons might be coded as high volume surgeons 
and vice-a-versa. Likewise, low volume hospitals would be coded as high volume 
hospitals and vice-a-versa. These errors would most likely bias the results toward null. 
In-hospital complications were identified through secondary ICD-9-CM diagnosis codes, 
and LOS was identified through length of stay variable from the Florida hospital 
discharge data. Thus, it is possible that in-hospital complications after gastric bypass 
might be coded as the primary diagnoses instead of secondary. These misclassifications 
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of outcomes would most likely bias the results toward null. However, coding errors are 
unlikely for both volume and outcome in the study, as volume is computed based on 
hospital and surgeon identifier in the dataset and to address coding for outcomes, the 
hospital discharge data are abstracted from medical records with the help of experienced 
coders.
154
  
2) Bias- This cross-sectional study provides a snap-shot of the exposure-outcome 
relationship at patient-level. Survivor bias may be unlikely, as this study considered both 
patients who died after the gastric bypass procedure and patients who survived with 
postoperative complications. Although exposure (surgeon non-GBC volume and/or 
hospital non-GBC volume) and adverse outcomes were assessed simultaneously, temporal 
bias may be unlikely because surgeon non-GBC volume and/or hospital non-GBC volume 
would remain steady over time and it would precede the outcomes. In addition, this study 
considered current volume (volume in a year) and controlled for year in the model to 
account for any possible variation in volume across two years. 
Information bias, such as recall bias and interviewer‟s bias is unlikely, as the 
exposure and outcome data will be obtained through hospital discharge records and these 
are not collected through survey interviews. If exposure and adverse outcomes (for 
example- LOS and postoperative complications) data were collected through 
interviewing patients undergoing gastric bypass then, there could be a possible 
interviewer bias as well as recall bias. This could possibly under/ overestimate the true 
association. However, this bias appears to be quite unlikely in the present study. Finally, 
the Florida Inpatient Discharge Data does not allow identifying unique patients. 
Therefore, the unit of our analysis was inpatient-discharge, not patient. However, it is 
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extremely unlikely that the same patient would have had multiple discharges with GB 
during a given calendar year.   
3) Confounding- A number of variables, suspected and known as potential confounders 
between the surgeon- and/or hospital- non-GBC volume and adverse outcomes were 
controlled for in this study. However, there is the possibility of unmeasured potential 
confounding that could mask the true relationship between the surgeon- and/or hospital- 
non-GBC volume and adverse outcomes. This could lead to biased estimates and would 
under/overestimate the effect (i.e., odds ratios or beta values).  
Patient-level factors that are not available in the data and thus, were not controlled 
for included lifestyle or behavioral factors such as smoking, medications, dietary 
interventions or exercise, or other patient self-management techniques that occur in the 
community outside the influence of the health care system, or possibly as a result of 
interactions between the patient and the health care system. For example, patients who 
are likely to engage in unhealthy behaviors, such as smoking or improper diet, might be 
more likely to experience in-hospital mortality or in-hospital complications. Similarly, 
such patients might be less likely to get operated by high volume surgeons or at high 
volume hospitals. Thus, failure to control for these baseline behaviors could lead to bias, 
i.e., overestimate the true association between high volume surgeons and outcomes. 
However, this may not be a serious omitted variable bias due to two possible reasons: (1) 
prior to gastric bypass surgery it is important that patients quit smoking and engage in 
healthy diet, (2) there is no clear evidence that such patients are less likely to receive 
surgery from high volume surgeons.    
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Surgeon/ hospital- level unmeasured factors might also be possible confounders in 
the study. For example, surgeon‟s years from board certification might be positively 
correlated to surgeon‟s high volume, as increasing years from board certification is 
indicative of more experience and potentially high volume. Similarly, surgeon‟s years 
from board certification might be negatively correlated to in-hospital complications for 
their patients, i.e., surgeons with more experience will have fewer adverse outcomes for 
their patients. Thus, if the surgeon‟s number of years from board certification variable is 
not controlled, it could bias the coefficient on surgeon volume downward in the model of 
in-hospital complications. However, as indicated earlier, volume might be a proxy for 
years from board certification and was included in the analyses. 
4)  Generalizability- This population-based study used Florida-State hospital discharge 
data. Thus, the results could likely be generalized to patients ≥ 18 years of age 
undergoing gastric bypass in other areas of the U.S. that have surgeon- and/or hospital- 
non-GBC  and  non-GBNC volume mixes similar to that of Florida. 
The studies in this dissertation also had number of strengths. 
1) As previously mentioned, although very few studies on hospitals‟ non-specific 
procedural volume- outcome association have been conducted, there is no previous 
research related to the impact of provider‟s (surgeon and hospital) non-specific volume 
(both complex and non-complex procedures) on adverse outcomes after gastric bypass.  
This is a first study that provides insights into the associations between providers‟ total 
(non-specific and specific) volume and adverse in-hospital outcomes for gastric bypass 
patients. 
 
 
 
 
173 
2) The use of work RVU component, as a proxy for complexity, to segment provider‟s 
total practice load into complex and non-complex procedures aids in further 
understanding of the provider‟s procedural specificity aspect by incorporating complexity 
of procedures performed by the providers.  
3) The studies in this dissertation used Florida hospital discharge data to generate 
population-based information on the provider total volume-outcome association.  Both 
Urbach et al. and Allareddy et al. examined the specificity of only hospital volume–
outcome associations for surgical procedures in Canada using secondary data (1994-
1999) and in United States using National Inpatient Sample (2000-2003), respectively. 
Thus, the studies in this dissertation would strengthen the literature on hospital non-
specific volume-outcome association by using relatively recent data (2003-2004). Unlike 
the National Inpatient Sample data where there are variations within states and hospitals 
with regards to reporting surgeon identifiers,
198
 the Florida hospital discharge data 
contains uniformly reported information on all data variables including surgeon 
identifiers.
199, 200
 This allows for the ability to study surgeons‟ non-specific volume-
outcome association. Therefore, the studies in this dissertation would augment the 
surgeon‟s specific volume-outcome literature by providing surgeon‟s total volume 
dimension to it. 
Significance 
The studies in the dissertation enhance current understanding of the volume-
outcome relationship by providing insights into the importance of procedure specificity 
and the composition of the total surgical practice in examining the volume-outcome 
relationship for general surgeons and hospitals. In particular, this dissertation work 
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developed a novel method of using work RVU, as a proxy measure for complexity, to 
segregate procedures into complex and non-complex for examining the volume-outcome 
association and further enhance the understanding of this association. In general, as the 
rates of morbid obesity continue to rise and so does the number of gastric bypass/bariatric 
surgeries performed in the United States, these studies provide a potential new dimension 
to aid policymakers, health insurers and healthcare providers in decision-making, 
especially, rethinking the volume-based regionalization policies adopted/debated for 
gastric bypass procedures. Thus, the development of population-based information on the 
relationship between “non-specific” volume and outcomes would be helpful to identify 
potential areas for quality improvement. 
Summary, Conclusions and Implications 
In summary, the analyses in this dissertation demonstrate that the likelihood of in-
hospital composite and systemic complications from GB procedures is increased 70% 
and 88% respectively, for patients operated by general surgeons that have high non-
gastric bypass non-complex surgical loads. Thus, in addition to confirming that general 
surgeons‟ GB volumes matter for in-hospital complications, the complexity of their 
overall procedural loads may also matter. When considering hospital non-gastric bypass 
volume, the likelihood of composite and technical complications from GB procedures is 
decreased by 49% and 40% for patients operated at hospitals that have high non-gastric 
bypass non-complex surgical loads. Thus, indicating that the overall scale may matter for 
hospitals to deliver better in-hospital outcomes for gastric bypass. Finally, if similar 
association for non-specific (both complex and non-complex) procedural volume and 
outcome is demonstrated across a wide range of relatively low volume but high risk 
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procedures, then researchers, purchasers, and policy makers might need to rethink the 
current volume-based quality improvement initiatives that are based only on the 
association demonstrated between the provider volume of a specific procedure alone and 
outcomes from that particular procedure. Therefore, the total provider practice volume in 
addition to the specific procedural volume may need to be considered in developing 
volume-based guidelines for selectively referring patients to high volume providers who 
typically perform such overall low volume high risk procedures. 
Future Research 
The studies in the dissertation provide a novel approach of using work RVU to 
identify complex and non-complex non-GB procedures. The validation of this approach 
using an expert panel is recommended. Based on the findings for general surgeon‟s and 
hospital‟s non-GB non-complex procedural volume on in-hospital outcomes, possible 
potential areas for future research could include: (1) profiling the provider (both hospital 
and surgeon) to characterize the complex and non-complex nature of the provider 
procedural case loads, and (2) examining the effect of hospital volume (both complex and 
non-complex) per surgeon on the outcomes for gastric bypass and/or other high-risk 
surgical procedures. The studies were focused on the total (GB, non-GBC and non-GBNC) 
procedural volume effect on short-term outcomes for gastric bypass. Future studies could 
investigate providers‟ total procedural volume complexity effect on short-term as well as 
long-term outcomes, such as readmission rates and long-term survival, for a range of 
certain other complex and high-risk surgical procedures. The analyses have only 
addressed the provider‟s total practice volume and GB outcome association, however, 
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examining disparities in the access to high GB and non-GB (both complex and non-
complex procedures) volume providers would be of interest. 
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APPENDIX A: DESCRIPTIVES - PROVIDER VOLUMES AND GASTRIC BYPASS 
OUTCOMES: A GRAPHICAL REPRESENTATION 
 
1. GB Complication Rates by High (vs. Low) Gastric Bypass Volume General 
Surgeons 
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3. GB Complication Rates by High (vs. Low) Non-GBNC Volume General Surgeons 
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4. GB Length of Stay by high (vs. low) General Surgeon Volumes 
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5. GB Complication Rates by High (vs. Low) Gastric Bypass Volume Hospitals 
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7. GB Complication Rates by High (vs. Low) Non-GBNC Volume Hospitals 
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8. GB Length of Stay by High (vs. Low) Hospital Volumes 
3.5
3.2
3.53.5 3.5
3.4
3
3.1
3.2
3.3
3.4
3.5
3.6
non-GBC non-GBNC GB
M
e
a
n
 l
e
n
g
th
 o
f 
st
a
y
 (
in
 d
a
y
s)
Hospital Volume
Low Volume
High Volume
 
non-GBC = non-gastric bypass complex procedures 
non-GBNC = non-gastric bypass non-complex procedures 
GB = gastric bypass 
 
 
